name,id,code,shortName,Indicator,formName,domainType,valueType,aggregationoperator,fieldMask,categoryCombo.id,class,data,type,Inverse
[GC7/H-KRCS/COMMIT/FINANCE] PR Commitments,JEYXa5x711c,GC7/H-KRCS/COMMIT/FINANCE,GC7/H-KRCS/COMMIT/FINANCE,Commitments,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/H-KRCS/CONDOMS-AMC/RESULT/COMMODITIES] Condoms AMC,aFK6b288CDm,GC7/H-KRCS/CONDOMS-AMC/RESULT/COMMODITIES,GC7/H-KRCS/CONDOMS-AMC/RESULT/COMMODITIES,Condoms AMC,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-KRCS/CONDOMS-BAL/RESULT/COMMODITIES] Condoms Ending Balance,vwtiyqGtRMc,GC7/H-KRCS/CONDOMS-BAL/RESULT/COMMODITIES,GC7/H-KRCS/CONDOMS-BAL/RESULT/COMMODITIES,Condoms Ending Balance,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-KRCS/CONDOMS-COMMENT/COMMENT/COMMODITIES] Condoms Comments,SXhkiEjXkox,GC7/H-KRCS/CONDOMS-COMMENT/COMMENT/COMMODITIES,GC7/H-KRCS/CONDOMS-COMMENT/COMMENT/COMMODITIES,Condoms Comments,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Products,Comment,,No
[GC7/H-KRCS/CONDOMS-PROC/RESULT/COMMODITIES] Condoms Under Procurement,qVdByBFDHgv,GC7/H-KRCS/CONDOMS-PROC/RESULT/COMMODITIES,GC7/H-KRCS/CONDOMS-PROC/RESULT/COMMODITIES,Condoms Under Procurement,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-KRCS/CONDOMS-SOR-D/RESULT/COMMODITIES] Condoms SOR Denominator,cR5gi2LHh9Q,GC7/H-KRCS/CONDOMS-SOR-D/RESULT/COMMODITIES,GC7/H-KRCS/CONDOMS-SOR-D/RESULT/COMMODITIES,Condoms SOR Denominator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-KRCS/CONDOMS-SOR-N/RESULT/COMMODITIES] Condoms SOR Numerator,fM6QowAocHr,GC7/H-KRCS/CONDOMS-SOR-N/RESULT/COMMODITIES,GC7/H-KRCS/CONDOMS-SOR-N/RESULT/COMMODITIES,Condoms SOR Numerator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-KRCS/CUM_BUDGET/FINANCE] PR Cumulative Budget,OtZHSRbaSPo,GC7/H-KRCS/CUM_BUDGET/FINANCE,GC7/H-KRCS/CUM_BUDGET/FINANCE,Cumulative Budget,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/H-KRCS/CUM_EXP_PR/FINANCE] PR Cumulative Funds Expensed by PR,Cr0s5ElP4R3,GC7/H-KRCS/CUM_EXP_PR/FINANCE,GC7/H-KRCS/CUM_EXP_PR/FINANCE,Cumulative Funds Expensed by PR,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/H-KRCS/CUM_EXP_SR/FINANCE] PR Cumulative Funds Expensed by Sub Recipients,j8iPnSChenl,GC7/H-KRCS/CUM_EXP_SR/FINANCE,GC7/H-KRCS/CUM_EXP_SR/FINANCE,Cumulative Funds Expensed by Sub Recipients,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/H-KRCS/CUM_FUNDS_DISB_PR/FINANCE] PR Cumulative Funds Disbursed to PR,AmPHSDGTjDn,GC7/H-KRCS/CUM_FUNDS_DISB_PR/FINANCE,GC7/H-KRCS/CUM_FUNDS_DISB_PR/FINANCE,Cumulative Funds Disbursed to PR,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/H-KRCS/CUM_FUNDS_DISB_SR/FINANCE] PR Cumulative Funds Disbursed to Sub Recipients,mGNEe6VjWR5,GC7/H-KRCS/CUM_FUNDS_DISB_SR/FINANCE,GC7/H-KRCS/CUM_FUNDS_DISB_SR/FINANCE,Cumulative Funds Disbursed to Sub Recipients,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/H-KRCS/CUM_SR_BUDGET/FINANCE] PR Cumulative Sub Recipients Budget Amount,QjsH8MgWs8w,GC7/H-KRCS/CUM_SR_BUDGET/FINANCE,GC7/H-KRCS/CUM_SR_BUDGET/FINANCE,Cumulative Sub Recipients Budget Amount,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/H-KRCS/FIN_NARR/FINANCE] PR Comments,wVD2Rgtx8vb,GC7/H-KRCS/FIN_NARR/FINANCE,GC7/H-KRCS/FIN_NARR/FINANCE,Comments,NUMBER,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Finance,,,No
[GC7/H-KRCS/FIN_RATING/RATING] PR Financial Rating,dRbbsMsGnIB,GC7/H-KRCS/FIN_RATING/RATING,GC7/H-KRCS/FIN_RATING/RATING,Financial Rating,NUMBER,AGGREGATE,TEXT,,,bjDvmb4bfuf,Rating,,,No
[GC7/H-KRCS/FIN_RATING_COMMENT/RATING] PR Financial Rating Comments,haHfZViW7IK,GC7/H-KRCS/FIN_RATING_COMMENT/RATING,GC7/H-KRCS/FIN_RATING_COMMENT/RATING,Financial Rating Comments,NUMBER,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Rating,,,No
[GC7/H-KRCS/FIN_RATING_END/RATING] PR Financial Rating End Date,YNOBFXiUdvJ,GC7/H-KRCS/FIN_RATING_END/RATING,GC7/H-KRCS/FIN_RATING_END/RATING,Financial Rating End Date,NUMBER,AGGREGATE,DATE,,,bjDvmb4bfuf,Rating,,,No
[GC7/H-KRCS/FIN_RATING_START/RATING] PR Financial Rating Start Date,ZIZwEDU56WP,GC7/H-KRCS/FIN_RATING_START/RATING,GC7/H-KRCS/FIN_RATING_START/RATING,Financial Rating Start Date,NUMBER,AGGREGATE,DATE,,,bjDvmb4bfuf,Rating,,,No
[GC7/H-KRCS/HIV I-14/COMMENT/IMPACT] # of new HIV infections per 1000 uninfected population,ZRYZFrbQeGx,GC7/H-KRCS/HIV I-14/COMMENT/IMPACT,GC7/H-KRCS/HIV I-14/COMMENT/IMPACT,# of new HIV infections per 1000 uninfected population,LONG_TEXT,AGGREGATE,LONG_TEXT,,Inverse,bjDvmb4bfuf,Program,Comment,Impact,No
[GC7/H-KRCS/HIV I-14/RESULT/IMPACT] # of new HIV infections per 1000 uninfected population,bnByxyfBc0w,GC7/H-KRCS/HIV I-14/RESULT/IMPACT,GC7/H-KRCS/HIV I-14/RESULT/IMPACT,# of new HIV infections per 1000 uninfected population,NUMBER,AGGREGATE,NUMBER,,Inverse,bjDvmb4bfuf,Program,Result,Impact,No
[GC7/H-KRCS/HIV I-14/TARGET/IMPACT] # of new HIV infections per 1000 uninfected population,q0HeDFo5bAb,GC7/H-KRCS/HIV I-14/TARGET/IMPACT,GC7/H-KRCS/HIV I-14/TARGET/IMPACT,# of new HIV infections per 1000 uninfected population,NUMBER,AGGREGATE,NUMBER,,Inverse,bjDvmb4bfuf,Program,Target,Impact,No
"[GC7/H-KRCS/HIV I-4/COMMENT/IMPACT] # of AIDS-related deaths per 100,000 population",AytchAc6UeD,GC7/H-KRCS/HIV I-4/COMMENT/IMPACT,GC7/H-KRCS/HIV I-4/COMMENT/IMPACT,"# of AIDS-related deaths per 100,000 population",LONG_TEXT,AGGREGATE,LONG_TEXT,,Inverse,bjDvmb4bfuf,Program,Comment,Impact,No
"[GC7/H-KRCS/HIV I-4/RESULT/IMPACT] # of AIDS-related deaths per 100,000 population",GEvuwuun5E0,GC7/H-KRCS/HIV I-4/RESULT/IMPACT,GC7/H-KRCS/HIV I-4/RESULT/IMPACT,"# of AIDS-related deaths per 100,000 population",NUMBER,AGGREGATE,NUMBER,,Inverse,bjDvmb4bfuf,Program,Result,Impact,No
"[GC7/H-KRCS/HIV I-4/TARGET/IMPACT] # of AIDS-related deaths per 100,000 population",aqnck5zoQXi,GC7/H-KRCS/HIV I-4/TARGET/IMPACT,GC7/H-KRCS/HIV I-4/TARGET/IMPACT,"# of AIDS-related deaths per 100,000 population",NUMBER,AGGREGATE,NUMBER,,Inverse,bjDvmb4bfuf,Program,Target,Impact,No
[GC7/H-KRCS/HIV I-6/COMMENT/IMPACT] Estimated % of children newly infected with HIV from MTCT among women living with HIV delivering in the past 12 months,DDd0Tsd9Iuw,GC7/H-KRCS/HIV I-6/COMMENT/IMPACT,GC7/H-KRCS/HIV I-6/COMMENT/IMPACT,Estimated % of children newly infected with HIV from MTCT among women living with HIV delivering in the past 12 months,LONG_TEXT,AGGREGATE,LONG_TEXT,,Inverse,bjDvmb4bfuf,Program,Comment,Impact,No
[GC7/H-KRCS/HIV I-6/RESULT/IMPACT] Estimated % of children newly infected with HIV from MTCT among women living with HIV delivering in the past 12 months,EfaXi5S7haT,GC7/H-KRCS/HIV I-6/RESULT/IMPACT,GC7/H-KRCS/HIV I-6/RESULT/IMPACT,Estimated % of children newly infected with HIV from MTCT among women living with HIV delivering in the past 12 months,NUMBER,AGGREGATE,PERCENTAGE,,Inverse,bjDvmb4bfuf,Program,Result,Impact,No
[GC7/H-KRCS/HIV I-6/TARGET/IMPACT] Estimated % of children newly infected with HIV from MTCT among women living with HIV delivering in the past 12 months,afLjVULlKYU,GC7/H-KRCS/HIV I-6/TARGET/IMPACT,GC7/H-KRCS/HIV I-6/TARGET/IMPACT,Estimated % of children newly infected with HIV from MTCT among women living with HIV delivering in the past 12 months,NUMBER,AGGREGATE,PERCENTAGE,,Inverse,bjDvmb4bfuf,Program,Target,Impact,No
"[GC7/H-KRCS/HIV O-10/COMMENT/OUTCOME] % of high risk AGYW (15-24) who say they used a condom the last time they had sex with a non-regular partner, of those who have had sex with such a partner in the last 12 months.",xmSRBHkrVIQ,GC7/H-KRCS/HIV O-10/COMMENT/OUTCOME,GC7/H-KRCS/HIV O-10/COMMENT/OUTCOME,"% of high risk AGYW (15-24) who say they used a condom the last time they had sex with a non-regular partner, of those who have had sex with such a partner in the last 12 months.",LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Outcome,No
"[GC7/H-KRCS/HIV O-10/RESULT/OUTCOME] % of high risk AGYW (15-24) who say they used a condom the last time they had sex with a non-regular partner, of those who have had sex with such a partner in the last 12 months.",Dlhl9uhmbzk,GC7/H-KRCS/HIV O-10/RESULT/OUTCOME,GC7/H-KRCS/HIV O-10/RESULT/OUTCOME,"% of high risk AGYW (15-24) who say they used a condom the last time they had sex with a non-regular partner, of those who have had sex with such a partner in the last 12 months.",NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Outcome,No
"[GC7/H-KRCS/HIV O-10/TARGET/OUTCOME] % of high risk AGYW (15-24) who say they used a condom the last time they had sex with a non-regular partner, of those who have had sex with such a partner in the last 12 months.",Qi8iqiQ9jYC,GC7/H-KRCS/HIV O-10/TARGET/OUTCOME,GC7/H-KRCS/HIV O-10/TARGET/OUTCOME,"% of high risk AGYW (15-24) who say they used a condom the last time they had sex with a non-regular partner, of those who have had sex with such a partner in the last 12 months.",NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Outcome,No
[GC7/H-KRCS/HIV O-16a/COMMENT/OUTCOME] % of men who have sex with men who avoid health care because of stigma and discrimination,H52SVtyNeBT,GC7/H-KRCS/HIV O-16a/COMMENT/OUTCOME,GC7/H-KRCS/HIV O-16a/COMMENT/OUTCOME,% of men who have sex with men who avoid health care because of stigma and discrimination,LONG_TEXT,AGGREGATE,LONG_TEXT,,Inverse,bjDvmb4bfuf,Program,Comment,Outcome,No
[GC7/H-KRCS/HIV O-16a/RESULT/OUTCOME] % of men who have sex with men who avoid health care because of stigma and discrimination,CB9DBJCpZj8,GC7/H-KRCS/HIV O-16a/RESULT/OUTCOME,GC7/H-KRCS/HIV O-16a/RESULT/OUTCOME,% of men who have sex with men who avoid health care because of stigma and discrimination,NUMBER,AGGREGATE,PERCENTAGE,,Inverse,bjDvmb4bfuf,Program,Result,Outcome,No
[GC7/H-KRCS/HIV O-16a/TARGET/OUTCOME] % of men who have sex with men who avoid health care because of stigma and discrimination,qnxX3q8y8PB,GC7/H-KRCS/HIV O-16a/TARGET/OUTCOME,GC7/H-KRCS/HIV O-16a/TARGET/OUTCOME,% of men who have sex with men who avoid health care because of stigma and discrimination,NUMBER,AGGREGATE,PERCENTAGE,,Inverse,bjDvmb4bfuf,Program,Target,Outcome,No
[GC7/H-KRCS/HIV O-16c/COMMENT/OUTCOME] % of sex workers who avoid health care because of stigma and discrimination,dJwScqKA9qn,GC7/H-KRCS/HIV O-16c/COMMENT/OUTCOME,GC7/H-KRCS/HIV O-16c/COMMENT/OUTCOME,% of sex workers who avoid health care because of stigma and discrimination,LONG_TEXT,AGGREGATE,LONG_TEXT,,Inverse,bjDvmb4bfuf,Program,Comment,Outcome,No
[GC7/H-KRCS/HIV O-16c/RESULT/OUTCOME] % of sex workers who avoid health care because of stigma and discrimination,CH0NaaedrzY,GC7/H-KRCS/HIV O-16c/RESULT/OUTCOME,GC7/H-KRCS/HIV O-16c/RESULT/OUTCOME,% of sex workers who avoid health care because of stigma and discrimination,NUMBER,AGGREGATE,PERCENTAGE,,Inverse,bjDvmb4bfuf,Program,Result,Outcome,No
[GC7/H-KRCS/HIV O-16c/TARGET/OUTCOME] % of sex workers who avoid health care because of stigma and discrimination,QhclDuIGEAi,GC7/H-KRCS/HIV O-16c/TARGET/OUTCOME,GC7/H-KRCS/HIV O-16c/TARGET/OUTCOME,% of sex workers who avoid health care because of stigma and discrimination,NUMBER,AGGREGATE,PERCENTAGE,,Inverse,bjDvmb4bfuf,Program,Target,Outcome,No
[GC7/H-KRCS/HIV O-25/COMMENT/OUTCOME] Percentage of law enforcement officers who report negative attitudes towards key populations,aAXhCN22euf,GC7/H-KRCS/HIV O-25/COMMENT/OUTCOME,GC7/H-KRCS/HIV O-25/COMMENT/OUTCOME,Percentage of law enforcement officers who report negative attitudes towards key populations,LONG_TEXT,AGGREGATE,LONG_TEXT,,Inverse,bjDvmb4bfuf,Program,Comment,Outcome,No
[GC7/H-KRCS/HIV O-25/RESULT/OUTCOME] Percentage of law enforcement officers who report negative attitudes towards key populations,rHSMkJswsah,GC7/H-KRCS/HIV O-25/RESULT/OUTCOME,GC7/H-KRCS/HIV O-25/RESULT/OUTCOME,Percentage of law enforcement officers who report negative attitudes towards key populations,NUMBER,AGGREGATE,PERCENTAGE,,Inverse,bjDvmb4bfuf,Program,Result,Outcome,No
[GC7/H-KRCS/HIV O-25/TARGET/OUTCOME] Percentage of law enforcement officers who report negative attitudes towards key populations,F8NhKhwDcHG,GC7/H-KRCS/HIV O-25/TARGET/OUTCOME,GC7/H-KRCS/HIV O-25/TARGET/OUTCOME,Percentage of law enforcement officers who report negative attitudes towards key populations,NUMBER,AGGREGATE,PERCENTAGE,,Inverse,bjDvmb4bfuf,Program,Target,Outcome,No
[GC7/H-KRCS/HIV O-26/COMMENT/OUTCOME] % of people living with HIV who report having experienced stigma and discrimination in the general community in the last 12 months.,aU9MOwO06iv,GC7/H-KRCS/HIV O-26/COMMENT/OUTCOME,GC7/H-KRCS/HIV O-26/COMMENT/OUTCOME,% of people living with HIV who report having experienced stigma and discrimination in the general community in the last 12 months.,LONG_TEXT,AGGREGATE,LONG_TEXT,,Inverse,bjDvmb4bfuf,Program,Comment,Outcome,No
[GC7/H-KRCS/HIV O-26/RESULT/OUTCOME] % of people living with HIV who report having experienced stigma and discrimination in the general community in the last 12 months.,gxgheNfr5F3,GC7/H-KRCS/HIV O-26/RESULT/OUTCOME,GC7/H-KRCS/HIV O-26/RESULT/OUTCOME,% of people living with HIV who report having experienced stigma and discrimination in the general community in the last 12 months.,NUMBER,AGGREGATE,PERCENTAGE,,Inverse,bjDvmb4bfuf,Program,Result,Outcome,No
[GC7/H-KRCS/HIV O-26/TARGET/OUTCOME] % of people living with HIV who report having experienced stigma and discrimination in the general community in the last 12 months.,dmG7pLXYpFx,GC7/H-KRCS/HIV O-26/TARGET/OUTCOME,GC7/H-KRCS/HIV O-26/TARGET/OUTCOME,% of people living with HIV who report having experienced stigma and discrimination in the general community in the last 12 months.,NUMBER,AGGREGATE,PERCENTAGE,,Inverse,bjDvmb4bfuf,Program,Target,Outcome,No
[GC7/H-KRCS/HIV O-28c/COMMENT/OUTCOME] Percentage of sex workers who report having experienced stigma and discrimination in the last 6 months,GlzXCBzogiE,GC7/H-KRCS/HIV O-28c/COMMENT/OUTCOME,GC7/H-KRCS/HIV O-28c/COMMENT/OUTCOME,Percentage of sex workers who report having experienced stigma and discrimination in the last 6 months,LONG_TEXT,AGGREGATE,LONG_TEXT,,Inverse,bjDvmb4bfuf,Program,Comment,Outcome,No
[GC7/H-KRCS/HIV O-28c/RESULT/OUTCOME] Percentage of sex workers who report having experienced stigma and discrimination in the last 6 months,ZeWxyGoA6J1,GC7/H-KRCS/HIV O-28c/RESULT/OUTCOME,GC7/H-KRCS/HIV O-28c/RESULT/OUTCOME,Percentage of sex workers who report having experienced stigma and discrimination in the last 6 months,NUMBER,AGGREGATE,PERCENTAGE,,Inverse,bjDvmb4bfuf,Program,Result,Outcome,No
[GC7/H-KRCS/HIV O-28c/TARGET/OUTCOME] Percentage of sex workers who report having experienced stigma and discrimination in the last 6 months,Dyw3bMhLzn2,GC7/H-KRCS/HIV O-28c/TARGET/OUTCOME,GC7/H-KRCS/HIV O-28c/TARGET/OUTCOME,Percentage of sex workers who report having experienced stigma and discrimination in the last 6 months,NUMBER,AGGREGATE,PERCENTAGE,,Inverse,bjDvmb4bfuf,Program,Target,Outcome,No
[GC7/H-KRCS/HIV O-28d/COMMENT/OUTCOME] % of people who inject drugs who report having experienced stigma and discrimination in the last 6 months,nYgh57yuGCP,GC7/H-KRCS/HIV O-28d/COMMENT/OUTCOME,GC7/H-KRCS/HIV O-28d/COMMENT/OUTCOME,% of people who inject drugs who report having experienced stigma and discrimination in the last 6 months,LONG_TEXT,AGGREGATE,LONG_TEXT,,Inverse,bjDvmb4bfuf,Program,Comment,Outcome,No
[GC7/H-KRCS/HIV O-28d/RESULT/OUTCOME] % of people who inject drugs who report having experienced stigma and discrimination in the last 6 months,mWYmNUY99jy,GC7/H-KRCS/HIV O-28d/RESULT/OUTCOME,GC7/H-KRCS/HIV O-28d/RESULT/OUTCOME,% of people who inject drugs who report having experienced stigma and discrimination in the last 6 months,NUMBER,AGGREGATE,PERCENTAGE,,Inverse,bjDvmb4bfuf,Program,Result,Outcome,No
[GC7/H-KRCS/HIV O-28d/TARGET/OUTCOME] % of people who inject drugs who report having experienced stigma and discrimination in the last 6 months,RdAEXoHeNKb,GC7/H-KRCS/HIV O-28d/TARGET/OUTCOME,GC7/H-KRCS/HIV O-28d/TARGET/OUTCOME,% of people who inject drugs who report having experienced stigma and discrimination in the last 6 months,NUMBER,AGGREGATE,PERCENTAGE,,Inverse,bjDvmb4bfuf,Program,Target,Outcome,No
[GC7/H-KRCS/HIV O-4.1b/COMMENT/OUTCOME] Percentage of transgender people reporting using a condom during their most recent sexual intercourse or anal sex,BhaqeLMrLlp,GC7/H-KRCS/HIV O-4.1b/COMMENT/OUTCOME,GC7/H-KRCS/HIV O-4.1b/COMMENT/OUTCOME,Percentage of transgender people reporting using a condom during their most recent sexual intercourse or anal sex,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Outcome,No
[GC7/H-KRCS/HIV O-4.1b/RESULT/OUTCOME] Percentage of transgender people reporting using a condom during their most recent sexual intercourse or anal sex,OHfQ6c5QMmy,GC7/H-KRCS/HIV O-4.1b/RESULT/OUTCOME,GC7/H-KRCS/HIV O-4.1b/RESULT/OUTCOME,Percentage of transgender people reporting using a condom during their most recent sexual intercourse or anal sex,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Outcome,No
[GC7/H-KRCS/HIV O-4.1b/TARGET/OUTCOME] Percentage of transgender people reporting using a condom during their most recent sexual intercourse or anal sex,WPNxH8BjA4q,GC7/H-KRCS/HIV O-4.1b/TARGET/OUTCOME,GC7/H-KRCS/HIV O-4.1b/TARGET/OUTCOME,Percentage of transgender people reporting using a condom during their most recent sexual intercourse or anal sex,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Outcome,No
[GC7/H-KRCS/HIV O-4a/COMMENT/OUTCOME] % of men reporting using a condom the last time they had anal sex with a male partner,WO63HpNGWgX,GC7/H-KRCS/HIV O-4a/COMMENT/OUTCOME,GC7/H-KRCS/HIV O-4a/COMMENT/OUTCOME,% of men reporting using a condom the last time they had anal sex with a male partner,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Outcome,No
[GC7/H-KRCS/HIV O-4a/RESULT/OUTCOME] % of men reporting using a condom the last time they had anal sex with a male partner,qO7m9jwFFFW,GC7/H-KRCS/HIV O-4a/RESULT/OUTCOME,GC7/H-KRCS/HIV O-4a/RESULT/OUTCOME,% of men reporting using a condom the last time they had anal sex with a male partner,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Outcome,No
[GC7/H-KRCS/HIV O-4a/TARGET/OUTCOME] % of men reporting using a condom the last time they had anal sex with a male partner,Bnurhnf7jQh,GC7/H-KRCS/HIV O-4a/TARGET/OUTCOME,GC7/H-KRCS/HIV O-4a/TARGET/OUTCOME,% of men reporting using a condom the last time they had anal sex with a male partner,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Outcome,No
[GC7/H-KRCS/HIV O-5/COMMENT/OUTCOME] % of sex workers reporting using a condom with their most recent client,nArr4xbTPxP,GC7/H-KRCS/HIV O-5/COMMENT/OUTCOME,GC7/H-KRCS/HIV O-5/COMMENT/OUTCOME,% of sex workers reporting using a condom with their most recent client,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Outcome,No
[GC7/H-KRCS/HIV O-5/RESULT/OUTCOME] % of sex workers reporting using a condom with their most recent client,GCLH1jdB1of,GC7/H-KRCS/HIV O-5/RESULT/OUTCOME,GC7/H-KRCS/HIV O-5/RESULT/OUTCOME,% of sex workers reporting using a condom with their most recent client,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Outcome,No
[GC7/H-KRCS/HIV O-5/TARGET/OUTCOME] % of sex workers reporting using a condom with their most recent client,h5jm6EuuSie,GC7/H-KRCS/HIV O-5/TARGET/OUTCOME,GC7/H-KRCS/HIV O-5/TARGET/OUTCOME,% of sex workers reporting using a condom with their most recent client,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Outcome,No
[GC7/H-KRCS/HIV O-6/COMMENT/OUTCOME] Percentage of people who inject drugs reporting using sterile injecting equipment the last time they injected,jAsPpcpSq1F,GC7/H-KRCS/HIV O-6/COMMENT/OUTCOME,GC7/H-KRCS/HIV O-6/COMMENT/OUTCOME,Percentage of people who inject drugs reporting using sterile injecting equipment the last time they injected,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Outcome,No
[GC7/H-KRCS/HIV O-6/RESULT/OUTCOME] Percentage of people who inject drugs reporting using sterile injecting equipment the last time they injected,jhw0Ve3DYnS,GC7/H-KRCS/HIV O-6/RESULT/OUTCOME,GC7/H-KRCS/HIV O-6/RESULT/OUTCOME,Percentage of people who inject drugs reporting using sterile injecting equipment the last time they injected,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Outcome,No
[GC7/H-KRCS/HIV O-6/TARGET/OUTCOME] Percentage of people who inject drugs reporting using sterile injecting equipment the last time they injected,nOXfGTqBZLy,GC7/H-KRCS/HIV O-6/TARGET/OUTCOME,GC7/H-KRCS/HIV O-6/TARGET/OUTCOME,Percentage of people who inject drugs reporting using sterile injecting equipment the last time they injected,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Outcome,No
[GC7/H-KRCS/HTS-2/COMMENT/COVERAGE] % of high risk AGYW that have received an HIV test during the reporting period in AGYW programs,t6A9lBDfceo,GC7/H-KRCS/HTS-2/COMMENT/COVERAGE,GC7/H-KRCS/HTS-2/COMMENT/COVERAGE,% of high risk AGYW that have received an HIV test during the reporting period in AGYW programs,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/H-KRCS/HTS-2/RESULT/COVERAGE] % of high risk AGYW that have received an HIV test during the reporting period in AGYW programs,HtZHkowHuub,GC7/H-KRCS/HTS-2/RESULT/COVERAGE,GC7/H-KRCS/HTS-2/RESULT/COVERAGE,% of high risk AGYW that have received an HIV test during the reporting period in AGYW programs,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/H-KRCS/HTS-2/TARGET/COVERAGE] % of high risk AGYW that have received an HIV test during the reporting period in AGYW programs,G3zciiC4C1b,GC7/H-KRCS/HTS-2/TARGET/COVERAGE,GC7/H-KRCS/HTS-2/TARGET/COVERAGE,% of high risk AGYW that have received an HIV test during the reporting period in AGYW programs,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/H-KRCS/HTS-3a/COMMENT/COVERAGE] % of MSM that have received an HIV test during the reporting period in KP-specific programs and know their results,NYSeHOxc1QJ,GC7/H-KRCS/HTS-3a/COMMENT/COVERAGE,GC7/H-KRCS/HTS-3a/COMMENT/COVERAGE,% of MSM that have received an HIV test during the reporting period in KP-specific programs and know their results,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/H-KRCS/HTS-3a/RESULT/COVERAGE] % of MSM that have received an HIV test during the reporting period in KP-specific programs and know their results,TLJPawfejXu,GC7/H-KRCS/HTS-3a/RESULT/COVERAGE,GC7/H-KRCS/HTS-3a/RESULT/COVERAGE,% of MSM that have received an HIV test during the reporting period in KP-specific programs and know their results,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/H-KRCS/HTS-3a/TARGET/COVERAGE] % of MSM that have received an HIV test during the reporting period in KP-specific programs and know their results,zP2oyxbzEFl,GC7/H-KRCS/HTS-3a/TARGET/COVERAGE,GC7/H-KRCS/HTS-3a/TARGET/COVERAGE,% of MSM that have received an HIV test during the reporting period in KP-specific programs and know their results,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/H-KRCS/HTS-3b/COMMENT/COVERAGE] % of TG that have received an HIV test during the reporting period in KP-specific programs and know their results,GgkzO6K64FF,GC7/H-KRCS/HTS-3b/COMMENT/COVERAGE,GC7/H-KRCS/HTS-3b/COMMENT/COVERAGE,% of TG that have received an HIV test during the reporting period in KP-specific programs and know their results,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/H-KRCS/HTS-3b/RESULT/COVERAGE] % of TG that have received an HIV test during the reporting period in KP-specific programs and know their results,MN4t5w2HKtD,GC7/H-KRCS/HTS-3b/RESULT/COVERAGE,GC7/H-KRCS/HTS-3b/RESULT/COVERAGE,% of TG that have received an HIV test during the reporting period in KP-specific programs and know their results,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/H-KRCS/HTS-3b/TARGET/COVERAGE] % of TG that have received an HIV test during the reporting period in KP-specific programs and know their results,sX2007imFQs,GC7/H-KRCS/HTS-3b/TARGET/COVERAGE,GC7/H-KRCS/HTS-3b/TARGET/COVERAGE,% of TG that have received an HIV test during the reporting period in KP-specific programs and know their results,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/H-KRCS/HTS-3c/COMMENT/COVERAGE] % of sex workers that have received an HIV test during the reporting period in KP-specific programs and know their results,iscE0FENMMT,GC7/H-KRCS/HTS-3c/COMMENT/COVERAGE,GC7/H-KRCS/HTS-3c/COMMENT/COVERAGE,% of sex workers that have received an HIV test during the reporting period in KP-specific programs and know their results,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/H-KRCS/HTS-3c/RESULT/COVERAGE] % of sex workers that have received an HIV test during the reporting period in KP-specific programs and know their results,mZWSnxjlcLh,GC7/H-KRCS/HTS-3c/RESULT/COVERAGE,GC7/H-KRCS/HTS-3c/RESULT/COVERAGE,% of sex workers that have received an HIV test during the reporting period in KP-specific programs and know their results,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/H-KRCS/HTS-3c/TARGET/COVERAGE] % of sex workers that have received an HIV test during the reporting period in KP-specific programs and know their results,xcOzyGlmaof,GC7/H-KRCS/HTS-3c/TARGET/COVERAGE,GC7/H-KRCS/HTS-3c/TARGET/COVERAGE,% of sex workers that have received an HIV test during the reporting period in KP-specific programs and know their results,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/H-KRCS/HTS-3d/COMMENT/COVERAGE] % of people who inject drugs that have received an HIV test during the reporting period in KP-specific programs and know their results,uEXtDMxNvuy,GC7/H-KRCS/HTS-3d/COMMENT/COVERAGE,GC7/H-KRCS/HTS-3d/COMMENT/COVERAGE,% of people who inject drugs that have received an HIV test during the reporting period in KP-specific programs and know their results,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/H-KRCS/HTS-3d/RESULT/COVERAGE] % of people who inject drugs that have received an HIV test during the reporting period in KP-specific programs and know their results,zJiQOrahaSV,GC7/H-KRCS/HTS-3d/RESULT/COVERAGE,GC7/H-KRCS/HTS-3d/RESULT/COVERAGE,% of people who inject drugs that have received an HIV test during the reporting period in KP-specific programs and know their results,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/H-KRCS/HTS-3d/TARGET/COVERAGE] % of people who inject drugs that have received an HIV test during the reporting period in KP-specific programs and know their results,gcgbaONAUG1,GC7/H-KRCS/HTS-3d/TARGET/COVERAGE,GC7/H-KRCS/HTS-3d/TARGET/COVERAGE,% of people who inject drugs that have received an HIV test during the reporting period in KP-specific programs and know their results,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/H-KRCS/HTS-3e/COMMENT/COVERAGE] Percentage of other vulnerable populations that have received an HIV test during the reporting period and know their results,VsIKlSy0eP6,GC7/H-KRCS/HTS-3e/COMMENT/COVERAGE,GC7/H-KRCS/HTS-3e/COMMENT/COVERAGE,Percentage of other vulnerable populations that have received an HIV test during the reporting period and know their results,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/H-KRCS/HTS-3e/RESULT/COVERAGE] Percentage of other vulnerable populations that have received an HIV test during the reporting period and know their results,P11kikn525r,GC7/H-KRCS/HTS-3e/RESULT/COVERAGE,GC7/H-KRCS/HTS-3e/RESULT/COVERAGE,Percentage of other vulnerable populations that have received an HIV test during the reporting period and know their results,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/H-KRCS/HTS-3e/TARGET/COVERAGE] Percentage of other vulnerable populations that have received an HIV test during the reporting period and know their results,Q9iAPDBOMrw,GC7/H-KRCS/HTS-3e/TARGET/COVERAGE,GC7/H-KRCS/HTS-3e/TARGET/COVERAGE,Percentage of other vulnerable populations that have received an HIV test during the reporting period and know their results,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Target,Coverage,No
"[GC7/H-KRCS/HTS-5/COMMENT/COVERAGE] Percentage of Key and Vulnerable Population (high-risk AGYW, TG, FSW, MSM, PWID, Fisher Folk & Truckers) newly diagnosed with HIV initiated on ART",DWb1gdzwD8t,GC7/H-KRCS/HTS-5/COMMENT/COVERAGE,GC7/H-KRCS/HTS-5/COMMENT/COVERAGE,"Percentage of Key and Vulnerable Population (high-risk AGYW, TG, FSW, MSM, PWID, Fisher Folk & Truckers) newly diagnosed with HIV initiated on ART",LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
"[GC7/H-KRCS/HTS-5/RESULT/COVERAGE] Percentage of Key and Vulnerable Population (high-risk AGYW, TG, FSW, MSM, PWID, Fisher Folk & Truckers) newly diagnosed with HIV initiated on ART",wPRSGfNQ8Zf,GC7/H-KRCS/HTS-5/RESULT/COVERAGE,GC7/H-KRCS/HTS-5/RESULT/COVERAGE,"Percentage of Key and Vulnerable Population (high-risk AGYW, TG, FSW, MSM, PWID, Fisher Folk & Truckers) newly diagnosed with HIV initiated on ART",NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Result,Coverage,No
"[GC7/H-KRCS/HTS-5/TARGET/COVERAGE] Percentage of Key and Vulnerable Population (high-risk AGYW, TG, FSW, MSM, PWID, Fisher Folk & Truckers) newly diagnosed with HIV initiated on ART",VWy4Funy8wD,GC7/H-KRCS/HTS-5/TARGET/COVERAGE,GC7/H-KRCS/HTS-5/TARGET/COVERAGE,"Percentage of Key and Vulnerable Population (high-risk AGYW, TG, FSW, MSM, PWID, Fisher Folk & Truckers) newly diagnosed with HIV initiated on ART",NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/H-KRCS/HTS_KITS-AMC/RESULT/COMMODITIES] HTS Kits AMC,TYEKO6haKaX,GC7/H-KRCS/HTS_KITS-AMC/RESULT/COMMODITIES,GC7/H-KRCS/HTS_KITS-AMC/RESULT/COMMODITIES,HTS Kits AMC,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-KRCS/HTS_KITS-BAL/RESULT/COMMODITIES] HTS Kits Ending Balance,elVRhpM1Ry4,GC7/H-KRCS/HTS_KITS-BAL/RESULT/COMMODITIES,GC7/H-KRCS/HTS_KITS-BAL/RESULT/COMMODITIES,HTS Kits Ending Balance,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-KRCS/HTS_KITS-COMMENT/COMMENT/COMMODITIES] HTS Kits Comments,nwkJCCqafvJ,GC7/H-KRCS/HTS_KITS-COMMENT/COMMENT/COMMODITIES,GC7/H-KRCS/HTS_KITS-COMMENT/COMMENT/COMMODITIES,HTS Kits Comments,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Products,Comment,,No
[GC7/H-KRCS/HTS_KITS-PROC/RESULT/COMMODITIES] HTS Kits Under Procurement,xdbGEUpbCwD,GC7/H-KRCS/HTS_KITS-PROC/RESULT/COMMODITIES,GC7/H-KRCS/HTS_KITS-PROC/RESULT/COMMODITIES,HTS Kits Under Procurement,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-KRCS/HTS_KITS-SOR-D/RESULT/COMMODITIES] HTS Kits SOR Denominator,U6zIKuOeL5N,GC7/H-KRCS/HTS_KITS-SOR-D/RESULT/COMMODITIES,GC7/H-KRCS/HTS_KITS-SOR-D/RESULT/COMMODITIES,HTS Kits SOR Denominator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-KRCS/HTS_KITS-SOR-N/RESULT/COMMODITIES] HTS Kits SOR Numerator,AR3CylMa3tN,GC7/H-KRCS/HTS_KITS-SOR-N/RESULT/COMMODITIES,GC7/H-KRCS/HTS_KITS-SOR-N/RESULT/COMMODITIES,HTS Kits SOR Numerator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-KRCS/KP-1a/COMMENT/COVERAGE] # of men who have sex with men reached with HIV prevention programs - defined package of services,tpnqtHeQOXK,GC7/H-KRCS/KP-1a/COMMENT/COVERAGE,GC7/H-KRCS/KP-1a/COMMENT/COVERAGE,# of men who have sex with men reached with HIV prevention programs - defined package of services,LONG_TEXT,AGGREGATE,LONG_TEXT,,Coverage,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/H-KRCS/KP-1a/RESULT/COVERAGE] # of men who have sex with men reached with HIV prevention programs - defined package of services,hwQOgwrrKLC,GC7/H-KRCS/KP-1a/RESULT/COVERAGE,GC7/H-KRCS/KP-1a/RESULT/COVERAGE,# of men who have sex with men reached with HIV prevention programs - defined package of services,NUMBER,AGGREGATE,NUMBER,,Coverage,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/H-KRCS/KP-1a/TARGET/COVERAGE] # of men who have sex with men reached with HIV prevention programs - defined package of services,SudDZ0BgWIG,GC7/H-KRCS/KP-1a/TARGET/COVERAGE,GC7/H-KRCS/KP-1a/TARGET/COVERAGE,# of men who have sex with men reached with HIV prevention programs - defined package of services,NUMBER,AGGREGATE,NUMBER,,Coverage,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/H-KRCS/KP-1b/COMMENT/COVERAGE] % of transgender people reached with HIV prevention programs - defined package of services,dLlO4m6ORTT,GC7/H-KRCS/KP-1b/COMMENT/COVERAGE,GC7/H-KRCS/KP-1b/COMMENT/COVERAGE,% of transgender people reached with HIV prevention programs - defined package of services,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/H-KRCS/KP-1b/RESULT/COVERAGE] % of transgender people reached with HIV prevention programs - defined package of services,Mw5TpFsSz6g,GC7/H-KRCS/KP-1b/RESULT/COVERAGE,GC7/H-KRCS/KP-1b/RESULT/COVERAGE,% of transgender people reached with HIV prevention programs - defined package of services,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/H-KRCS/KP-1b/TARGET/COVERAGE] % of transgender people reached with HIV prevention programs - defined package of services,sHVrgOhbGGt,GC7/H-KRCS/KP-1b/TARGET/COVERAGE,GC7/H-KRCS/KP-1b/TARGET/COVERAGE,% of transgender people reached with HIV prevention programs - defined package of services,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/H-KRCS/KP-1c/COMMENT/COVERAGE] % of sex workers reached with HIV prevention programs - defined package of services,wsRZUyZE7SU,GC7/H-KRCS/KP-1c/COMMENT/COVERAGE,GC7/H-KRCS/KP-1c/COMMENT/COVERAGE,% of sex workers reached with HIV prevention programs - defined package of services,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/H-KRCS/KP-1c/RESULT/COVERAGE] % of sex workers reached with HIV prevention programs - defined package of services,KqLGZlnwOpS,GC7/H-KRCS/KP-1c/RESULT/COVERAGE,GC7/H-KRCS/KP-1c/RESULT/COVERAGE,% of sex workers reached with HIV prevention programs - defined package of services,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/H-KRCS/KP-1c/TARGET/COVERAGE] % of sex workers reached with HIV prevention programs - defined package of services,ACVRZPt7E7b,GC7/H-KRCS/KP-1c/TARGET/COVERAGE,GC7/H-KRCS/KP-1c/TARGET/COVERAGE,% of sex workers reached with HIV prevention programs - defined package of services,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/H-KRCS/KP-1d/COMMENT/COVERAGE] % of people who inject drugs reached with HIV prevention programs - defined package of services,G71sIzWFban,GC7/H-KRCS/KP-1d/COMMENT/COVERAGE,GC7/H-KRCS/KP-1d/COMMENT/COVERAGE,% of people who inject drugs reached with HIV prevention programs - defined package of services,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/H-KRCS/KP-1d/RESULT/COVERAGE] % of people who inject drugs reached with HIV prevention programs - defined package of services,H5g6NA5oCzI,GC7/H-KRCS/KP-1d/RESULT/COVERAGE,GC7/H-KRCS/KP-1d/RESULT/COVERAGE,% of people who inject drugs reached with HIV prevention programs - defined package of services,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/H-KRCS/KP-1d/TARGET/COVERAGE] % of people who inject drugs reached with HIV prevention programs - defined package of services,a3MpjeCQBwK,GC7/H-KRCS/KP-1d/TARGET/COVERAGE,GC7/H-KRCS/KP-1d/TARGET/COVERAGE,% of people who inject drugs reached with HIV prevention programs - defined package of services,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/H-KRCS/KP-1e/COMMENT/COVERAGE] Percentage of other vulnerable populations reached with HIV prevention programs - defined package of services,bNdpGK40f2K,GC7/H-KRCS/KP-1e/COMMENT/COVERAGE,GC7/H-KRCS/KP-1e/COMMENT/COVERAGE,Percentage of other vulnerable populations reached with HIV prevention programs - defined package of services,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/H-KRCS/KP-1e/RESULT/COVERAGE] Percentage of other vulnerable populations reached with HIV prevention programs - defined package of services,Zt2sgw4V5A9,GC7/H-KRCS/KP-1e/RESULT/COVERAGE,GC7/H-KRCS/KP-1e/RESULT/COVERAGE,Percentage of other vulnerable populations reached with HIV prevention programs - defined package of services,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/H-KRCS/KP-1e/TARGET/COVERAGE] Percentage of other vulnerable populations reached with HIV prevention programs - defined package of services,Ok1CHpVDmOT,GC7/H-KRCS/KP-1e/TARGET/COVERAGE,GC7/H-KRCS/KP-1e/TARGET/COVERAGE,Percentage of other vulnerable populations reached with HIV prevention programs - defined package of services,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/H-KRCS/KP-6a/COMMENT/COVERAGE] # of MSM who received any PrEP product at least once during the reporting period,wCsAK5jQpOq,GC7/H-KRCS/KP-6a/COMMENT/COVERAGE,GC7/H-KRCS/KP-6a/COMMENT/COVERAGE,# of MSM who received any PrEP product at least once during the reporting period,LONG_TEXT,AGGREGATE,LONG_TEXT,,Coverage,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/H-KRCS/KP-6a/RESULT/COVERAGE] # of MSM who received any PrEP product at least once during the reporting period,cZTenEiimJI,GC7/H-KRCS/KP-6a/RESULT/COVERAGE,GC7/H-KRCS/KP-6a/RESULT/COVERAGE,# of MSM who received any PrEP product at least once during the reporting period,NUMBER,AGGREGATE,NUMBER,,Coverage,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/H-KRCS/KP-6a/TARGET/COVERAGE] # of MSM who received any PrEP product at least once during the reporting period,Cqf70TOjjyO,GC7/H-KRCS/KP-6a/TARGET/COVERAGE,GC7/H-KRCS/KP-6a/TARGET/COVERAGE,# of MSM who received any PrEP product at least once during the reporting period,NUMBER,AGGREGATE,NUMBER,,Coverage,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/H-KRCS/KP-6b/COMMENT/COVERAGE] # of transgender people who received any PrEP product at least once during the reporting period,zKbUDE9C5y7,GC7/H-KRCS/KP-6b/COMMENT/COVERAGE,GC7/H-KRCS/KP-6b/COMMENT/COVERAGE,# of transgender people who received any PrEP product at least once during the reporting period,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/H-KRCS/KP-6b/RESULT/COVERAGE] # of transgender people who received any PrEP product at least once during the reporting period,sid8iSF3Miq,GC7/H-KRCS/KP-6b/RESULT/COVERAGE,GC7/H-KRCS/KP-6b/RESULT/COVERAGE,# of transgender people who received any PrEP product at least once during the reporting period,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/H-KRCS/KP-6b/TARGET/COVERAGE] # of transgender people who received any PrEP product at least once during the reporting period,GUJfZ1hP5nn,GC7/H-KRCS/KP-6b/TARGET/COVERAGE,GC7/H-KRCS/KP-6b/TARGET/COVERAGE,# of transgender people who received any PrEP product at least once during the reporting period,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/H-KRCS/KP-6c/COMMENT/COVERAGE] # of sex workers who received any PrEP product at least once during the reporting period,q1oo4NWDnay,GC7/H-KRCS/KP-6c/COMMENT/COVERAGE,GC7/H-KRCS/KP-6c/COMMENT/COVERAGE,# of sex workers who received any PrEP product at least once during the reporting period,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/H-KRCS/KP-6c/RESULT/COVERAGE] # of sex workers who received any PrEP product at least once during the reporting period,oVLWwqvH7rO,GC7/H-KRCS/KP-6c/RESULT/COVERAGE,GC7/H-KRCS/KP-6c/RESULT/COVERAGE,# of sex workers who received any PrEP product at least once during the reporting period,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/H-KRCS/KP-6c/TARGET/COVERAGE] # of sex workers who received any PrEP product at least once during the reporting period,NwI5XYJ39GR,GC7/H-KRCS/KP-6c/TARGET/COVERAGE,GC7/H-KRCS/KP-6c/TARGET/COVERAGE,# of sex workers who received any PrEP product at least once during the reporting period,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/H-KRCS/KP-6d/COMMENT/COVERAGE] # of PWID who received any PrEP product at least once during the reporting period,WLNLecUfDxq,GC7/H-KRCS/KP-6d/COMMENT/COVERAGE,GC7/H-KRCS/KP-6d/COMMENT/COVERAGE,# of PWID who received any PrEP product at least once during the reporting period,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/H-KRCS/KP-6d/RESULT/COVERAGE] # of PWID who received any PrEP product at least once during the reporting period,r32CpQpVCp5,GC7/H-KRCS/KP-6d/RESULT/COVERAGE,GC7/H-KRCS/KP-6d/RESULT/COVERAGE,# of PWID who received any PrEP product at least once during the reporting period,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/H-KRCS/KP-6d/TARGET/COVERAGE] # of PWID who received any PrEP product at least once during the reporting period,asoKY06vTWO,GC7/H-KRCS/KP-6d/TARGET/COVERAGE,GC7/H-KRCS/KP-6d/TARGET/COVERAGE,# of PWID who received any PrEP product at least once during the reporting period,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/H-KRCS/NSP1-AMC/RESULT/COMMODITIES] NSP Kit 1 AMC,QuIDdIjJBfE,GC7/H-KRCS/NSP1-AMC/RESULT/COMMODITIES,GC7/H-KRCS/NSP1-AMC/RESULT/COMMODITIES,NSP Kit 1 AMC,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-KRCS/NSP1-BAL/RESULT/COMMODITIES] NSP Kit 1 Ending Balance,NIJzBk495Md,GC7/H-KRCS/NSP1-BAL/RESULT/COMMODITIES,GC7/H-KRCS/NSP1-BAL/RESULT/COMMODITIES,NSP Kit 1 Ending Balance,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-KRCS/NSP1-COMMENT/COMMENT/COMMODITIES] NSP Kit 1 Comments,CJHehHsqoHj,GC7/H-KRCS/NSP1-COMMENT/COMMENT/COMMODITIES,GC7/H-KRCS/NSP1-COMMENT/COMMENT/COMMODITIES,NSP Kit 1 Comments,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Products,Comment,,No
[GC7/H-KRCS/NSP1-PROC/RESULT/COMMODITIES] NSP Kit 1 Under Procurement,f6JX4wySAqN,GC7/H-KRCS/NSP1-PROC/RESULT/COMMODITIES,GC7/H-KRCS/NSP1-PROC/RESULT/COMMODITIES,NSP Kit 1 Under Procurement,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-KRCS/NSP1-SOR-D/RESULT/COMMODITIES] NSP Kit 1 SOR Denominator,yiBD5lTCwTQ,GC7/H-KRCS/NSP1-SOR-D/RESULT/COMMODITIES,GC7/H-KRCS/NSP1-SOR-D/RESULT/COMMODITIES,NSP Kit 1 SOR Denominator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-KRCS/NSP1-SOR-N/RESULT/COMMODITIES] NSP Kit 1 SOR Numerator,GjQJtjAr1pM,GC7/H-KRCS/NSP1-SOR-N/RESULT/COMMODITIES,GC7/H-KRCS/NSP1-SOR-N/RESULT/COMMODITIES,NSP Kit 1 SOR Numerator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-KRCS/NSP2-AMC/RESULT/COMMODITIES] NSP Kit 2 AMC,E7epAV8Qla7,GC7/H-KRCS/NSP2-AMC/RESULT/COMMODITIES,GC7/H-KRCS/NSP2-AMC/RESULT/COMMODITIES,NSP Kit 2 AMC,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-KRCS/NSP2-BAL/RESULT/COMMODITIES] NSP Kit 2 Ending Balance,ppLfmJUntu8,GC7/H-KRCS/NSP2-BAL/RESULT/COMMODITIES,GC7/H-KRCS/NSP2-BAL/RESULT/COMMODITIES,NSP Kit 2 Ending Balance,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-KRCS/NSP2-COMMENT/COMMENT/COMMODITIES] NSP Kit 2 Comments,iheBA9gbpev,GC7/H-KRCS/NSP2-COMMENT/COMMENT/COMMODITIES,GC7/H-KRCS/NSP2-COMMENT/COMMENT/COMMODITIES,NSP Kit 2 Comments,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Products,Comment,,No
[GC7/H-KRCS/NSP2-PROC/RESULT/COMMODITIES] NSP Kit 2 Under Procurement,PPqLcqKAJEO,GC7/H-KRCS/NSP2-PROC/RESULT/COMMODITIES,GC7/H-KRCS/NSP2-PROC/RESULT/COMMODITIES,NSP Kit 2 Under Procurement,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-KRCS/NSP2-SOR-D/RESULT/COMMODITIES] NSP Kit 2 SOR Denominator,VIlFnKL5C0M,GC7/H-KRCS/NSP2-SOR-D/RESULT/COMMODITIES,GC7/H-KRCS/NSP2-SOR-D/RESULT/COMMODITIES,NSP Kit 2 SOR Denominator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-KRCS/NSP2-SOR-N/RESULT/COMMODITIES] NSP Kit 2 SOR Numerator,Nmf9yqdeAhf,GC7/H-KRCS/NSP2-SOR-N/RESULT/COMMODITIES,GC7/H-KRCS/NSP2-SOR-N/RESULT/COMMODITIES,NSP Kit 2 SOR Numerator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-KRCS/OBLIG/FINANCE] PR Obligations,AFDaM7inBFK,GC7/H-KRCS/OBLIG/FINANCE,GC7/H-KRCS/OBLIG/FINANCE,Obligations,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/H-KRCS/POST_OUTFLOWS/FINANCE] PR Postponed Outflows,kxzsP1siqaU,GC7/H-KRCS/POST_OUTFLOWS/FINANCE,GC7/H-KRCS/POST_OUTFLOWS/FINANCE,Postponed Outflows,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/H-KRCS/PROG_RATING/RATING] PR Programmatic Rating,w8G2gEn0MVW,GC7/H-KRCS/PROG_RATING/RATING,GC7/H-KRCS/PROG_RATING/RATING,Programmatic Rating,NUMBER,AGGREGATE,TEXT,,,bjDvmb4bfuf,Rating,,,No
[GC7/H-KRCS/PROG_RATING_COMMENT/RATING] PR Programmatic Rating Comments,vosGrFg5eYz,GC7/H-KRCS/PROG_RATING_COMMENT/RATING,GC7/H-KRCS/PROG_RATING_COMMENT/RATING,Programmatic Rating Comments,NUMBER,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Rating,,,No
[GC7/H-KRCS/PROG_RATING_END/RATING] PR Programmatic Rating End Date,nUMDjwYosOS,GC7/H-KRCS/PROG_RATING_END/RATING,GC7/H-KRCS/PROG_RATING_END/RATING,Programmatic Rating End Date,NUMBER,AGGREGATE,DATE,,,bjDvmb4bfuf,Rating,,,No
[GC7/H-KRCS/PROG_RATING_START/RATING] PR Programmatic Rating Start Date,tDwoEdNcka7,GC7/H-KRCS/PROG_RATING_START/RATING,GC7/H-KRCS/PROG_RATING_START/RATING,Programmatic Rating Start Date,NUMBER,AGGREGATE,DATE,,,bjDvmb4bfuf,Rating,,,No
"[GC7/H-KRCS/PSEAH-CA/COMM_PSEAH] % of community level actors/agents (TB Champions, peer educators, mentor mothers etc) sensitized on PSEAH/SEAH including SEAH reporting channels and have Signed Compliance Document ",Xg9mAoWu3lv,GC7/H-KRCS/PSEAH-CA/COMM_PSEAH,GC7/H-KRCS/PSEAH-CA/COMM_PSEAH,"% of community level actors/agents (TB Champions, peer educators, mentor mothers etc) sensitized on PSEAH/SEAH including SEAH reporting channels and have Signed Compliance Document ",LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,PSEAH,Comment,PSEAH,No
"[GC7/H-KRCS/PSEAH-CA/RES_PSEAH] % of community level actors/agents (TB Champions, peer educators, mentor mothers etc) sensitized on PSEAH/SEAH including SEAH reporting channels and have Signed Compliance Document ",DtMKJankyax,GC7/H-KRCS/PSEAH-CA/RES_PSEAH,GC7/H-KRCS/PSEAH-CA/RES_PSEAH,"% of community level actors/agents (TB Champions, peer educators, mentor mothers etc) sensitized on PSEAH/SEAH including SEAH reporting channels and have Signed Compliance Document ",PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Result,PSEAH,No
"[GC7/H-KRCS/PSEAH-CA/TAR_PSEAH] % of community level actors/agents (TB Champions, peer educators, mentor mothers etc) sensitized on PSEAH/SEAH including SEAH reporting channels and have Signed Compliance Document ",pdKNzsgs7lV,GC7/H-KRCS/PSEAH-CA/TAR_PSEAH,GC7/H-KRCS/PSEAH-CA/TAR_PSEAH,"% of community level actors/agents (TB Champions, peer educators, mentor mothers etc) sensitized on PSEAH/SEAH including SEAH reporting channels and have Signed Compliance Document ",PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Target,PSEAH,No
[GC7/H-KRCS/PSEAH-PB/COMM_PSEAH] % of programme beneficiaries at community level assessed as being at high/medium risk of SEAH[1] sensitized on PSEAH/SEAH including SEAH reporting channels,zT2oa93gr0b,GC7/H-KRCS/PSEAH-PB/COMM_PSEAH,GC7/H-KRCS/PSEAH-PB/COMM_PSEAH,% of programme beneficiaries at community level assessed as being at high/medium risk of SEAH sensitized on PSEAH/SEAH including SEAH reporting channels,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,PSEAH,Comment,PSEAH,No
[GC7/H-KRCS/PSEAH-PB/RES_PSEAH] % of programme beneficiaries at community level assessed as being at high/medium risk of SEAH[1] sensitized on PSEAH/SEAH including SEAH reporting channels,ofnosSV222K,GC7/H-KRCS/PSEAH-PB/RES_PSEAH,GC7/H-KRCS/PSEAH-PB/RES_PSEAH,% of programme beneficiaries at community level assessed as being at high/medium risk of SEAH sensitized on PSEAH/SEAH including SEAH reporting channels,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Result,PSEAH,No
[GC7/H-KRCS/PSEAH-PB/TAR_PSEAH] % of programme beneficiaries at community level assessed as being at high/medium risk of SEAH[1] sensitized on PSEAH/SEAH including SEAH reporting channels,iZ2v7480NJP,GC7/H-KRCS/PSEAH-PB/TAR_PSEAH,GC7/H-KRCS/PSEAH-PB/TAR_PSEAH,% of programme beneficiaries at community level assessed as being at high/medium risk of SEAH sensitized on PSEAH/SEAH including SEAH reporting channels,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Target,PSEAH,No
[GC7/H-KRCS/PSEAH-PR/COMM_PSEAH] % of Principal Recipient (PR) Staff (including Interns and Volunteers) and Board Members Trained on PR PSEAH Policy and Signed Compliance Document Annually,tgCu20L0kkT,GC7/H-KRCS/PSEAH-PR/COMM_PSEAH,GC7/H-KRCS/PSEAH-PR/COMM_PSEAH,% of Principal Recipient (PR) Staff (including Interns and Volunteers) and Board Members Trained on PR PSEAH Policy and Signed Compliance Document Annually,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,PSEAH,Comment,PSEAH,No
[GC7/H-KRCS/PSEAH-PR/RES_PSEAH] % of Principal Recipient (PR) Staff (including Interns and Volunteers) and Board Members Trained on PR PSEAH Policy and Signed Compliance Document Annually,VJK90CnsJzd,GC7/H-KRCS/PSEAH-PR/RES_PSEAH,GC7/H-KRCS/PSEAH-PR/RES_PSEAH,% of Principal Recipient (PR) Staff (including Interns and Volunteers) and Board Members Trained on PR PSEAH Policy and Signed Compliance Document Annually,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Result,PSEAH,No
[GC7/H-KRCS/PSEAH-PR/TAR_PSEAH] % of Principal Recipient (PR) Staff (including Interns and Volunteers) and Board Members Trained on PR PSEAH Policy and Signed Compliance Document Annually,vDwTeRC5mHQ,GC7/H-KRCS/PSEAH-PR/TAR_PSEAH,GC7/H-KRCS/PSEAH-PR/TAR_PSEAH,% of Principal Recipient (PR) Staff (including Interns and Volunteers) and Board Members Trained on PR PSEAH Policy and Signed Compliance Document Annually,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Target,PSEAH,No
[GC7/H-KRCS/PSEAH-SR/COMM_PSEAH] % of Sub-Recipient (SRs) whose Staff (including Interns and Volunteers) and Board Members Trained on PSEAH Policy and have Signed Compliance Document Annually,OHYQ9L6YGUC,GC7/H-KRCS/PSEAH-SR/COMM_PSEAH,GC7/H-KRCS/PSEAH-SR/COMM_PSEAH,% of Sub-Recipient (SRs) whose Staff (including Interns and Volunteers) and Board Members Trained on PSEAH Policy and have Signed Compliance Document Annually,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,PSEAH,Comment,PSEAH,No
[GC7/H-KRCS/PSEAH-SR/RES_PSEAH] % of Sub-Recipient (SRs) whose Staff (including Interns and Volunteers) and Board Members Trained on PSEAH Policy and have Signed Compliance Document Annually,r1gaDVzddSU,GC7/H-KRCS/PSEAH-SR/RES_PSEAH,GC7/H-KRCS/PSEAH-SR/RES_PSEAH,% of Sub-Recipient (SRs) whose Staff (including Interns and Volunteers) and Board Members Trained on PSEAH Policy and have Signed Compliance Document Annually,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Result,PSEAH,No
[GC7/H-KRCS/PSEAH-SR/TAR_PSEAH] % of Sub-Recipient (SRs) whose Staff (including Interns and Volunteers) and Board Members Trained on PSEAH Policy and have Signed Compliance Document Annually,wHX5FVk5Dgd,GC7/H-KRCS/PSEAH-SR/TAR_PSEAH,GC7/H-KRCS/PSEAH-SR/TAR_PSEAH,% of Sub-Recipient (SRs) whose Staff (including Interns and Volunteers) and Board Members Trained on PSEAH Policy and have Signed Compliance Document Annually,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Target,PSEAH,No
[GC7/H-KRCS/PSEAH-ZT/COMM_PSEAH] % of Sub-Recipients (SRs) with PSEAH Policy highlighting Zero Tolerance of SEAH,JWLXw8xzzum,GC7/H-KRCS/PSEAH-ZT/COMM_PSEAH,GC7/H-KRCS/PSEAH-ZT/COMM_PSEAH,% of Sub-Recipients (SRs) with PSEAH Policy highlighting Zero Tolerance of SEAH,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,PSEAH,Comment,PSEAH,No
[GC7/H-KRCS/PSEAH-ZT/RES_PSEAH] % of Sub-Recipients (SRs) with PSEAH Policy highlighting Zero Tolerance of SEAH,YqlzO5UzaW6,GC7/H-KRCS/PSEAH-ZT/RES_PSEAH,GC7/H-KRCS/PSEAH-ZT/RES_PSEAH,% of Sub-Recipients (SRs) with PSEAH Policy highlighting Zero Tolerance of SEAH,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Result,PSEAH,No
[GC7/H-KRCS/PSEAH-ZT/TAR_PSEAH] % of Sub-Recipients (SRs) with PSEAH Policy highlighting Zero Tolerance of SEAH,Lt77xzNhmfX,GC7/H-KRCS/PSEAH-ZT/TAR_PSEAH,GC7/H-KRCS/PSEAH-ZT/TAR_PSEAH,% of Sub-Recipients (SRs) with PSEAH Policy highlighting Zero Tolerance of SEAH,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Target,PSEAH,No
"[GC7/H-KRCS/RSSH O-3/COMMENT/OUTCOME] On-shelf availability: Percentage of facilities with tracer health products for the three diseases - HIV, TB, malaria (as applicable) available on the day of the visit or day of reporting.",jpc72J2dcVq,GC7/H-KRCS/RSSH O-3/COMMENT/OUTCOME,GC7/H-KRCS/RSSH O-3/COMMENT/OUTCOME,"On-shelf availability: Percentage of facilities with tracer health products for the three diseases - HIV, TB, malaria (as applicable) available on the day of the visit or day of reporting.",LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,RSSH,No
"[GC7/H-KRCS/RSSH O-3/RESULT/OUTCOME] On-shelf availability: Percentage of facilities with tracer health products for the three diseases - HIV, TB, malaria (as applicable) available on the day of the visit or day of reporting.",WLnBAGvTN8f,GC7/H-KRCS/RSSH O-3/RESULT/OUTCOME,GC7/H-KRCS/RSSH O-3/RESULT/OUTCOME,"On-shelf availability: Percentage of facilities with tracer health products for the three diseases - HIV, TB, malaria (as applicable) available on the day of the visit or day of reporting.",NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,RSSH,No
"[GC7/H-KRCS/RSSH O-3/TARGET/OUTCOME] On-shelf availability: Percentage of facilities with tracer health products for the three diseases - HIV, TB, malaria (as applicable) available on the day of the visit or day of reporting.",iNWXDLbQrIP,GC7/H-KRCS/RSSH O-3/TARGET/OUTCOME,GC7/H-KRCS/RSSH O-3/TARGET/OUTCOME,"On-shelf availability: Percentage of facilities with tracer health products for the three diseases - HIV, TB, malaria (as applicable) available on the day of the visit or day of reporting.",NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,RSSH,No
[GC7/H-KRCS/SAVINGS/FINANCE] PR Savings,aux6CFQiUAD,GC7/H-KRCS/SAVINGS/FINANCE,GC7/H-KRCS/SAVINGS/FINANCE,Savings,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/H-KRCS/TCS-Other/COMMENT/COVERAGE] Number of people living with HIV reached and re-integrated into ART through health facility client tracing mechanism by the community resource persons.,KhfVOPJxPOS,GC7/H-KRCS/TCS-Other/COMMENT/COVERAGE,GC7/H-KRCS/TCS-Other/COMMENT/COVERAGE,Number of people living with HIV reached and re-integrated into ART through health facility client tracing mechanism by the community resource persons.,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/H-KRCS/TCS-Other/RESULT/COVERAGE] Number of people living with HIV reached and re-integrated into ART through health facility client tracing mechanism by the community resource persons.,QZJKfpEnKlx,GC7/H-KRCS/TCS-Other/RESULT/COVERAGE,GC7/H-KRCS/TCS-Other/RESULT/COVERAGE,Number of people living with HIV reached and re-integrated into ART through health facility client tracing mechanism by the community resource persons.,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/H-KRCS/TCS-Other/TARGET/COVERAGE] Number of people living with HIV reached and re-integrated into ART through health facility client tracing mechanism by the community resource persons.,y0h6zvZ067G,GC7/H-KRCS/TCS-Other/TARGET/COVERAGE,GC7/H-KRCS/TCS-Other/TARGET/COVERAGE,Number of people living with HIV reached and re-integrated into ART through health facility client tracing mechanism by the community resource persons.,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/H-KRCS/TOTAL_BUDGET/FINANCE] PR Total Budget,xpyzDtK5p2K,GC7/H-KRCS/TOTAL_BUDGET/FINANCE,GC7/H-KRCS/TOTAL_BUDGET/FINANCE,Total Budget,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/H-KRCS/TOTAL_SR_BUDGET/FINANCE] PR Total Sub Recipients Budget Amount,Bvbv11olLBh,GC7/H-KRCS/TOTAL_SR_BUDGET/FINANCE,GC7/H-KRCS/TOTAL_SR_BUDGET/FINANCE,Total Sub Recipients Budget Amount,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/H-KRCS/YP-2/COMMENT/COVERAGE] % of high-risk adolescent girls and young women reached with HIV prevention programs - defined package of services,Zw63Th36LA9,GC7/H-KRCS/YP-2/COMMENT/COVERAGE,GC7/H-KRCS/YP-2/COMMENT/COVERAGE,% of high-risk adolescent girls and young women reached with HIV prevention programs - defined package of services,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/H-KRCS/YP-2/RESULT/COVERAGE] % of high-risk adolescent girls and young women reached with HIV prevention programs - defined package of services,tqzYFzjwWTe,GC7/H-KRCS/YP-2/RESULT/COVERAGE,GC7/H-KRCS/YP-2/RESULT/COVERAGE,% of high-risk adolescent girls and young women reached with HIV prevention programs - defined package of services,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/H-KRCS/YP-2/TARGET/COVERAGE] % of high-risk adolescent girls and young women reached with HIV prevention programs - defined package of services,wftJBSezy33,GC7/H-KRCS/YP-2/TARGET/COVERAGE,GC7/H-KRCS/YP-2/TARGET/COVERAGE,% of high-risk adolescent girls and young women reached with HIV prevention programs - defined package of services,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/H-KRCS/YP-4/COMMENT/COVERAGE] # of high-risk adolescent girls and young women who received any PrEP product at least once during the reporting period,RRILtUrlsPj,GC7/H-KRCS/YP-4/COMMENT/COVERAGE,GC7/H-KRCS/YP-4/COMMENT/COVERAGE,# of high-risk adolescent girls and young women who received any PrEP product at least once during the reporting period,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/H-KRCS/YP-4/RESULT/COVERAGE] # of high-risk adolescent girls and young women who received any PrEP product at least once during the reporting period,T4qSn1aaVn0,GC7/H-KRCS/YP-4/RESULT/COVERAGE,GC7/H-KRCS/YP-4/RESULT/COVERAGE,# of high-risk adolescent girls and young women who received any PrEP product at least once during the reporting period,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/H-KRCS/YP-4/TARGET/COVERAGE] # of high-risk adolescent girls and young women who received any PrEP product at least once during the reporting period,S4xeE6s5UIf,GC7/H-KRCS/YP-4/TARGET/COVERAGE,GC7/H-KRCS/YP-4/TARGET/COVERAGE,# of high-risk adolescent girls and young women who received any PrEP product at least once during the reporting period,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/H-TNT/ABC/3TC 120/60-AMC/RESULT/COMMODITIES] ABC/3TC 120/60 AMC,sfx5ciwc7uN,GC7/H-TNT/ABC/3TC 120/60-AMC/RESULT/COMMODITIES,GC7/H-TNT/ABC/3TC 120/60-AMC/RESULT/COMMODITIES,ABC/3TC 120/60 AMC,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-TNT/ABC/3TC 120/60-BAL/RESULT/COMMODITIES] ABC/3TC 120/60 Ending Balance,OKjzuzcSW8X,GC7/H-TNT/ABC/3TC 120/60-BAL/RESULT/COMMODITIES,GC7/H-TNT/ABC/3TC 120/60-BAL/RESULT/COMMODITIES,ABC/3TC 120/60 Ending Balance,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-TNT/ABC/3TC 120/60-COMMENT/COMMENT/COMMODITIES] ABC/3TC 120/60 Comments,OAtCR8lEBy6,GC7/H-TNT/ABC/3TC 120/60-COMMENT/COMMENT/COMMODITI,GC7/H-TNT/ABC/3TC 120/60-COMMENT/COMMENT/COMMODITI,ABC/3TC 120/60 Comments,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Products,Comment,,No
[GC7/H-TNT/ABC/3TC 120/60-PROC/RESULT/COMMODITIES] ABC/3TC 120/60 Under Procurement,Tjj0z0FVVb2,GC7/H-TNT/ABC/3TC 120/60-PROC/RESULT/COMMODITIES,GC7/H-TNT/ABC/3TC 120/60-PROC/RESULT/COMMODITIES,ABC/3TC 120/60 Under Procurement,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-TNT/ABC/3TC 120/60-SOR-D/RESULT/COMMODITIES] ABC/3TC 120/60 SOR - Denominator,ysr5ukIAAYE,GC7/H-TNT/ABC/3TC 120/60-SOR-D/RESULT/COMMODITIES,GC7/H-TNT/ABC/3TC 120/60-SOR-D/RESULT/COMMODITIES,ABC/3TC 120/60 SOR - Denominator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-TNT/ABC/3TC 120/60-SOR-N/RESULT/COMMODITIES] ABC/3TC 120/60 SOR - Numerator,yYGlijOlyaK,GC7/H-TNT/ABC/3TC 120/60-SOR-N/RESULT/COMMODITIES,GC7/H-TNT/ABC/3TC 120/60-SOR-N/RESULT/COMMODITIES,ABC/3TC 120/60 SOR - Numerator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-TNT/DTG 10mg-AMC/RESULT/COMMODITIES] DTG 10mg AMC,J7Djeekta4f,GC7/H-TNT/DTG 10mg-AMC/RESULT/COMMODITIES,GC7/H-TNT/DTG 10mg-AMC/RESULT/COMMODITIES,DTG 10mg AMC,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-TNT/DTG 10mg-BAL/RESULT/COMMODITIES] DTG 10mg Ending Balance,Ypei5Ml6u5C,GC7/H-TNT/DTG 10mg-BAL/RESULT/COMMODITIES,GC7/H-TNT/DTG 10mg-BAL/RESULT/COMMODITIES,DTG 10mg Ending Balance,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-TNT/DTG 10mg-COMMENT/COMMENT/COMMODITIES] DTG 10mg Comments,LccPq9zvaz1,GC7/H-TNT/DTG 10mg-COMMENT/COMMENT/COMMODITIES,GC7/H-TNT/DTG 10mg-COMMENT/COMMENT/COMMODITIES,DTG 10mg Comments,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Products,Comment,,No
[GC7/H-TNT/DTG 10mg-PROC/RESULT/COMMODITIES] DTG 10mg Under Procurement,TrGjJLCUK8I,GC7/H-TNT/DTG 10mg-PROC/RESULT/COMMODITIES,GC7/H-TNT/DTG 10mg-PROC/RESULT/COMMODITIES,DTG 10mg Under Procurement,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-TNT/DTG 10mg-SOR-D/RESULT/COMMODITIES] DTG 10mg SOR - Denominator,kzmY7AM1BJm,GC7/H-TNT/DTG 10mg-SOR-D/RESULT/COMMODITIES,GC7/H-TNT/DTG 10mg-SOR-D/RESULT/COMMODITIES,DTG 10mg SOR - Denominator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-TNT/DTG 10mg-SOR-N/RESULT/COMMODITIES] DTG 10mg SOR - Numerator,mF7csDsV13M,GC7/H-TNT/DTG 10mg-SOR-N/RESULT/COMMODITIES,GC7/H-TNT/DTG 10mg-SOR-N/RESULT/COMMODITIES,DTG 10mg SOR - Numerator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-TNT/EID  Qualitative (Roche)-AMC/RESULT/COMMODITIES] EID  Qualitative (Roche) AMC,suunJhs19NE,GC7/H-TNT/EID  Qualitative (Roche)-AMC/RESULT/CO,GC7/H-TNT/EID  Qualitative (Roche)-AMC/RESULT/CO,EID  Qualitative (Roche) AMC,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-TNT/EID  Qualitative (Roche)-BAL/RESULT/COMMODITIES] EID  Qualitative (Roche) Ending Balance,aFqOEg7oZ8H,GC7/H-TNT/EID  Qualitative (Roche)-BAL/RESULT/CO,GC7/H-TNT/EID  Qualitative (Roche)-BAL/RESULT/CO,EID  Qualitative (Roche) Ending Balance,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-TNT/EID  Qualitative (Roche)-COMMENT/COMMENT/COMMODITIES] EID  Qualitative (Roche) Comments,vF7gujXOtmm,GC7/H-TNT/EID  Qualitative (Roche)-COMMENT/COMMEN,GC7/H-TNT/EID  Qualitative (Roche)-COMMENT/COMMEN,EID  Qualitative (Roche) Comments,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Products,Comment,,No
[GC7/H-TNT/EID  Qualitative (Roche)-PROC/RESULT/COMMODITIES] EID  Qualitative (Roche) Under Procurement,gBCISqEJmzJ,GC7/H-TNT/EID  Qualitative (Roche)-PROC/RESULT/C,GC7/H-TNT/EID  Qualitative (Roche)-PROC/RESULT/C,EID  Qualitative (Roche) Under Procurement,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-TNT/EID  Qualitative (Roche)-SOR-D/RESULT/COMMODITIES] EID  Qualitative (Roche) SOR - Denominator,Q5PaImT9y3t,GC7/H-TNT/EID  Qualitative (Roche)-SOR-D/RESULT/,GC7/H-TNT/EID  Qualitative (Roche)-SOR-D/RESULT/,EID  Qualitative (Roche) SOR - Denominator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-TNT/EID  Qualitative (Roche)-SOR-N/RESULT/COMMODITIES] EID  Qualitative (Roche) SOR - Numerator,RO5bUiGSKTg,GC7/H-TNT/EID  Qualitative (Roche)-SOR-N/RESULT/,GC7/H-TNT/EID  Qualitative (Roche)-SOR-N/RESULT/,EID  Qualitative (Roche) SOR - Numerator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-TNT/HIV I-13/COMMENT/IMPACT] Percentage of people living with HIV,Eq3jxxXgrOT,GC7/H-TNT/COMMENT/HIV I-13/COMMENT/IMPACT,GC7/H-TNT/COMMENT/HIV I-13/COMMENT/IMPACT,Percentage of people living with HIV,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Impact,No
[GC7/H-TNT/HIV I-13/RESULT/IMPACT] Percentage of people living with HIV,Z882BK3Zj24,GC7/H-TNT/RESULT/HIV I-13/RESULT/IMPACT,GC7/H-TNT/RESULT/HIV I-13/RESULT/IMPACT,Percentage of people living with HIV,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Impact,No
[GC7/H-TNT/HIV I-13/TARGET/IMPACT] Percentage of people living with HIV,eXVVEy4nbjU,GC7/H-TNT/TARGET/HIV I-13/TARGET/IMPACT,GC7/H-TNT/TARGET/HIV I-13/TARGET/IMPACT,Percentage of people living with HIV,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Impact,No
[GC7/H-TNT/HIV I-14/COMMENT/IMPACT] Number of new HIV infections per 1000 uninfected population,paLHoeeYeWf,GC7/H-TNT/COMMENT/HIV I-14/COMMENT/IMPACT,GC7/H-TNT/COMMENT/HIV I-14/COMMENT/IMPACT,Number of new HIV infections per 1000 uninfected population,LONG_TEXT,AGGREGATE,LONG_TEXT,,Inverse,bjDvmb4bfuf,Program,Comment,Impact,No
[GC7/H-TNT/HIV I-14/RESULT/IMPACT] Number of new HIV infections per 1000 uninfected population,psVUzUy0QmW,GC7/H-TNT/RESULT/HIV I-14/RESULT/IMPACT,GC7/H-TNT/RESULT/HIV I-14/RESULT/IMPACT,Number of new HIV infections per 1000 uninfected population,NUMBER,AGGREGATE,NUMBER,,Inverse,bjDvmb4bfuf,Program,Result,Impact,No
[GC7/H-TNT/HIV I-14/TARGET/IMPACT] Number of new HIV infections per 1000 uninfected population,J3frSOHc7W4,GC7/H-TNT/TARGET/HIV I-14/TARGET/IMPACT,GC7/H-TNT/TARGET/HIV I-14/TARGET/IMPACT,Number of new HIV infections per 1000 uninfected population,NUMBER,AGGREGATE,NUMBER,,Inverse,bjDvmb4bfuf,Program,Target,Impact,No
[GC7/H-TNT/HIV I-6/COMMENT/IMPACT] Estimated percentage of children newly infected with HIV from mother-to-child transmission among women living with HIV delivering in the past 12 months,irqX3d5P9lS,GC7/H-TNT/COMMENT/HIV I-6/COMMENT/IMPACT,GC7/H-TNT/COMMENT/HIV I-6/COMMENT/IMPACT,Estimated percentage of children newly infected with HIV from mother-to-child transmission among women living with HIV delivering in the past 12 months,LONG_TEXT,AGGREGATE,LONG_TEXT,,Inverse,bjDvmb4bfuf,Program,Comment,Impact,No
[GC7/H-TNT/HIV I-6/RESULT/IMPACT] Estimated percentage of children newly infected with HIV from mother-to-child transmission among women living with HIV delivering in the past 12 months,SEDILr3dvNF,GC7/H-TNT/RESULT/HIV I-6/RESULT/IMPACT,GC7/H-TNT/RESULT/HIV I-6/RESULT/IMPACT,Estimated percentage of children newly infected with HIV from mother-to-child transmission among women living with HIV delivering in the past 12 months,NUMBER,AGGREGATE,PERCENTAGE,,Inverse,bjDvmb4bfuf,Program,Result,Impact,No
[GC7/H-TNT/HIV I-6/TARGET/IMPACT] Estimated percentage of children newly infected with HIV from mother-to-child transmission among women living with HIV delivering in the past 12 months,oiJ51TWRLTF,GC7/H-TNT/TARGET/HIV I-6/TARGET/IMPACT,GC7/H-TNT/TARGET/HIV I-6/TARGET/IMPACT,Estimated percentage of children newly infected with HIV from mother-to-child transmission among women living with HIV delivering in the past 12 months,NUMBER,AGGREGATE,PERCENTAGE,,Inverse,bjDvmb4bfuf,Program,Target,Impact,No
[GC7/H-TNT/HIV O-11/COMMENT/OUTCOME] Percentage of people living with HIV who know their HIV status at the end of the reporting period,LPBwJdjzLc0,GC7/H-TNT/COMMENT/HIV O-11/COMMENT/OUTCOME,GC7/H-TNT/COMMENT/HIV O-11/COMMENT/OUTCOME,Percentage of people living with HIV who know their HIV status at the end of the reporting period,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Outcome,No
[GC7/H-TNT/HIV O-11/RESULT/OUTCOME] Percentage of people living with HIV who know their HIV status at the end of the reporting period,jtK1sAycw9K,GC7/H-TNT/RESULT/HIV O-11/RESULT/OUTCOME,GC7/H-TNT/RESULT/HIV O-11/RESULT/OUTCOME,Percentage of people living with HIV who know their HIV status at the end of the reporting period,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Outcome,No
[GC7/H-TNT/HIV O-11/TARGET/OUTCOME] Percentage of people living with HIV who know their HIV status at the end of the reporting period,mrrWrYk2tGZ,GC7/H-TNT/TARGET/HIV O-11/TARGET/OUTCOME,GC7/H-TNT/TARGET/HIV O-11/TARGET/OUTCOME,Percentage of people living with HIV who know their HIV status at the end of the reporting period,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Outcome,No
[GC7/H-TNT/HIV O-12/COMMENT/OUTCOME] Percentage of people living with HIV and on ART who are virologically suppressed,kJGOdldSahw,GC7/H-TNT/COMMENT/HIV O-12/COMMENT/OUTCOME,GC7/H-TNT/COMMENT/HIV O-12/COMMENT/OUTCOME,Percentage of people living with HIV and on ART who are virologically suppressed,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Outcome,No
[GC7/H-TNT/HIV O-12/RESULT/OUTCOME] Percentage of people living with HIV and on ART who are virologically suppressed,YFXNDqC85J7,GC7/H-TNT/RESULT/HIV O-12/RESULT/OUTCOME,GC7/H-TNT/RESULT/HIV O-12/RESULT/OUTCOME,Percentage of people living with HIV and on ART who are virologically suppressed,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Outcome,No
[GC7/H-TNT/HIV O-12/TARGET/OUTCOME] Percentage of people living with HIV and on ART who are virologically suppressed,ZT4bmw1zLpi,GC7/H-TNT/TARGET/HIV O-12/TARGET/OUTCOME,GC7/H-TNT/TARGET/HIV O-12/TARGET/OUTCOME,Percentage of people living with HIV and on ART who are virologically suppressed,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Outcome,No
[GC7/H-TNT/HIV O-21/COMMENT/OUTCOME] Percentage of people living with HIV reported on ART at the end of the last reporting period and newly initiating ART during the current reporting period who were not on ART at the end of curre,TPsG114MAmf,GC7/H-TNT/COMMENT/HIV O-21/COMMENT/OUTCOME,GC7/H-TNT/COMMENT/HIV O-21/COMMENT/OUTCOME,Percentage of people living with HIV reported on ART at the end of the last reporting period and newly initiating ART during the current reporting period who were not on ART at the end of current reporting period,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Outcome,No
[GC7/H-TNT/HIV O-21/RESULT/OUTCOME] Percentage of people living with HIV reported on ART at the end of the last reporting period and newly initiating ART during the current reporting period who were not on ART at the end of curren,gJjdaULxbn7,GC7/H-TNT/RESULT/HIV O-21/RESULT/OUTCOME,GC7/H-TNT/RESULT/HIV O-21/RESULT/OUTCOME,Percentage of people living with HIV reported on ART at the end of the last reporting period and newly initiating ART during the current reporting period who were not on ART at the end of current reporting period,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Outcome,No
[GC7/H-TNT/HIV O-21/TARGET/OUTCOME] Percentage of people living with HIV reported on ART at the end of the last reporting period and newly initiating ART during the current reporting period who were not on ART at the end of curren,L3RyomH9Fte,GC7/H-TNT/TARGET/HIV O-21/TARGET/OUTCOME,GC7/H-TNT/TARGET/HIV O-21/TARGET/OUTCOME,Percentage of people living with HIV reported on ART at the end of the last reporting period and newly initiating ART during the current reporting period who were not on ART at the end of current reporting period,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Outcome,No
[GC7/H-TNT/HIV O-29/COMMENT/OUTCOME] Percentage of HIV-positive results among the total HIV tests,KMH8212cThY,GC7/H-TNT/COMMENT/HIV O-29/COMMENT/OUTCOME,GC7/H-TNT/COMMENT/HIV O-29/COMMENT/OUTCOME,Percentage of HIV-positive results among the total HIV tests,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Outcome,No
[GC7/H-TNT/HIV O-29/RESULT/OUTCOME] Percentage of HIV-positive results among the total HIV tests,oexvpXG8Owt,GC7/H-TNT/RESULT/HIV O-29/RESULT/OUTCOME,GC7/H-TNT/RESULT/HIV O-29/RESULT/OUTCOME,Percentage of HIV-positive results among the total HIV tests,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Outcome,No
[GC7/H-TNT/HIV O-29/TARGET/OUTCOME] Percentage of HIV-positive results among the total HIV tests,OWk2gZpdEFB,GC7/H-TNT/TARGET/HIV O-29/TARGET/OUTCOME,GC7/H-TNT/TARGET/HIV O-29/TARGET/OUTCOME,Percentage of HIV-positive results among the total HIV tests,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Outcome,No
[GC7/H-TNT/HTS-5/COMMENT/COVERAGE] Percentage of people newly diagnosed with HIV initiated on ART,caRRcGCZ0NV,GC7/H-TNT/COMMENT/HTS-5/COMMENT/COVERAGE,GC7/H-TNT/COMMENT/HTS-5/COMMENT/COVERAGE,Percentage of people newly diagnosed with HIV initiated on ART,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/H-TNT/HTS-5/RESULT/COVERAGE] Percentage of people newly diagnosed with HIV initiated on ART,UdVMJJLcmwq,GC7/H-TNT/RESULT/HTS-5/RESULT/COVERAGE,GC7/H-TNT/RESULT/HTS-5/RESULT/COVERAGE,Percentage of people newly diagnosed with HIV initiated on ART,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/H-TNT/HTS-5/TARGET/COVERAGE] Percentage of people newly diagnosed with HIV initiated on ART,G8fOwVv8PRe,GC7/H-TNT/TARGET/HTS-5/TARGET/COVERAGE,GC7/H-TNT/TARGET/HTS-5/TARGET/COVERAGE,Percentage of people newly diagnosed with HIV initiated on ART,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/H-TNT/Nevirapine suspension 10mg/ml-AMC/RESULT/COMMODITIES] Nevirapine suspension 10mg/ml AMC,BacSwNlS6VN,GC7/H-TNT/Nevirapine suspension 10mg/ml-AMC/RESULT,GC7/H-TNT/Nevirapine suspension 10mg/ml-AMC/RESULT,Nevirapine suspension 10mg/ml AMC,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-TNT/Nevirapine suspension 10mg/ml-BAL/RESULT/COMMODITIES] Nevirapine suspension 10mg/ml Ending Balance,dDZ7jZAbTNZ,GC7/H-TNT/Nevirapine suspension 10mg/ml-BAL/RESULT,GC7/H-TNT/Nevirapine suspension 10mg/ml-BAL/RESULT,Nevirapine suspension 10mg/ml Ending Balance,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-TNT/Nevirapine suspension 10mg/ml-COMMENT/COMMENT/COMMODITIES] Nevirapine suspension 10mg/ml Comments,P3doZVNNUWg,GC7/H-TNT/Nevirapine suspension 10mg/ml-COMMENT/CO,GC7/H-TNT/Nevirapine suspension 10mg/ml-COMMENT/CO,Nevirapine suspension 10mg/ml Comments,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Products,Comment,,No
[GC7/H-TNT/Nevirapine suspension 10mg/ml-PROC/RESULT/COMMODITIES] Nevirapine suspension 10mg/ml Under Procurement,fuiYtGzTAgh,GC7/H-TNT/Nevirapine suspension 10mg/ml-PROC/RESUL,GC7/H-TNT/Nevirapine suspension 10mg/ml-PROC/RESUL,Nevirapine suspension 10mg/ml Under Procurement,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-TNT/Nevirapine suspension 10mg/ml-SOR-D/RESULT/COMMODITIES] Nevirapine suspension 10mg/ml SOR - Denominator,ASuyKerbnL5,GC7/H-TNT/Nevirapine suspension 10mg/ml-SOR-D/RESU,GC7/H-TNT/Nevirapine suspension 10mg/ml-SOR-D/RESU,Nevirapine suspension 10mg/ml SOR - Denominator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-TNT/Nevirapine suspension 10mg/ml-SOR-N/RESULT/COMMODITIES] Nevirapine suspension 10mg/ml SOR - Numerator,IFMLXTgX58Y,GC7/H-TNT/Nevirapine suspension 10mg/ml-SOR-N/RESU,GC7/H-TNT/Nevirapine suspension 10mg/ml-SOR-N/RESU,Nevirapine suspension 10mg/ml SOR - Numerator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
"[GC7/H-TNT/PSEAH-CA/COMM_PSEAH] % of community level actors/agents (TB Champions, peer educators, mentor mothers etc) sensitized on PSEAH/SEAH including SEAH reporting channels and have Signed Compliance Document ",ccpe0Ku5Buz,GC7/H-TNT/PSEAH-CA/COMM_PSEAH/COVERAGE,GC7/H-TNT/PSEAH-CA/COMM_PSEAH/COVERAGE,"% of community level actors/agents (TB Champions, peer educators, mentor mothers etc) sensitized on PSEAH/SEAH including SEAH reporting channels and have Signed Compliance Document ",LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,PSEAH,Comment,PSEAH,No
"[GC7/H-TNT/PSEAH-CA/RES_PSEAH] % of community level actors/agents (TB Champions, peer educators, mentor mothers etc) sensitized on PSEAH/SEAH including SEAH reporting channels and have Signed Compliance Document ",RH2Tebc3NmV,GC7/H-TNT/PSEAH-CA/RES_PSEAH/COVERAGE,GC7/H-TNT/PSEAH-CA/RES_PSEAH/COVERAGE,"% of community level actors/agents (TB Champions, peer educators, mentor mothers etc) sensitized on PSEAH/SEAH including SEAH reporting channels and have Signed Compliance Document ",PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Result,PSEAH,No
"[GC7/H-TNT/PSEAH-CA/TAR_PSEAH] % of community level actors/agents (TB Champions, peer educators, mentor mothers etc) sensitized on PSEAH/SEAH including SEAH reporting channels and have Signed Compliance Document ",E4ah5G6Sp2P,GC7/H-TNT/PSEAH-CA/TAR_PSEAH/COVERAGE,GC7/H-TNT/PSEAH-CA/TAR_PSEAH/COVERAGE,"% of community level actors/agents (TB Champions, peer educators, mentor mothers etc) sensitized on PSEAH/SEAH including SEAH reporting channels and have Signed Compliance Document ",PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Target,PSEAH,No
[GC7/H-TNT/PSEAH-PB/COMM_PSEAH] % of programme beneficiaries at community level assessed as being at high/medium risk of SEAH[1] sensitized on PSEAH/SEAH including SEAH reporting channels,xdGSDfrDxup,GC7/H-TNT/PSEAH-PB/COMM_PSEAH/COVERAGE,GC7/H-TNT/PSEAH-PB/COMM_PSEAH/COVERAGE,% of programme beneficiaries at community level assessed as being at high/medium risk of SEAH sensitized on PSEAH/SEAH including SEAH reporting channels,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,PSEAH,Comment,PSEAH,No
[GC7/H-TNT/PSEAH-PB/RES_PSEAH] % of programme beneficiaries at community level assessed as being at high/medium risk of SEAH[1] sensitized on PSEAH/SEAH including SEAH reporting channels,jc1olT64uu4,GC7/H-TNT/PSEAH-PB/RES_PSEAH/COVERAGE,GC7/H-TNT/PSEAH-PB/RES_PSEAH/COVERAGE,% of programme beneficiaries at community level assessed as being at high/medium risk of SEAH sensitized on PSEAH/SEAH including SEAH reporting channels,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Result,PSEAH,No
[GC7/H-TNT/PSEAH-PB/TAR_PSEAH] % of programme beneficiaries at community level assessed as being at high/medium risk of SEAH sensitized on PSEAH/SEAH including SEAH reporting channels,dLiMaGHVDLH,GC7/H-TNT/PSEAH-PB/TAR_PSEAH/COVERAGE,GC7/H-TNT/PSEAH-PB/TAR_PSEAH/COVERAGE,% of programme beneficiaries at community level assessed as being at high/medium risk of SEAH sensitized on PSEAH/SEAH including SEAH reporting channels,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Target,PSEAH,No
[GC7/H-TNT/PSEAH-PR/COMM_PSEAH] % of Principal Recipient (PR) Staff (including Interns and Volunteers) and Board Members Trained on PR PSEAH Policy and Signed Compliance Document Annually,LNqmYfgxHHB,GC7/H-TNT/PSEAH-PR/COMM_PSEAH/COVERAGE,GC7/H-TNT/PSEAH-PR/COMM_PSEAH/COVERAGE,% of Principal Recipient (PR) Staff (including Interns and Volunteers) and Board Members Trained on PR PSEAH Policy and Signed Compliance Document Annually,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,PSEAH,Comment,PSEAH,No
[GC7/H-TNT/PSEAH-PR/RES_PSEAH] % of Principal Recipient (PR) Staff (including Interns and Volunteers) and Board Members Trained on PR PSEAH Policy and Signed Compliance Document Annually,JiuYDuG6Wj0,GC7/H-TNT/PSEAH-PR/RES_PSEAH/COVERAGE,GC7/H-TNT/PSEAH-PR/RES_PSEAH/COVERAGE,% of Principal Recipient (PR) Staff (including Interns and Volunteers) and Board Members Trained on PR PSEAH Policy and Signed Compliance Document Annually,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Result,PSEAH,No
[GC7/H-TNT/PSEAH-PR/TAR_PSEAH] % of Principal Recipient (PR) Staff (including Interns and Volunteers) and Board Members Trained on PR PSEAH Policy and Signed Compliance Document Annually,zd93yNAZ83G,GC7/H-TNT/PSEAH-PR/TAR_PSEAH/COVERAGE,GC7/H-TNT/PSEAH-PR/TAR_PSEAH/COVERAGE,% of Principal Recipient (PR) Staff (including Interns and Volunteers) and Board Members Trained on PR PSEAH Policy and Signed Compliance Document Annually,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Target,PSEAH,No
[GC7/H-TNT/PSEAH-SR/COMM_PSEAH] % of Sub-Recipient (SRs) whose Staff (including Interns and Volunteers) and Board Members Trained on PSEAH Policy and have Signed Compliance Document Annually,KoNVPb08kCC,GC7/H-TNT/PSEAH-SR/COMM_PSEAH/COVERAGE,GC7/H-TNT/PSEAH-SR/COMM_PSEAH/COVERAGE,% of Sub-Recipient (SRs) whose Staff (including Interns and Volunteers) and Board Members Trained on PSEAH Policy and have Signed Compliance Document Annually,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,PSEAH,Comment,PSEAH,No
[GC7/H-TNT/PSEAH-SR/RES_PSEAH] % of Sub-Recipient (SRs) whose Staff (including Interns and Volunteers) and Board Members Trained on PSEAH Policy and have Signed Compliance Document Annually,GAWKpnbWOez,GC7/H-TNT/PSEAH-SR/RES_PSEAH/COVERAGE,GC7/H-TNT/PSEAH-SR/RES_PSEAH/COVERAGE,% of Sub-Recipient (SRs) whose Staff (including Interns and Volunteers) and Board Members Trained on PSEAH Policy and have Signed Compliance Document Annually,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Result,PSEAH,No
[GC7/H-TNT/PSEAH-SR/TAR_PSEAH] % of Sub-Recipient (SRs) whose Staff (including Interns and Volunteers) and Board Members Trained on PSEAH Policy and have Signed Compliance Document Annually,P8VvQT259lr,GC7/H-TNT/PSEAH-SR/TAR_PSEAH/COVERAGE,GC7/H-TNT/PSEAH-SR/TAR_PSEAH/COVERAGE,% of Sub-Recipient (SRs) whose Staff (including Interns and Volunteers) and Board Members Trained on PSEAH Policy and have Signed Compliance Document Annually,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Target,PSEAH,No
[GC7/H-TNT/PSEAH-ZT/COMM_PSEAH] % of Sub-Recipients (SRs) with PSEAH Policy highlighting Zero Tolerance of SEAH,hNC06xeXi70,GC7/H-TNT/PSEAH-ZT/COMM_PSEAH/COVERAGE,GC7/H-TNT/PSEAH-ZT/COMM_PSEAH/COVERAGE,% of Sub-Recipients (SRs) with PSEAH Policy highlighting Zero Tolerance of SEAH,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,PSEAH,Comment,PSEAH,No
[GC7/H-TNT/PSEAH-ZT/RES_PSEAH] % of Sub-Recipients (SRs) with PSEAH Policy highlighting Zero Tolerance of SEAH,FIXo9oqXX2H,GC7/H-TNT/PSEAH-ZT/RES_PSEAH/COVERAGE,GC7/H-TNT/PSEAH-ZT/RES_PSEAH/COVERAGE,% of Sub-Recipients (SRs) with PSEAH Policy highlighting Zero Tolerance of SEAH,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Result,PSEAH,No
[GC7/H-TNT/PSEAH-ZT/TAR_PSEAH] % of Sub-Recipients (SRs) with PSEAH Policy highlighting Zero Tolerance of SEAH,fTQhR9XcRrU,GC7/H-TNT/PSEAH-ZT/TAR_PSEAH/COVERAGE,GC7/H-TNT/PSEAH-ZT/TAR_PSEAH/COVERAGE,% of Sub-Recipients (SRs) with PSEAH Policy highlighting Zero Tolerance of SEAH,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Target,PSEAH,No
"[GC7/H-TNT/RSSH O-3/COMMENT/OUTCOME] On-shelf availability: Percentage of facilities with tracer health products for the three diseases - HIV, TB, malaria (as applicable) available on the day of the visit or day of reporting",EQchMGEeWgk,GC7/H-TNT/COMMENT/RSSH O-3/COMMENT/OUTCOME,GC7/H-TNT/COMMENT/RSSH O-3/COMMENT/OUTCOME,"On-shelf availability: Percentage of facilities with tracer health products for the three diseases - HIV, TB, malaria (as applicable) available on the day of the visit or day of reporting",LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,RSSH,No
"[GC7/H-TNT/RSSH O-3/RESULT/OUTCOME] On-shelf availability: Percentage of facilities with tracer health products for the three diseases - HIV, TB, malaria (as applicable) available on the day of the visit or day of reporting",cNzqdgXahDr,GC7/H-TNT/RESULT/RSSH O-3/RESULT/OUTCOME,GC7/H-TNT/RESULT/RSSH O-3/RESULT/OUTCOME,"On-shelf availability: Percentage of facilities with tracer health products for the three diseases - HIV, TB, malaria (as applicable) available on the day of the visit or day of reporting",NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,RSSH,No
"[GC7/H-TNT/RSSH O-3/TARGET/OUTCOME] On-shelf availability: Percentage of facilities with tracer health products for the three diseases - HIV, TB, malaria (as applicable) available on the day of the visit or day of reporting",mDO7D6x9oFU,GC7/H-TNT/TARGET/RSSH O-3/TARGET/OUTCOME,GC7/H-TNT/TARGET/RSSH O-3/TARGET/OUTCOME,"On-shelf availability: Percentage of facilities with tracer health products for the three diseases - HIV, TB, malaria (as applicable) available on the day of the visit or day of reporting",NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,RSSH,No
[GC7/H-TNT/RSSH/PP LAB-3/COMMENT/COVERAGE] Percentage of laboratories successfully participating in external quality assurance (EQA) or proficiency testing (PT) schemes.,pbC0cNZtQle,GC7/H-TNT/COMMENT/RSSH/PP LAB-3/COMMENT/COVERAGE,GC7/H-TNT/COMMENT/RSSH/PP LAB-3/COMMENT/COVERAGE,Percentage of laboratories successfully participating in external quality assurance (EQA) or proficiency testing (PT) schemes.,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,RSSH,No
[GC7/H-TNT/RSSH/PP LAB-3/RESULT/COVERAGE] Percentage of laboratories successfully participating in external quality assurance (EQA) or proficiency testing (PT) schemes.,ohtfuJqyvfs,GC7/H-TNT/RESULT/RSSH/PP LAB-3/RESULT/COVERAGE,GC7/H-TNT/RESULT/RSSH/PP LAB-3/RESULT/COVERAGE,Percentage of laboratories successfully participating in external quality assurance (EQA) or proficiency testing (PT) schemes.,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,RSSH,No
[GC7/H-TNT/RSSH/PP LAB-3/TARGET/COVERAGE] Percentage of laboratories successfully participating in external quality assurance (EQA) or proficiency testing (PT) schemes.,yIy5lNbpwvO,GC7/H-TNT/TARGET/RSSH/PP LAB-3/TARGET/COVERAGE,GC7/H-TNT/TARGET/RSSH/PP LAB-3/TARGET/COVERAGE,Percentage of laboratories successfully participating in external quality assurance (EQA) or proficiency testing (PT) schemes.,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,RSSH,No
[GC7/H-TNT/TB/HIV-3.1a/COMMENT/COVERAGE] Percentage of people living with HIV newly initiated on ART who were screened for TB,cosz84WnWCF,GC7/H-TNT/COMMENT/TB/HIV-3.1a/COMMENT/COVERAGE,GC7/H-TNT/COMMENT/TB/HIV-3.1a/COMMENT/COVERAGE,Percentage of people living with HIV newly initiated on ART who were screened for TB,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/H-TNT/TB/HIV-3.1a/RESULT/COVERAGE] Percentage of people living with HIV newly initiated on ART who were screened for TB,u8MqKSJMLo7,GC7/H-TNT/RESULT/TB/HIV-3.1a/RESULT/COVERAGE,GC7/H-TNT/RESULT/TB/HIV-3.1a/RESULT/COVERAGE,Percentage of people living with HIV newly initiated on ART who were screened for TB,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/H-TNT/TB/HIV-3.1a/TARGET/COVERAGE] Percentage of people living with HIV newly initiated on ART who were screened for TB,NLsmsgoecWr,GC7/H-TNT/TARGET/TB/HIV-3.1a/TARGET/COVERAGE,GC7/H-TNT/TARGET/TB/HIV-3.1a/TARGET/COVERAGE,Percentage of people living with HIV newly initiated on ART who were screened for TB,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/H-TNT/TB/HIV-7.1/COMMENT/COVERAGE] Percentage of people living with HIV currently enrolled on antiretroviral therapy who started TB preventive treatment (TPT) during the reporting period,Ka7uD31Ribu,GC7/H-TNT/COMMENT/TB/HIV-7.1/COMMENT/COVERAGE,GC7/H-TNT/COMMENT/TB/HIV-7.1/COMMENT/COVERAGE,Percentage of people living with HIV currently enrolled on antiretroviral therapy who started TB preventive treatment (TPT) during the reporting period,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/H-TNT/TB/HIV-7.1/RESULT/COVERAGE] Percentage of people living with HIV currently enrolled on antiretroviral therapy who started TB preventive treatment (TPT) during the reporting period,fWeywafKw3m,GC7/H-TNT/RESULT/TB/HIV-7.1/RESULT/COVERAGE,GC7/H-TNT/RESULT/TB/HIV-7.1/RESULT/COVERAGE,Percentage of people living with HIV currently enrolled on antiretroviral therapy who started TB preventive treatment (TPT) during the reporting period,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/H-TNT/TB/HIV-7.1/TARGET/COVERAGE] Percentage of people living with HIV currently enrolled on antiretroviral therapy who started TB preventive treatment (TPT) during the reporting period,TnirZliWIav,GC7/H-TNT/TARGET/TB/HIV-7.1/TARGET/COVERAGE,GC7/H-TNT/TARGET/TB/HIV-7.1/TARGET/COVERAGE,Percentage of people living with HIV currently enrolled on antiretroviral therapy who started TB preventive treatment (TPT) during the reporting period,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/H-TNT/TCS-1.1/COMMENT/COVERAGE] Percentage of people on ART among all people living with HIV at the end of the reporting period.,GVguxzsGm7M,GC7/H-TNT/COMMENT/TCS-1.1/COMMENT/COVERAGE,GC7/H-TNT/COMMENT/TCS-1.1/COMMENT/COVERAGE,Percentage of people on ART among all people living with HIV at the end of the reporting period.,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/H-TNT/TCS-1.1/RESULT/COVERAGE] Percentage of people on ART among all people living with HIV at the end of the reporting period.,ZHvXKks9e7p,GC7/H-TNT/RESULT/TCS-1.1/RESULT/COVERAGE,GC7/H-TNT/RESULT/TCS-1.1/RESULT/COVERAGE,Percentage of people on ART among all people living with HIV at the end of the reporting period.,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/H-TNT/TCS-1.1/TARGET/COVERAGE] Percentage of people on ART among all people living with HIV at the end of the reporting period.,XqNJF8Zr1nW,GC7/H-TNT/TARGET/TCS-1.1/TARGET/COVERAGE,GC7/H-TNT/TARGET/TCS-1.1/TARGET/COVERAGE,Percentage of people on ART among all people living with HIV at the end of the reporting period.,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/H-TNT/TCS-10/COMMENT/COVERAGE] Percentage of pregnant women living with HIV who received antiretroviral medicine to reduce the risk of vertical transmission of HIV,QwExyqF2irk,GC7/H-TNT/COMMENT/TCS-10/COMMENT/COVERAGE,GC7/H-TNT/COMMENT/TCS-10/COMMENT/COVERAGE,Percentage of pregnant women living with HIV who received antiretroviral medicine to reduce the risk of vertical transmission of HIV,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/H-TNT/TCS-10/RESULT/COVERAGE] Percentage of pregnant women living with HIV who received antiretroviral medicine to reduce the risk of vertical transmission of HIV,enr8JY02HAE,GC7/H-TNT/RESULT/TCS-10/RESULT/COVERAGE,GC7/H-TNT/RESULT/TCS-10/RESULT/COVERAGE,Percentage of pregnant women living with HIV who received antiretroviral medicine to reduce the risk of vertical transmission of HIV,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/H-TNT/TCS-10/TARGET/COVERAGE] Percentage of pregnant women living with HIV who received antiretroviral medicine to reduce the risk of vertical transmission of HIV,QEUFRdj1luB,GC7/H-TNT/TARGET/TCS-10/TARGET/COVERAGE,GC7/H-TNT/TARGET/TCS-10/TARGET/COVERAGE,Percentage of pregnant women living with HIV who received antiretroviral medicine to reduce the risk of vertical transmission of HIV,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/H-TNT/TCS-8/COMMENT/COVERAGE] Percentage of people living with HIV and on ART with viral load test result,JY3Vm61n0lh,GC7/H-TNT/COMMENT/TCS-8/COMMENT/COVERAGE,GC7/H-TNT/COMMENT/TCS-8/COMMENT/COVERAGE,Percentage of people living with HIV and on ART with viral load test result,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/H-TNT/TCS-8/RESULT/COVERAGE] Percentage of people living with HIV and on ART with viral load test result,gg50I5K2FpI,GC7/H-TNT/RESULT/TCS-8/RESULT/COVERAGE,GC7/H-TNT/RESULT/TCS-8/RESULT/COVERAGE,Percentage of people living with HIV and on ART with viral load test result,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/H-TNT/TCS-8/TARGET/COVERAGE] Percentage of people living with HIV and on ART with viral load test result,rWRxs3SIDzr,GC7/H-TNT/TARGET/TCS-8/TARGET/COVERAGE,GC7/H-TNT/TARGET/TCS-8/TARGET/COVERAGE,Percentage of people living with HIV and on ART with viral load test result,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/H-TNT/TDF/3TC/DTG 300/300/50mg-AMC/RESULT/COMMODITIES] TDF/3TC/DTG 300/300/50mg AMC,HEPS1glTdSb,GC7/H-TNT/TDF/3TC/DTG 300/300/50mg-AMC/RESULT/COMM,GC7/H-TNT/TDF/3TC/DTG 300/300/50mg-AMC/RESULT/COMM,TDF/3TC/DTG 300/300/50mg AMC,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-TNT/TDF/3TC/DTG 300/300/50mg-BAL/RESULT/COMMODITIES] TDF/3TC/DTG 300/300/50mg Ending Balance,iEk49jTko3x,GC7/H-TNT/TDF/3TC/DTG 300/300/50mg-BAL/RESULT/COMM,GC7/H-TNT/TDF/3TC/DTG 300/300/50mg-BAL/RESULT/COMM,TDF/3TC/DTG 300/300/50mg Ending Balance,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-TNT/TDF/3TC/DTG 300/300/50mg-COMMENT/COMMENT/COMMODITIES] TDF/3TC/DTG 300/300/50mg Comments,S2fvtmlQ1u1,GC7/H-TNT/TDF/3TC/DTG 300/300/50mg-COMMENT/COMMENT,GC7/H-TNT/TDF/3TC/DTG 300/300/50mg-COMMENT/COMMENT,TDF/3TC/DTG 300/300/50mg Comments,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Products,Comment,,No
[GC7/H-TNT/TDF/3TC/DTG 300/300/50mg-PROC/RESULT/COMMODITIES] TDF/3TC/DTG 300/300/50mg Under Procurement,YheseudKJM3,GC7/H-TNT/TDF/3TC/DTG 300/300/50mg-PROC/RESULT/COM,GC7/H-TNT/TDF/3TC/DTG 300/300/50mg-PROC/RESULT/COM,TDF/3TC/DTG 300/300/50mg Under Procurement,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-TNT/TDF/3TC/DTG 300/300/50mg-SOR-D/RESULT/COMMODITIES] TDF/3TC/DTG 300/300/50mg SOR - Denominator,P4Io8vTb0yi,GC7/H-TNT/TDF/3TC/DTG 300/300/50mg-SOR-D/RESULT/CO,GC7/H-TNT/TDF/3TC/DTG 300/300/50mg-SOR-D/RESULT/CO,TDF/3TC/DTG 300/300/50mg SOR - Denominator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-TNT/TDF/3TC/DTG 300/300/50mg-SOR-N/RESULT/COMMODITIES] TDF/3TC/DTG 300/300/50mg SOR - Numerator,INiKqw0etGE,GC7/H-TNT/TDF/3TC/DTG 300/300/50mg-SOR-N/RESULT/CO,GC7/H-TNT/TDF/3TC/DTG 300/300/50mg-SOR-N/RESULT/CO,TDF/3TC/DTG 300/300/50mg SOR - Numerator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-TNT/TFD/FTC 300/200mg-AMC/RESULT/COMMODITIES] TFD/FTC 300/200mg AMC,zGZBIV3mQ86,GC7/H-TNT/TFD/FTC 300/200mg-AMC/RESULT/COMMODITIES,GC7/H-TNT/TFD/FTC 300/200mg-AMC/RESULT/COMMODITIES,TFD/FTC 300/200mg AMC,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-TNT/TFD/FTC 300/200mg-BAL/RESULT/COMMODITIES] TFD/FTC 300/200mg Ending Balance,uFoF8liD4fr,GC7/H-TNT/TFD/FTC 300/200mg-BAL/RESULT/COMMODITIES,GC7/H-TNT/TFD/FTC 300/200mg-BAL/RESULT/COMMODITIES,TFD/FTC 300/200mg Ending Balance,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-TNT/TFD/FTC 300/200mg-COMMENT/COMMENT/COMMODITIES] TFD/FTC 300/200mg Comments,rrbTxyntCw2,GC7/H-TNT/TFD/FTC 300/200mg-COMMENT/COMMENT/COMMOD,GC7/H-TNT/TFD/FTC 300/200mg-COMMENT/COMMENT/COMMOD,TFD/FTC 300/200mg Comments,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Products,Comment,,No
[GC7/H-TNT/TFD/FTC 300/200mg-PROC/RESULT/COMMODITIES] TFD/FTC 300/200mg Under Procurement,NXritRlb9K4,GC7/H-TNT/TFD/FTC 300/200mg-PROC/RESULT/COMMODITIE,GC7/H-TNT/TFD/FTC 300/200mg-PROC/RESULT/COMMODITIE,TFD/FTC 300/200mg Under Procurement,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-TNT/TFD/FTC 300/200mg-SOR-D/RESULT/COMMODITIES] TFD/FTC 300/200mg SOR - Denominator,v8RKVCNJ6qA,GC7/H-TNT/TFD/FTC 300/200mg-SOR-D/RESULT/COMMODITI,GC7/H-TNT/TFD/FTC 300/200mg-SOR-D/RESULT/COMMODITI,TFD/FTC 300/200mg SOR - Denominator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-TNT/TFD/FTC 300/200mg-SOR-N/RESULT/COMMODITIES] TFD/FTC 300/200mg SOR - Numerator,spdW96DTHbG,GC7/H-TNT/TFD/FTC 300/200mg-SOR-N/RESULT/COMMODITI,GC7/H-TNT/TFD/FTC 300/200mg-SOR-N/RESULT/COMMODITI,TFD/FTC 300/200mg SOR - Numerator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-TNT/Test 1 (Determine/Trinscreen)-AMC/RESULT/COMMODITIES] Test 1 (Determine/Trinscreen) AMC,rRvlXJ5yqtX,GC7/H-TNT/Test 1 (Determine/Trinscreen)-AMC/RESULT,GC7/H-TNT/Test 1 (Determine/Trinscreen)-AMC/RESULT,Test 1 (Determine/Trinscreen) AMC,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-TNT/Test 1 (Determine/Trinscreen)-BAL/RESULT/COMMODITIES] Test 1 (Determine/Trinscreen) Ending Balance,jIDoqcxg2Ks,GC7/H-TNT/Test 1 (Determine/Trinscreen)-BAL/RESULT,GC7/H-TNT/Test 1 (Determine/Trinscreen)-BAL/RESULT,Test 1 (Determine/Trinscreen) Ending Balance,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-TNT/Test 1 (Determine/Trinscreen)-COMMENT/COMMENT/COMMODITIES] Test 1 (Determine/Trinscreen) Comments,a19tPJUw7r3,GC7/H-TNT/Test 1 (Determine/Trinscreen)-COMMENT/CO,GC7/H-TNT/Test 1 (Determine/Trinscreen)-COMMENT/CO,Test 1 (Determine/Trinscreen) Comments,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Products,Comment,,No
[GC7/H-TNT/Test 1 (Determine/Trinscreen)-PROC/RESULT/COMMODITIES] Test 1 (Determine/Trinscreen) Under Procurement,JRbbSiHps6P,GC7/H-TNT/Test 1 (Determine/Trinscreen)-PROC/RESUL,GC7/H-TNT/Test 1 (Determine/Trinscreen)-PROC/RESUL,Test 1 (Determine/Trinscreen) Under Procurement,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-TNT/Test 1 (Determine/Trinscreen)-SOR-D/RESULT/COMMODITIES] Test 1 (Determine/Trinscreen) SOR - Denominator,ZxFdbF3To6N,GC7/H-TNT/Test 1 (Determine/Trinscreen)-SOR-D/RESU,GC7/H-TNT/Test 1 (Determine/Trinscreen)-SOR-D/RESU,Test 1 (Determine/Trinscreen) SOR - Denominator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-TNT/Test 1 (Determine/Trinscreen)-SOR-N/RESULT/COMMODITIES] Test 1 (Determine/Trinscreen) SOR - Numerator,bajDhuPB4DY,GC7/H-TNT/Test 1 (Determine/Trinscreen)-SOR-N/RESU,GC7/H-TNT/Test 1 (Determine/Trinscreen)-SOR-N/RESU,Test 1 (Determine/Trinscreen) SOR - Numerator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-TNT/VL  Quantitative (Abbott)-AMC/RESULT/COMMODITIES] VL  Quantitative (Abbott) AMC,MIW2URrweI8,GC7/H-TNT/VL  Quantitative (Abbott)-AMC/RESULT/CO,GC7/H-TNT/VL  Quantitative (Abbott)-AMC/RESULT/CO,VL  Quantitative (Abbott) AMC,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-TNT/VL  Quantitative (Abbott)-BAL/RESULT/COMMODITIES] VL  Quantitative (Abbott) Ending Balance,i0Ad3vsOMJ9,GC7/H-TNT/VL  Quantitative (Abbott)-BAL/RESULT/CO,GC7/H-TNT/VL  Quantitative (Abbott)-BAL/RESULT/CO,VL  Quantitative (Abbott) Ending Balance,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-TNT/VL  Quantitative (Abbott)-COMMENT/COMMENT/COMMODITIES] VL  Quantitative (Abbott) Comments,cFyEoIxo2UY,GC7/H-TNT/VL  Quantitative (Abbott)-COMMENT/COMME,GC7/H-TNT/VL  Quantitative (Abbott)-COMMENT/COMME,VL  Quantitative (Abbott) Comments,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Products,Comment,,No
[GC7/H-TNT/VL  Quantitative (Abbott)-PROC/RESULT/COMMODITIES] VL  Quantitative (Abbott) Under Procurement,b9l9xJtBaqG,GC7/H-TNT/VL  Quantitative (Abbott)-PROC/RESULT,GC7/H-TNT/VL  Quantitative (Abbott)-PROC/RESULT,VL  Quantitative (Abbott) Under Procurement,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-TNT/VL  Quantitative (Abbott)-SOR-D/RESULT/COMMODITIES] VL  Quantitative (Abbott) SOR - Denominator,Q2Ce5WHFvgO,GC7/H-TNT/VL  Quantitative (Abbott)-SOR-D/RESULT,GC7/H-TNT/VL  Quantitative (Abbott)-SOR-D/RESULT,VL  Quantitative (Abbott) SOR - Denominator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-TNT/VL  Quantitative (Abbott)-SOR-N/RESULT/COMMODITIES] VL  Quantitative (Abbott) SOR - Numerator,Ks1WvH9wP9b,GC7/H-TNT/VL  Quantitative (Abbott)-SOR-N/RESULT,GC7/H-TNT/VL  Quantitative (Abbott)-SOR-N/RESULT,VL  Quantitative (Abbott) SOR - Numerator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/H-TNT/VT-1/COMMENT/COVERAGE] Percentage of pregnant women who know their HIV status,VtVNxkzCeQL,GC7/H-TNT/COMMENT/VT-1/COMMENT/COVERAGE,GC7/H-TNT/COMMENT/VT-1/COMMENT/COVERAGE,Percentage of pregnant women who know their HIV status,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/H-TNT/VT-1/RESULT/COVERAGE] Percentage of pregnant women who know their HIV status,m5Vp5vj7CHe,GC7/H-TNT/RESULT/VT-1/RESULT/COVERAGE,GC7/H-TNT/RESULT/VT-1/RESULT/COVERAGE,Percentage of pregnant women who know their HIV status,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/H-TNT/VT-1/TARGET/COVERAGE] Percentage of pregnant women who know their HIV status,qHB67BywLH4,GC7/H-TNT/TARGET/VT-1/TARGET/COVERAGE,GC7/H-TNT/TARGET/VT-1/TARGET/COVERAGE,Percentage of pregnant women who know their HIV status,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/H-TNT/VT-2/COMMENT/COVERAGE] Percentage of HIV-exposed infants receiving a virological test for HIV within 2 months of birth,jS6vZt0Mjob,GC7/H-TNT/COMMENT/VT-2/COMMENT/COVERAGE,GC7/H-TNT/COMMENT/VT-2/COMMENT/COVERAGE,Percentage of HIV-exposed infants receiving a virological test for HIV within 2 months of birth,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/H-TNT/VT-2/RESULT/COVERAGE] Percentage of HIV-exposed infants receiving a virological test for HIV within 2 months of birth,y6f7ULSeRHM,GC7/H-TNT/RESULT/VT-2/RESULT/COVERAGE,GC7/H-TNT/RESULT/VT-2/RESULT/COVERAGE,Percentage of HIV-exposed infants receiving a virological test for HIV within 2 months of birth,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/H-TNT/VT-2/TARGET/COVERAGE] Percentage of HIV-exposed infants receiving a virological test for HIV within 2 months of birth,ZVvWu2aXBkr,GC7/H-TNT/TARGET/VT-2/TARGET/COVERAGE,GC7/H-TNT/TARGET/VT-2/TARGET/COVERAGE,Percentage of HIV-exposed infants receiving a virological test for HIV within 2 months of birth,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/H-TNT/YP-6/COMMENT/COVERAGE] Number of medical male circumcisions performed according to national standards,DqIVryLayeC,GC7/H-TNT/COMMENT/YP-6/COMMENT/COVERAGE,GC7/H-TNT/COMMENT/YP-6/COMMENT/COVERAGE,Number of medical male circumcisions performed according to national standards,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/H-TNT/YP-6/RESULT/COVERAGE] Number of medical male circumcisions performed according to national standards,vKenNbauaBA,GC7/H-TNT/RESULT/YP-6/RESULT/COVERAGE,GC7/H-TNT/RESULT/YP-6/RESULT/COVERAGE,Number of medical male circumcisions performed according to national standards,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/H-TNT/YP-6/TARGET/COVERAGE] Number of medical male circumcisions performed according to national standards,LsmB0vBZrpG,GC7/H-TNT/TARGET/YP-6/TARGET/COVERAGE,GC7/H-TNT/TARGET/YP-6/TARGET/COVERAGE,Number of medical male circumcisions performed according to national standards,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/TNT-H/COMMIT/FINANCE] PR Commitments,ygONYkKSaRA,GC7/TNT-H/COMMIT/FINANCE,GC7/TNT-H/COMMIT/FINANCE,Commitments,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/TNT-H/CO_FINANCE_ALLOCATION/CO-FINANCE] Total Budget Allocation,ZIZo0IdNTUp,GC7/TNT-H/CO_FINANCE_ALLOCATION/CO-FINANCE,GC7/TNT-H/CO_FINANCE_ALLOCATION/CO-FINANCE,Total Budget Allocation,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Co-financing,,,No
[GC7/TNT-H/CO_FINANCE_BUDGET/CO-FINANCE] Cumulative budget,jzkmr8V8lVW,GC7/TNT-H/CO_FINANCE_BUDGET/CO-FINANCE,GC7/TNT-H/CO_FINANCE_BUDGET/CO-FINANCE,Cumulative budget,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Co-financing,,,No
[GC7/TNT-H/CO_FINANCE_COMMENT/CO-FINANCE] Comments,sKMIK3LvKx0,GC7/TNT-H/CO_FINANCE_COMMENT/CO-FINANCE,GC7/TNT-H/CO_FINANCE_COMMENT/CO-FINANCE,Comments,NUMBER,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Co-financing,,,No
[GC7/TNT-H/CO_FINANCE_COMMIT/CO-FINANCE] Commitments,ufnZTnVel8Q,GC7/TNT-H/CO_FINANCE_COMMIT/CO-FINANCE,GC7/TNT-H/CO_FINANCE_COMMIT/CO-FINANCE,Commitments,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Co-financing,,,No
[GC7/TNT-H/CO_FINANCE_EXPENSES/CO-FINANCE] Cumulative expenditure,PDUm9FCuJ13,GC7/TNT-H/CO_FINANCE_EXPENSES/CO-FINANCE,GC7/TNT-H/CO_FINANCE_EXPENSES/CO-FINANCE,Cumulative expenditure,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Co-financing,,,No
[GC7/TNT-H/CO_FINANCE_OBLIG/CO-FINANCE] Obligations,xQgaWtgyPil,GC7/TNT-H/CO_FINANCE_OBLIG/CO-FINANCE,GC7/TNT-H/CO_FINANCE_OBLIG/CO-FINANCE,Obligations,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Co-financing,,,No
[GC7/TNT-H/CUM_BUDGET/FINANCE] PR Cumulative Budget,ZAVuiMuHXN4,GC7/TNT-H/CUM_BUDGET/FINANCE,GC7/TNT-H/CUM_BUDGET/FINANCE,Cumulative Budget,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/TNT-H/CUM_EXP_PR/FINANCE] PR Cumulative Funds Expensed by PR,iQikdHA1moJ,GC7/TNT-H/CUM_EXP_PR/FINANCE,GC7/TNT-H/CUM_EXP_PR/FINANCE,Cumulative Funds Expensed by PR,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/TNT-H/CUM_EXP_SR/FINANCE] PR Cumulative Funds Expensed by Sub Recipients,gPcINyj8e47,GC7/TNT-H/CUM_EXP_SR/FINANCE,GC7/TNT-H/CUM_EXP_SR/FINANCE,Cumulative Funds Expensed by Sub Recipients,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/TNT-H/CUM_FUNDS_DISB_PR/FINANCE] PR Cumulative Funds Disbursed to PR,e3Sk11X6uTe,GC7/TNT-H/CUM_FUNDS_DISB_PR/FINANCE,GC7/TNT-H/CUM_FUNDS_DISB_PR/FINANCE,Cumulative Funds Disbursed to PR,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/TNT-H/CUM_FUNDS_DISB_SR/FINANCE] PR Cumulative Funds Disbursed to Sub Recipients,Criqh2z4lj7,GC7/TNT-H/CUM_FUNDS_DISB_SR/FINANCE,GC7/TNT-H/CUM_FUNDS_DISB_SR/FINANCE,Cumulative Funds Disbursed to Sub Recipients,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/TNT-H/CUM_SR_BUDGET/FINANCE] PR Cumulative Sub Recipients Budget Amount,oqdfOuX8581,GC7/TNT-H/CUM_SR_BUDGET/FINANCE,GC7/TNT-H/CUM_SR_BUDGET/FINANCE,Cumulative Sub Recipients Budget Amount,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/TNT-H/FIN_NARR/FINANCE] PR Comments,ikwgH6JM7js,GC7/TNT-H/FIN_NARR/FINANCE,GC7/TNT-H/FIN_NARR/FINANCE,Comments,NUMBER,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Finance,,,No
[GC7/TNT-H/FIN_RATING/RATING] PR Financial Rating,Uf1aXu6MbLE,GC7/TNT-H/FIN_RATING/RATING,GC7/TNT-H/FIN_RATING/RATING,Financial Rating,NUMBER,AGGREGATE,TEXT,,,bjDvmb4bfuf,Rating,,,No
[GC7/TNT-H/FIN_RATING_COMMENT/RATING] PR Financial Rating Comments,NsEXfS8P04w,GC7/TNT-H/FIN_RATING_COMMENT/RATING,GC7/TNT-H/FIN_RATING_COMMENT/RATING,Financial Rating Comments,NUMBER,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Rating,,,No
[GC7/TNT-H/FIN_RATING_END/RATING] PR Financial Rating End Date,UM3DEBdWKv2,GC7/TNT-H/FIN_RATING_END/RATING,GC7/TNT-H/FIN_RATING_END/RATING,Financial Rating End Date,NUMBER,AGGREGATE,DATE,,,bjDvmb4bfuf,Rating,,,No
[GC7/TNT-H/FIN_RATING_START/RATING] PR Financial Rating Start Date,BfAUun0m9tn,GC7/TNT-H/FIN_RATING_START/RATING,GC7/TNT-H/FIN_RATING_START/RATING,Financial Rating Start Date,NUMBER,AGGREGATE,DATE,,,bjDvmb4bfuf,Rating,,,No
[GC7/TNT-H/OBLIG/FINANCE] PR Obligations,NrQGFjayjiJ,GC7/TNT-H/OBLIG/FINANCE,GC7/TNT-H/OBLIG/FINANCE,Obligations,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/TNT-H/POST_OUTFLOWS/FINANCE] PR Postponed Outflows,cpOf7c0InUR,GC7/TNT-H/POST_OUTFLOWS/FINANCE,GC7/TNT-H/POST_OUTFLOWS/FINANCE,Postponed Outflows,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/TNT-H/PROG_RATING/RATING] PR Programmatic Rating,Aujs9vdHVBG,GC7/TNT-H/PROG_RATING/RATING,GC7/TNT-H/PROG_RATING/RATING,Programmatic Rating,NUMBER,AGGREGATE,TEXT,,,bjDvmb4bfuf,Rating,,,No
[GC7/TNT-H/PROG_RATING_COMMENT/RATING] PR Programmatic Rating Comments,FRB2S6m7Law,GC7/TNT-H/PROG_RATING_COMMENT/RATING,GC7/TNT-H/PROG_RATING_COMMENT/RATING,Programmatic Rating Comments,NUMBER,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Rating,,,No
[GC7/TNT-H/PROG_RATING_END/RATING] PR Programmatic Rating End Date,rUEsApCCDoa,GC7/TNT-H/PROG_RATING_END/RATING,GC7/TNT-H/PROG_RATING_END/RATING,Programmatic Rating End Date,NUMBER,AGGREGATE,DATE,,,bjDvmb4bfuf,Rating,,,No
[GC7/TNT-H/PROG_RATING_START/RATING] PR Programmatic Rating Start Date,TUB49239yre,GC7/TNT-H/PROG_RATING_START/RATING,GC7/TNT-H/PROG_RATING_START/RATING,Programmatic Rating Start Date,NUMBER,AGGREGATE,DATE,,,bjDvmb4bfuf,Rating,,,No
[GC7/TNT-H/SAVINGS/FINANCE] PR Savings,S7Y2bqFMOGa,GC7/TNT-H/SAVINGS/FINANCE,GC7/TNT-H/SAVINGS/FINANCE,Savings,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/TNT-H/TOTAL_BUDGET/FINANCE] PR Total Budget,GkHKtfq3TSY,GC7/TNT-H/TOTAL_BUDGET/FINANCE,GC7/TNT-H/TOTAL_BUDGET/FINANCE,Total Budget,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/TNT-H/TOTAL_SR_BUDGET/FINANCE] PR Total Sub Recipients Budget Amount,SbLq5dccN74,GC7/TNT-H/TOTAL_SR_BUDGET/FINANCE,GC7/TNT-H/TOTAL_SR_BUDGET/FINANCE,Total Sub Recipients Budget Amount,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/M-AMREF/CM-1b/COMMENT/COVERAGE] Proportion of suspected malaria cases that receive a parasitological test in the community,cOf1GtnuyOc,GC7/M-AMREF/CM-1b/COMMENT/COVERAGE,GC7/M-AMREF/CM-1b/COMMENT/COVERAGE,Proportion of suspected malaria cases that receive a parasitological test in the community,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/M-AMREF/CM-1b/RESULT/COVERAGE] Proportion of suspected malaria cases that receive a parasitological test in the community,A15HECUGxAw,GC7/M-AMREF/CM-1b/RESULT/COVERAGE,GC7/M-AMREF/CM-1b/RESULT/COVERAGE,Proportion of suspected malaria cases that receive a parasitological test in the community,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/M-AMREF/CM-1b/TARGET/COVERAGE] Proportion of suspected malaria cases that receive a parasitological test in the community,zs1J6pucZLQ,GC7/M-AMREF/CM-1b/TARGET/COVERAGE,GC7/M-AMREF/CM-1b/TARGET/COVERAGE,Proportion of suspected malaria cases that receive a parasitological test in the community,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/M-AMREF/CM-2b/COMMENT/COVERAGE] Proportion of confirmed malaria cases that received first-line antimalarial treatment in the community,xP6IAz0vnya,GC7/M-AMREF/CM-2b/COMMENT/COVERAGE,GC7/M-AMREF/CM-2b/COMMENT/COVERAGE,Proportion of confirmed malaria cases that received first-line antimalarial treatment in the community,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/M-AMREF/CM-2b/RESULT/COVERAGE] Proportion of confirmed malaria cases that received first-line antimalarial treatment in the community,VTrQ7KNR2UY,GC7/M-AMREF/CM-2b/RESULT/COVERAGE,GC7/M-AMREF/CM-2b/RESULT/COVERAGE,Proportion of confirmed malaria cases that received first-line antimalarial treatment in the community,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/M-AMREF/CM-2b/TARGET/COVERAGE] Proportion of confirmed malaria cases that received first-line antimalarial treatment in the community,pENMH9hCvhT,GC7/M-AMREF/CM-2b/TARGET/COVERAGE,GC7/M-AMREF/CM-2b/TARGET/COVERAGE,Proportion of confirmed malaria cases that received first-line antimalarial treatment in the community,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/M-AMREF/COMMIT/FINANCE] PR Commitments,xk19YXDCPdy,GC7/M-AMREF/COMMIT/FINANCE,GC7/M-AMREF/COMMIT/FINANCE,Commitments,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/M-AMREF/CUM_BUDGET/FINANCE] PR Cumulative Budget,svgQvRfqn2Q,GC7/M-AMREF/CUM_BUDGET/FINANCE,GC7/M-AMREF/CUM_BUDGET/FINANCE,Cumulative Budget,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/M-AMREF/CUM_EXP_PR/FINANCE] PR Cumulative Funds Expensed by PR,tvjGtw5QhuS,GC7/M-AMREF/CUM_EXP_PR/FINANCE,GC7/M-AMREF/CUM_EXP_PR/FINANCE,Cumulative Funds Expensed by PR,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/M-AMREF/CUM_EXP_SR/FINANCE] PR Cumulative Funds Expensed by Sub Recipients,Utto50MUIBG,GC7/M-AMREF/CUM_EXP_SR/FINANCE,GC7/M-AMREF/CUM_EXP_SR/FINANCE,Cumulative Funds Expensed by Sub Recipients,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/M-AMREF/CUM_FUNDS_DISB_PR/FINANCE] PR Cumulative Funds Disbursed to PR,wP9hN4wEPh8,GC7/M-AMREF/CUM_FUNDS_DISB_PR/FINANCE,GC7/M-AMREF/CUM_FUNDS_DISB_PR/FINANCE,Cumulative Funds Disbursed to PR,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/M-AMREF/CUM_FUNDS_DISB_SR/FINANCE] PR Cumulative Funds Disbursed to Sub Recipients,kLNkpVlKW66,GC7/M-AMREF/CUM_FUNDS_DISB_SR/FINANCE,GC7/M-AMREF/CUM_FUNDS_DISB_SR/FINANCE,Cumulative Funds Disbursed to Sub Recipients,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/M-AMREF/CUM_SR_BUDGET/FINANCE] PR Cumulative Sub Recipients Budget Amount,cR9myHwq5zk,GC7/M-AMREF/CUM_SR_BUDGET/FINANCE,GC7/M-AMREF/CUM_SR_BUDGET/FINANCE,Cumulative Sub Recipients Budget Amount,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/M-AMREF/FIN_NARR/FINANCE] PR Comments,SNDdEx9Apd6,GC7/M-AMREF/FIN_NARR/FINANCE,GC7/M-AMREF/FIN_NARR/FINANCE,Comments,NUMBER,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Finance,,,No
[GC7/M-AMREF/FIN_RATING/RATING] PR Financial Rating,PgEGhqUlefq,GC7/M-AMREF/FIN_RATING/RATING,GC7/M-AMREF/FIN_RATING/RATING,Financial Rating,NUMBER,AGGREGATE,TEXT,,,bjDvmb4bfuf,Rating,,,No
[GC7/M-AMREF/FIN_RATING_COMMENT/RATING] PR Financial Rating Comments,atSo4d7Vx9n,GC7/M-AMREF/FIN_RATING_COMMENT/RATING,GC7/M-AMREF/FIN_RATING_COMMENT/RATING,Financial Rating Comments,NUMBER,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Rating,,,No
[GC7/M-AMREF/FIN_RATING_END/RATING] PR Financial Rating End Date,OkwWLzCnJtD,GC7/M-AMREF/FIN_RATING_END/RATING,GC7/M-AMREF/FIN_RATING_END/RATING,Financial Rating End Date,NUMBER,AGGREGATE,DATE,,,bjDvmb4bfuf,Rating,,,No
[GC7/M-AMREF/FIN_RATING_START/RATING] PR Financial Rating Start Date,SrDJCDK4WyE,GC7/M-AMREF/FIN_RATING_START/RATING,GC7/M-AMREF/FIN_RATING_START/RATING,Financial Rating Start Date,NUMBER,AGGREGATE,DATE,,,bjDvmb4bfuf,Rating,,,No
[GC7/M-AMREF/Malaria I-1/COMMENT/IMPACT] Reported malaria cases (presumed and confirmed),Noddfw0EKqM,GC7/M-AMREF/Malaria I-1/COMMENT/IMPACT,GC7/M-AMREF/Malaria I-1/COMMENT/IMPACT,Reported malaria cases (presumed and confirmed),LONG_TEXT,AGGREGATE,LONG_TEXT,,Inverse,bjDvmb4bfuf,Program,Comment,Impact,No
[GC7/M-AMREF/Malaria I-1/RESULT/IMPACT] Reported malaria cases (presumed and confirmed),TZOBGStfDZd,GC7/M-AMREF/Malaria I-1/RESULT/IMPACT,GC7/M-AMREF/Malaria I-1/RESULT/IMPACT,Reported malaria cases (presumed and confirmed),NUMBER,AGGREGATE,NUMBER,,Inverse,bjDvmb4bfuf,Program,Result,Impact,No
[GC7/M-AMREF/Malaria I-1/TARGET/IMPACT] Reported malaria cases (presumed and confirmed),LLq0YzjJElk,GC7/M-AMREF/Malaria I-1/TARGET/IMPACT,GC7/M-AMREF/Malaria I-1/TARGET/IMPACT,Reported malaria cases (presumed and confirmed),NUMBER,AGGREGATE,NUMBER,,Inverse,bjDvmb4bfuf,Program,Target,Impact,No
[GC7/M-AMREF/Malaria I-2.1/COMMENT/IMPACT] Confirmed malaria cases (microscopy or RDT): rate per 1000 persons per year,iFKwDXYDTVi,GC7/M-AMREF/Malaria I-2.1/COMMENT/IMPACT,GC7/M-AMREF/Malaria I-2.1/COMMENT/IMPACT,Confirmed malaria cases (microscopy or RDT): rate per 1000 persons per year,LONG_TEXT,AGGREGATE,LONG_TEXT,,Inverse,bjDvmb4bfuf,Program,Comment,Impact,No
[GC7/M-AMREF/Malaria I-2.1/RESULT/IMPACT] Confirmed malaria cases (microscopy or RDT): rate per 1000 persons per year,E2rlzYr1Tu2,GC7/M-AMREF/Malaria I-2.1/RESULT/IMPACT,GC7/M-AMREF/Malaria I-2.1/RESULT/IMPACT,Confirmed malaria cases (microscopy or RDT): rate per 1000 persons per year,NUMBER,AGGREGATE,NUMBER,,Inverse,bjDvmb4bfuf,Program,Result,Impact,No
[GC7/M-AMREF/Malaria I-2.1/TARGET/IMPACT] Confirmed malaria cases (microscopy or RDT): rate per 1000 persons per year,co668hw6DqQ,GC7/M-AMREF/Malaria I-2.1/TARGET/IMPACT,GC7/M-AMREF/Malaria I-2.1/TARGET/IMPACT,Confirmed malaria cases (microscopy or RDT): rate per 1000 persons per year,NUMBER,AGGREGATE,NUMBER,,Inverse,bjDvmb4bfuf,Program,Target,Impact,No
"[GC7/M-AMREF/Malaria I-3.1/COMMENT/IMPACT] In-patient malaria deaths: rate per 100,000 persons per year",JWmKTDByKfb,GC7/M-AMREF/Malaria I-3.1/COMMENT/IMPACT,GC7/M-AMREF/Malaria I-3.1/COMMENT/IMPACT,"In-patient malaria deaths: rate per 100,000 persons per year",LONG_TEXT,AGGREGATE,LONG_TEXT,,Inverse,bjDvmb4bfuf,Program,Comment,Impact,No
"[GC7/M-AMREF/Malaria I-3.1/RESULT/IMPACT] In-patient malaria deaths: rate per 100,000 persons per year",wzcQz8VQHZp,GC7/M-AMREF/Malaria I-3.1/RESULT/IMPACT,GC7/M-AMREF/Malaria I-3.1/RESULT/IMPACT,"In-patient malaria deaths: rate per 100,000 persons per year",NUMBER,AGGREGATE,NUMBER,,Inverse,bjDvmb4bfuf,Program,Result,Impact,No
"[GC7/M-AMREF/Malaria I-3.1/TARGET/IMPACT] In-patient malaria deaths: rate per 100,000 persons per year",fLK96mRbhZn,GC7/M-AMREF/Malaria I-3.1/TARGET/IMPACT,GC7/M-AMREF/Malaria I-3.1/TARGET/IMPACT,"In-patient malaria deaths: rate per 100,000 persons per year",NUMBER,AGGREGATE,NUMBER,,Inverse,bjDvmb4bfuf,Program,Target,Impact,No
[GC7/M-AMREF/Malaria I-4/COMMENT/IMPACT] Malaria test positivity rate,MliVtXsUDrn,GC7/M-AMREF/Malaria I-4/COMMENT/IMPACT,GC7/M-AMREF/Malaria I-4/COMMENT/IMPACT,Malaria test positivity rate,LONG_TEXT,AGGREGATE,LONG_TEXT,,Inverse,bjDvmb4bfuf,Program,Comment,Impact,No
[GC7/M-AMREF/Malaria I-4/RESULT/IMPACT] Malaria test positivity rate,ihalremxirA,GC7/M-AMREF/Malaria I-4/RESULT/IMPACT,GC7/M-AMREF/Malaria I-4/RESULT/IMPACT,Malaria test positivity rate,PERCENTAGE,AGGREGATE,PERCENTAGE,,Inverse,bjDvmb4bfuf,Program,Result,Impact,No
[GC7/M-AMREF/Malaria I-4/TARGET/IMPACT] Malaria test positivity rate,DEWR7KCQ922,GC7/M-AMREF/Malaria I-4/TARGET/IMPACT,GC7/M-AMREF/Malaria I-4/TARGET/IMPACT,Malaria test positivity rate,PERCENTAGE,AGGREGATE,PERCENTAGE,,Inverse,bjDvmb4bfuf,Program,Target,Impact,No
[GC7/M-AMREF/Malaria I-5.1/COMMENT/IMPACT] Malaria Parasite prevalence: Proportion of population with malaria infection,RK0fmkDVWQJ,GC7/M-AMREF/Malaria I-5.1/COMMENT/IMPACT,GC7/M-AMREF/Malaria I-5.1/COMMENT/IMPACT,Malaria Parasite prevalence: Proportion of population with malaria infection,LONG_TEXT,AGGREGATE,LONG_TEXT,,Inverse,bjDvmb4bfuf,Program,Comment,Impact,No
[GC7/M-AMREF/Malaria I-5.1/RESULT/IMPACT] Malaria Parasite prevalence: Proportion of population with malaria infection,G5mf9ZGzjxC,GC7/M-AMREF/Malaria I-5.1/RESULT/IMPACT,GC7/M-AMREF/Malaria I-5.1/RESULT/IMPACT,Malaria Parasite prevalence: Proportion of population with malaria infection,NUMBER,AGGREGATE,NUMBER,,Inverse,bjDvmb4bfuf,Program,Result,Impact,No
[GC7/M-AMREF/Malaria I-5.1/TARGET/IMPACT] Malaria Parasite prevalence: Proportion of population with malaria infection,CANVcKDyYcA,GC7/M-AMREF/Malaria I-5.1/TARGET/IMPACT,GC7/M-AMREF/Malaria I-5.1/TARGET/IMPACT,Malaria Parasite prevalence: Proportion of population with malaria infection,NUMBER,AGGREGATE,NUMBER,,Inverse,bjDvmb4bfuf,Program,Target,Impact,No
[GC7/M-AMREF/Malaria O-14/COMMENT/OUTCOME] Proportion of children aged < 5 years with fever in previous 2 weeks who had a finger or heel stick,XubAGERvsGA,GC7/M-AMREF/Malaria O-14/COMMENT/OUTCOME,GC7/M-AMREF/Malaria O-14/COMMENT/OUTCOME,Proportion of children aged < 5 years with fever in previous 2 weeks who had a finger or heel stick,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Outcome,No
[GC7/M-AMREF/Malaria O-14/RESULT/OUTCOME] Proportion of children aged < 5 years with fever in previous 2 weeks who had a finger or heel stick,dvKzEZu8dwk,GC7/M-AMREF/Malaria O-14/RESULT/OUTCOME,GC7/M-AMREF/Malaria O-14/RESULT/OUTCOME,Proportion of children aged < 5 years with fever in previous 2 weeks who had a finger or heel stick,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Outcome,No
[GC7/M-AMREF/Malaria O-14/TARGET/OUTCOME] Proportion of children aged < 5 years with fever in previous 2 weeks who had a finger or heel stick,WVe30w2efNS,GC7/M-AMREF/Malaria O-14/TARGET/OUTCOME,GC7/M-AMREF/Malaria O-14/TARGET/OUTCOME,Proportion of children aged < 5 years with fever in previous 2 weeks who had a finger or heel stick,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Outcome,No
[GC7/M-AMREF/Malaria O-1a/COMMENT/OUTCOME] Proportion of population that slept under an insecticide-treated net the previous night,EeoeMM05bl7,GC7/M-AMREF/Malaria O-1a/COMMENT/OUTCOME,GC7/M-AMREF/Malaria O-1a/COMMENT/OUTCOME,Proportion of population that slept under an insecticide-treated net the previous night,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Outcome,No
[GC7/M-AMREF/Malaria O-1a/RESULT/OUTCOME] Proportion of population that slept under an insecticide-treated net the previous night,iL3fzxfJKzm,GC7/M-AMREF/Malaria O-1a/RESULT/OUTCOME,GC7/M-AMREF/Malaria O-1a/RESULT/OUTCOME,Proportion of population that slept under an insecticide-treated net the previous night,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Outcome,No
[GC7/M-AMREF/Malaria O-1a/TARGET/OUTCOME] Proportion of population that slept under an insecticide-treated net the previous night,rtqr727j42S,GC7/M-AMREF/Malaria O-1a/TARGET/OUTCOME,GC7/M-AMREF/Malaria O-1a/TARGET/OUTCOME,Proportion of population that slept under an insecticide-treated net the previous night,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Outcome,No
[GC7/M-AMREF/Malaria O-1b/COMMENT/OUTCOME] Proportion of children under five years old who slept under an insecticide-treated net the previous night,C7L7LiXoYgy,GC7/M-AMREF/Malaria O-1b/COMMENT/OUTCOME,GC7/M-AMREF/Malaria O-1b/COMMENT/OUTCOME,Proportion of children under five years old who slept under an insecticide-treated net the previous night,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Outcome,No
[GC7/M-AMREF/Malaria O-1b/RESULT/OUTCOME] Proportion of children under five years old who slept under an insecticide-treated net the previous night,OEOSGwQnhxD,GC7/M-AMREF/Malaria O-1b/RESULT/OUTCOME,GC7/M-AMREF/Malaria O-1b/RESULT/OUTCOME,Proportion of children under five years old who slept under an insecticide-treated net the previous night,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Outcome,No
[GC7/M-AMREF/Malaria O-1b/TARGET/OUTCOME] Proportion of children under five years old who slept under an insecticide-treated net the previous night,cJX3uudc14T,GC7/M-AMREF/Malaria O-1b/TARGET/OUTCOME,GC7/M-AMREF/Malaria O-1b/TARGET/OUTCOME,Proportion of children under five years old who slept under an insecticide-treated net the previous night,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Outcome,No
[GC7/M-AMREF/Malaria O-1c/COMMENT/OUTCOME] Proportion of pregnant women who slept under an insecticide-treated net the previous night,gJefMtOWMqN,GC7/M-AMREF/Malaria O-1c/COMMENT/OUTCOME,GC7/M-AMREF/Malaria O-1c/COMMENT/OUTCOME,Proportion of pregnant women who slept under an insecticide-treated net the previous night,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Outcome,No
[GC7/M-AMREF/Malaria O-1c/RESULT/OUTCOME] Proportion of pregnant women who slept under an insecticide-treated net the previous night,TXv2A5zehbw,GC7/M-AMREF/Malaria O-1c/RESULT/OUTCOME,GC7/M-AMREF/Malaria O-1c/RESULT/OUTCOME,Proportion of pregnant women who slept under an insecticide-treated net the previous night,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Outcome,No
[GC7/M-AMREF/Malaria O-1c/TARGET/OUTCOME] Proportion of pregnant women who slept under an insecticide-treated net the previous night,mKZvYVYq6vW,GC7/M-AMREF/Malaria O-1c/TARGET/OUTCOME,GC7/M-AMREF/Malaria O-1c/TARGET/OUTCOME,Proportion of pregnant women who slept under an insecticide-treated net the previous night,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Outcome,No
[GC7/M-AMREF/Malaria O-2/COMMENT/OUTCOME] Proportion of population with access to an ITN within their household,ykAhoWDOwv3,GC7/M-AMREF/Malaria O-2/COMMENT/OUTCOME,GC7/M-AMREF/Malaria O-2/COMMENT/OUTCOME,Proportion of population with access to an ITN within their household,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Outcome,No
[GC7/M-AMREF/Malaria O-2/RESULT/OUTCOME] Proportion of population with access to an ITN within their household,iz03jt5nzvv,GC7/M-AMREF/Malaria O-2/RESULT/OUTCOME,GC7/M-AMREF/Malaria O-2/RESULT/OUTCOME,Proportion of population with access to an ITN within their household,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Outcome,No
[GC7/M-AMREF/Malaria O-2/TARGET/OUTCOME] Proportion of population with access to an ITN within their household,LLbAkLdi6KW,GC7/M-AMREF/Malaria O-2/TARGET/OUTCOME,GC7/M-AMREF/Malaria O-2/TARGET/OUTCOME,Proportion of population with access to an ITN within their household,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Outcome,No
[GC7/M-AMREF/Malaria O-4.1/COMMENT/OUTCOME] Proportion of households with at least one insecticide-treated net for every two people,WGIzkNe8MHj,GC7/M-AMREF/Malaria O-4.1/COMMENT/OUTCOME,GC7/M-AMREF/Malaria O-4.1/COMMENT/OUTCOME,Proportion of households with at least one insecticide-treated net for every two people,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Outcome,No
[GC7/M-AMREF/Malaria O-4.1/RESULT/OUTCOME] Proportion of households with at least one insecticide-treated net for every two people,h2nN698OthA,GC7/M-AMREF/Malaria O-4.1/RESULT/OUTCOME,GC7/M-AMREF/Malaria O-4.1/RESULT/OUTCOME,Proportion of households with at least one insecticide-treated net for every two people,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Outcome,No
[GC7/M-AMREF/Malaria O-4.1/TARGET/OUTCOME] Proportion of households with at least one insecticide-treated net for every two people,aRT2ZPXyP6H,GC7/M-AMREF/Malaria O-4.1/TARGET/OUTCOME,GC7/M-AMREF/Malaria O-4.1/TARGET/OUTCOME,Proportion of households with at least one insecticide-treated net for every two people,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Outcome,No
[GC7/M-AMREF/OBLIG/FINANCE] PR Obligations,Ph0gReEwBEK,GC7/M-AMREF/OBLIG/FINANCE,GC7/M-AMREF/OBLIG/FINANCE,Obligations,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/M-AMREF/POST_OUTFLOWS/FINANCE] PR Postponed Outflows,Z2V3s50ttgT,GC7/M-AMREF/POST_OUTFLOWS/FINANCE,GC7/M-AMREF/POST_OUTFLOWS/FINANCE,Postponed Outflows,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/M-AMREF/PROG_RATING/RATING] PR Programmatic Rating,J8hLb1vJ8R0,GC7/M-AMREF/PROG_RATING/RATING,GC7/M-AMREF/PROG_RATING/RATING,Programmatic Rating,NUMBER,AGGREGATE,TEXT,,,bjDvmb4bfuf,Rating,,,No
[GC7/M-AMREF/PROG_RATING_COMMENT/RATING] PR Programmatic Rating Comments,N6Nfm5dBNz6,GC7/M-AMREF/PROG_RATING_COMMENT/RATING,GC7/M-AMREF/PROG_RATING_COMMENT/RATING,Programmatic Rating Comments,NUMBER,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Rating,,,No
[GC7/M-AMREF/PROG_RATING_END/RATING] PR Programmatic Rating End Date,RPlNhWqzTf1,GC7/M-AMREF/PROG_RATING_END/RATING,GC7/M-AMREF/PROG_RATING_END/RATING,Programmatic Rating End Date,NUMBER,AGGREGATE,DATE,,,bjDvmb4bfuf,Rating,,,No
[GC7/M-AMREF/PROG_RATING_START/RATING] PR Programmatic Rating Start Date,tGEpdGjXOr1,GC7/M-AMREF/PROG_RATING_START/RATING,GC7/M-AMREF/PROG_RATING_START/RATING,Programmatic Rating Start Date,NUMBER,AGGREGATE,DATE,,,bjDvmb4bfuf,Rating,,,No
"[GC7/M-AMREF/PSEAH-CA/COMM_PSEAH] % of community level actors/agents (TB Champions, peer educators, mentor mothers etc) sensitized on PSEAH/SEAH including SEAH reporting channels and have Signed Compliance Document ",dFEOSJbbkb7,GC7/M-AMREF/PSEAH-CA/COMM_PSEAH/COVERAGE,GC7/M-AMREF/PSEAH-CA/COMM_PSEAH/COVERAGE,"% of community level actors/agents (TB Champions, peer educators, mentor mothers etc) sensitized on PSEAH/SEAH including SEAH reporting channels and have Signed Compliance Document ",LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,PSEAH,Comment,PSEAH,No
"[GC7/M-AMREF/PSEAH-CA/RES_PSEAH] % of community level actors/agents (TB Champions, peer educators, mentor mothers etc) sensitized on PSEAH/SEAH including SEAH reporting channels and have Signed Compliance Document ",YT6jLZV3fCY,GC7/M-AMREF/PSEAH-CA/RES_PSEAH/COVERAGE,GC7/M-AMREF/PSEAH-CA/RES_PSEAH/COVERAGE,"% of community level actors/agents (TB Champions, peer educators, mentor mothers etc) sensitized on PSEAH/SEAH including SEAH reporting channels and have Signed Compliance Document ",PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Result,PSEAH,No
"[GC7/M-AMREF/PSEAH-CA/TAR_PSEAH] % of community level actors/agents (TB Champions, peer educators, mentor mothers etc) sensitized on PSEAH/SEAH including SEAH reporting channels and have Signed Compliance Document ",OzMtu5rl6TA,GC7/M-AMREF/PSEAH-CA/TAR_PSEAH/COVERAGE,GC7/M-AMREF/PSEAH-CA/TAR_PSEAH/COVERAGE,"% of community level actors/agents (TB Champions, peer educators, mentor mothers etc) sensitized on PSEAH/SEAH including SEAH reporting channels and have Signed Compliance Document ",PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Target,PSEAH,No
[GC7/M-AMREF/PSEAH-PB/COMM_PSEAH] % of programme beneficiaries at community level assessed as being at high/medium risk of SEAH sensitized on PSEAH/SEAH including SEAH reporting channels,D67Oeycg4xk,GC7/M-AMREF/PSEAH-PB/COMM_PSEAH/COVERAGE,GC7/M-AMREF/PSEAH-PB/COMM_PSEAH/COVERAGE,% of programme beneficiaries at community level assessed as being at high/medium risk of SEAH sensitized on PSEAH/SEAH including SEAH reporting channels,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,PSEAH,Comment,PSEAH,No
[GC7/M-AMREF/PSEAH-PB/RES_PSEAH] % of programme beneficiaries at community level assessed as being at high/medium risk of SEAH sensitized on PSEAH/SEAH including SEAH reporting channels,nYnn1YcvpQE,GC7/M-AMREF/PSEAH-PB/RES_PSEAH/COVERAGE,GC7/M-AMREF/PSEAH-PB/RES_PSEAH/COVERAGE,% of programme beneficiaries at community level assessed as being at high/medium risk of SEAH sensitized on PSEAH/SEAH including SEAH reporting channels,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Result,PSEAH,No
[GC7/M-AMREF/PSEAH-PB/TAR_PSEAH] % of programme beneficiaries at community level assessed as being at high/medium risk of SEAH sensitized on PSEAH/SEAH including SEAH reporting channels,oLLdpd1aryz,GC7/M-AMREF/PSEAH-PB/TAR_PSEAH/COVERAGE,GC7/M-AMREF/PSEAH-PB/TAR_PSEAH/COVERAGE,% of programme beneficiaries at community level assessed as being at high/medium risk of SEAH sensitized on PSEAH/SEAH including SEAH reporting channels,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Target,PSEAH,No
[GC7/M-AMREF/PSEAH-PR/COMM_PSEAH] % of Principal Recipient (PR) Staff (including Interns and Volunteers) and Board Members Trained on PR PSEAH Policy and Signed Compliance Document Annually,mPDMejFyj1m,GC7/M-AMREF/PSEAH-PR/COMM_PSEAH/COVERAGE,GC7/M-AMREF/PSEAH-PR/COMM_PSEAH/COVERAGE,% of Principal Recipient (PR) Staff (including Interns and Volunteers) and Board Members Trained on PR PSEAH Policy and Signed Compliance Document Annually,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,PSEAH,Comment,PSEAH,No
[GC7/M-AMREF/PSEAH-PR/RES_PSEAH] % of Principal Recipient (PR) Staff (including Interns and Volunteers) and Board Members Trained on PR PSEAH Policy and Signed Compliance Document Annually,uU5h1o5hGjn,GC7/M-AMREF/PSEAH-PR/RES_PSEAH/COVERAGE,GC7/M-AMREF/PSEAH-PR/RES_PSEAH/COVERAGE,% of Principal Recipient (PR) Staff (including Interns and Volunteers) and Board Members Trained on PR PSEAH Policy and Signed Compliance Document Annually,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Result,PSEAH,No
[GC7/M-AMREF/PSEAH-PR/TAR_PSEAH] % of Principal Recipient (PR) Staff (including Interns and Volunteers) and Board Members Trained on PR PSEAH Policy and Signed Compliance Document Annually,UrUku9XPyc1,GC7/M-AMREF/PSEAH-PR/TAR_PSEAH/COVERAGE,GC7/M-AMREF/PSEAH-PR/TAR_PSEAH/COVERAGE,% of Principal Recipient (PR) Staff (including Interns and Volunteers) and Board Members Trained on PR PSEAH Policy and Signed Compliance Document Annually,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Target,PSEAH,No
[GC7/M-AMREF/PSEAH-SR/COMM_PSEAH] % of Sub-Recipient (SRs) whose Staff (including Interns and Volunteers) and Board Members Trained on PSEAH Policy and have Signed Compliance Document Annually,hJ603y6alms,GC7/M-AMREF/PSEAH-SR/COMM_PSEAH/COVERAGE,GC7/M-AMREF/PSEAH-SR/COMM_PSEAH/COVERAGE,% of Sub-Recipient (SRs) whose Staff (including Interns and Volunteers) and Board Members Trained on PSEAH Policy and have Signed Compliance Document Annually,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,PSEAH,Comment,PSEAH,No
[GC7/M-AMREF/PSEAH-SR/RES_PSEAH] % of Sub-Recipient (SRs) whose Staff (including Interns and Volunteers) and Board Members Trained on PSEAH Policy and have Signed Compliance Document Annually,bQSXxrNjklk,GC7/M-AMREF/PSEAH-SR/RES_PSEAH/COVERAGE,GC7/M-AMREF/PSEAH-SR/RES_PSEAH/COVERAGE,% of Sub-Recipient (SRs) whose Staff (including Interns and Volunteers) and Board Members Trained on PSEAH Policy and have Signed Compliance Document Annually,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Result,PSEAH,No
[GC7/M-AMREF/PSEAH-SR/TAR_PSEAH] % of Sub-Recipient (SRs) whose Staff (including Interns and Volunteers) and Board Members Trained on PSEAH Policy and have Signed Compliance Document Annually,iVIrWjTFxXp,GC7/M-AMREF/PSEAH-SR/TAR_PSEAH/COVERAGE,GC7/M-AMREF/PSEAH-SR/TAR_PSEAH/COVERAGE,% of Sub-Recipient (SRs) whose Staff (including Interns and Volunteers) and Board Members Trained on PSEAH Policy and have Signed Compliance Document Annually,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Target,PSEAH,No
[GC7/M-AMREF/PSEAH-ZT/COMM_PSEAH] % of Sub-Recipients (SRs) with PSEAH Policy highlighting Zero Tolerance of SEAH,Rd0Jz7PupM4,GC7/M-AMREF/PSEAH-ZT/COMM_PSEAH/COVERAGE,GC7/M-AMREF/PSEAH-ZT/COMM_PSEAH/COVERAGE,% of Sub-Recipients (SRs) with PSEAH Policy highlighting Zero Tolerance of SEAH,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,PSEAH,Comment,PSEAH,No
[GC7/M-AMREF/PSEAH-ZT/RES_PSEAH] % of Sub-Recipients (SRs) with PSEAH Policy highlighting Zero Tolerance of SEAH,kIQTSVwabAk,GC7/M-AMREF/PSEAH-ZT/RES_PSEAH/COVERAGE,GC7/M-AMREF/PSEAH-ZT/RES_PSEAH/COVERAGE,% of Sub-Recipients (SRs) with PSEAH Policy highlighting Zero Tolerance of SEAH,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Result,PSEAH,No
[GC7/M-AMREF/PSEAH-ZT/TAR_PSEAH] % of Sub-Recipients (SRs) with PSEAH Policy highlighting Zero Tolerance of SEAH,AaLCq4MtOBX,GC7/M-AMREF/PSEAH-ZT/TAR_PSEAH/COVERAGE,GC7/M-AMREF/PSEAH-ZT/TAR_PSEAH/COVERAGE,% of Sub-Recipients (SRs) with PSEAH Policy highlighting Zero Tolerance of SEAH,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Target,PSEAH,No
[GC7/M-AMREF/RSSH/PP M&E-1/COMMENT/COVERAGE] Completeness of reporting: Percentage of expected monthly reports (for the reporting period) that are actually received,GKUdD2FDHjj,GC7/M-AMREF/RSSH/PP M&E-1/COMMENT/COVERAGE,GC7/M-AMREF/RSSH/PP M&E-1/COMMENT/COVERAGE,Completeness of reporting: Percentage of expected monthly reports (for the reporting period) that are actually received,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,RSSH,No
[GC7/M-AMREF/RSSH/PP M&E-1/RESULT/COVERAGE] Completeness of reporting: Percentage of expected monthly reports (for the reporting period) that are actually received,pXw8fvXQTHw,GC7/M-AMREF/RSSH/PP M&E-1/RESULT/COVERAGE,GC7/M-AMREF/RSSH/PP M&E-1/RESULT/COVERAGE,Completeness of reporting: Percentage of expected monthly reports (for the reporting period) that are actually received,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,RSSH,No
[GC7/M-AMREF/RSSH/PP M&E-1/TARGET/COVERAGE] Completeness of reporting: Percentage of expected monthly reports (for the reporting period) that are actually received,qlGZyT6eXKl,GC7/M-AMREF/RSSH/PP M&E-1/TARGET/COVERAGE,GC7/M-AMREF/RSSH/PP M&E-1/TARGET/COVERAGE,Completeness of reporting: Percentage of expected monthly reports (for the reporting period) that are actually received,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,RSSH,No
[GC7/M-AMREF/RSSH/PP M&E-2/COMMENT/COVERAGE] Timeliness of reporting: Percentage of submitted monthly reports (for the reporting period) that are received on time per the national guidelines,Bj8WP045k7b,GC7/M-AMREF/RSSH/PP M&E-2/COMMENT/COVERAGE,GC7/M-AMREF/RSSH/PP M&E-2/COMMENT/COVERAGE,Timeliness of reporting: Percentage of submitted monthly reports (for the reporting period) that are received on time per the national guidelines,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,RSSH,No
[GC7/M-AMREF/RSSH/PP M&E-2/RESULT/COVERAGE] Timeliness of reporting: Percentage of submitted monthly reports (for the reporting period) that are received on time per the national guidelines,wu2G38bbUZN,GC7/M-AMREF/RSSH/PP M&E-2/RESULT/COVERAGE,GC7/M-AMREF/RSSH/PP M&E-2/RESULT/COVERAGE,Timeliness of reporting: Percentage of submitted monthly reports (for the reporting period) that are received on time per the national guidelines,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,RSSH,No
[GC7/M-AMREF/RSSH/PP M&E-2/TARGET/COVERAGE] Timeliness of reporting: Percentage of submitted monthly reports (for the reporting period) that are received on time per the national guidelines,Mf5By5k4Nlc,GC7/M-AMREF/RSSH/PP M&E-2/TARGET/COVERAGE,GC7/M-AMREF/RSSH/PP M&E-2/TARGET/COVERAGE,Timeliness of reporting: Percentage of submitted monthly reports (for the reporting period) that are received on time per the national guidelines,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,RSSH,No
[GC7/M-AMREF/SAVINGS/FINANCE] PR Savings,W4cR3pfNkSi,GC7/M-AMREF/SAVINGS/FINANCE,GC7/M-AMREF/SAVINGS/FINANCE,Savings,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/M-AMREF/SPI-1/COMMENT/COVERAGE] Proportion of pregnant women attending antenatal clinics who received three or more doses of intermittent preventive treatment for malaria,HlvCFUFvf5i,GC7/M-AMREF/SPI-1/COMMENT/COVERAGE,GC7/M-AMREF/SPI-1/COMMENT/COVERAGE,Proportion of pregnant women attending antenatal clinics who received three or more doses of intermittent preventive treatment for malaria,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/M-AMREF/SPI-1/RESULT/COVERAGE] Proportion of pregnant women attending antenatal clinics who received three or more doses of intermittent preventive treatment for malaria,xp0kJ65zaRG,GC7/M-AMREF/SPI-1/RESULT/COVERAGE,GC7/M-AMREF/SPI-1/RESULT/COVERAGE,Proportion of pregnant women attending antenatal clinics who received three or more doses of intermittent preventive treatment for malaria,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/M-AMREF/SPI-1/TARGET/COVERAGE] Proportion of pregnant women attending antenatal clinics who received three or more doses of intermittent preventive treatment for malaria,LnOyG8MNyKh,GC7/M-AMREF/SPI-1/TARGET/COVERAGE,GC7/M-AMREF/SPI-1/TARGET/COVERAGE,Proportion of pregnant women attending antenatal clinics who received three or more doses of intermittent preventive treatment for malaria,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/M-AMREF/TOTAL_BUDGET/FINANCE] PR Total Budget,tNruptWLWxP,GC7/M-AMREF/TOTAL_BUDGET/FINANCE,GC7/M-AMREF/TOTAL_BUDGET/FINANCE,Total Budget,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/M-AMREF/TOTAL_SR_BUDGET/FINANCE] PR Total Sub Recipients Budget Amount,p4crwq3gK6d,GC7/M-AMREF/TOTAL_SR_BUDGET/FINANCE,GC7/M-AMREF/TOTAL_SR_BUDGET/FINANCE,Total Sub Recipients Budget Amount,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/M-TNT/AL12-AMC/RESULT/COMMODITIES] AL 12's AMC,xgf56l4w0ir,GC7/M-TNT/AL12-AMC/RESULT/COMMODITIES,GC7/M-TNT/AL12-AMC/RESULT/COMMODITIES,AL 12's AMC,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/M-TNT/AL12-BAL/RESULT/COMMODITIES] AL 12's Ending Balance,rXBfj4H08EG,GC7/M-TNT/AL12-BAL/RESULT/COMMODITIES,GC7/M-TNT/AL12-BAL/RESULT/COMMODITIES,AL 12's Ending Balance,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/M-TNT/AL12-COMMENT/COMMENT/COMMODITIES] AL 12's Comments,mvLah2Fso9L,GC7/M-TNT/AL12-COMMENT/COMMENT/COMMODITIES,GC7/M-TNT/AL12-COMMENT/COMMENT/COMMODITIES,AL 12's Comments,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Products,Comment,,No
[GC7/M-TNT/AL12-PROC/RESULT/COMMODITIES] AL 12's Under Procurement,CwumeZZjEzb,GC7/M-TNT/AL12-PROC/RESULT/COMMODITIES,GC7/M-TNT/AL12-PROC/RESULT/COMMODITIES,AL 12's Under Procurement,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/M-TNT/AL12-SOR-D/RESULT/COMMODITIES] AL 12's SOR - Denominator,gvJIeaawyIS,GC7/M-TNT/AL12-SOR-D/RESULT/COMMODITIES,GC7/M-TNT/AL12-SOR-D/RESULT/COMMODITIES,AL 12's SOR - Denominator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/M-TNT/AL12-SOR-N/RESULT/COMMODITIES] AL 12's SOR - Numerator,bSQkbkw6N6k,GC7/M-TNT/AL12-SOR-N/RESULT/COMMODITIES,GC7/M-TNT/AL12-SOR-N/RESULT/COMMODITIES,AL 12's SOR - Numerator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/M-TNT/AL18-AMC/RESULT/COMMODITIES] AL 18's AMC,gD0nsjSRIfK,GC7/M-TNT/AL18-AMC/RESULT/COMMODITIES,GC7/M-TNT/AL18-AMC/RESULT/COMMODITIES,AL 18's AMC,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/M-TNT/AL18-BAL/RESULT/COMMODITIES] AL 18's Ending Balance,PgJLcarbBXN,GC7/M-TNT/AL18-BAL/RESULT/COMMODITIES,GC7/M-TNT/AL18-BAL/RESULT/COMMODITIES,AL 18's Ending Balance,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/M-TNT/AL18-COMMENT/COMMENT/COMMODITIES] AL 18's Comments,PNz1UhN5hBV,GC7/M-TNT/AL18-COMMENT/COMMENT/COMMODITIES,GC7/M-TNT/AL18-COMMENT/COMMENT/COMMODITIES,AL 18's Comments,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Products,Comment,,No
[GC7/M-TNT/AL18-PROC/RESULT/COMMODITIES] AL 18's Under Procurement,TBjAlIFdBIW,GC7/M-TNT/AL18-PROC/RESULT/COMMODITIES,GC7/M-TNT/AL18-PROC/RESULT/COMMODITIES,AL 18's Under Procurement,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/M-TNT/AL18-SOR-D/RESULT/COMMODITIES] AL 18's SOR - Denominator,FVPEpJ1xASI,GC7/M-TNT/AL18-SOR-D/RESULT/COMMODITIES,GC7/M-TNT/AL18-SOR-D/RESULT/COMMODITIES,AL 18's SOR - Denominator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/M-TNT/AL18-SOR-N/RESULT/COMMODITIES] AL 18's SOR - Numerator,CzrmqR4oye1,GC7/M-TNT/AL18-SOR-N/RESULT/COMMODITIES,GC7/M-TNT/AL18-SOR-N/RESULT/COMMODITIES,AL 18's SOR - Numerator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/M-TNT/AL24-AMC/RESULT/COMMODITIES] AL 24's AMC,HWYNrQVatSg,GC7/M-TNT/AL24-AMC/RESULT/COMMODITIES,GC7/M-TNT/AL24-AMC/RESULT/COMMODITIES,AL 24's AMC,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/M-TNT/AL24-BAL/RESULT/COMMODITIES] AL 24's Ending Balance,yMFiqybwNea,GC7/M-TNT/AL24-BAL/RESULT/COMMODITIES,GC7/M-TNT/AL24-BAL/RESULT/COMMODITIES,AL 24's Ending Balance,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/M-TNT/AL24-COMMENT/COMMENT/COMMODITIES] AL 24's Comments,ExEsfQOxJCx,GC7/M-TNT/AL24-COMMENT/COMMENT/COMMODITIES,GC7/M-TNT/AL24-COMMENT/COMMENT/COMMODITIES,AL 24's Comments,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Products,Comment,,No
[GC7/M-TNT/AL24-PROC/RESULT/COMMODITIES] AL 24's Under Procurement,hQw03xv9rdx,GC7/M-TNT/AL24-PROC/RESULT/COMMODITIES,GC7/M-TNT/AL24-PROC/RESULT/COMMODITIES,AL 24's Under Procurement,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/M-TNT/AL24-SOR-D/RESULT/COMMODITIES] AL 24's SOR - Denominator,qaifPBtHpL2,GC7/M-TNT/AL24-SOR-D/RESULT/COMMODITIES,GC7/M-TNT/AL24-SOR-D/RESULT/COMMODITIES,AL 24's SOR - Denominator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/M-TNT/AL24-SOR-N/RESULT/COMMODITIES] AL 24's SOR - Numerator,tKxH3aWA8ri,GC7/M-TNT/AL24-SOR-N/RESULT/COMMODITIES,GC7/M-TNT/AL24-SOR-N/RESULT/COMMODITIES,AL 24's SOR - Numerator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/M-TNT/AL6-AMC/RESULT/COMMODITIES] AL 6's AMC,XZkdU8vB8Am,GC7/M-TNT/AL6-AMC/RESULT/COMMODITIES,GC7/M-TNT/AL6-AMC/RESULT/COMMODITIES,AL 6's AMC,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/M-TNT/AL6-BAL/RESULT/COMMODITIES] AL 6's Ending Balance,uSdDwdtpbEu,GC7/M-TNT/AL6-BAL/RESULT/COMMODITIES,GC7/M-TNT/AL6-BAL/RESULT/COMMODITIES,AL 6's Ending Balance,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/M-TNT/AL6-COMMENT/COMMENT/COMMODITIES] AL 6's Comments,JNKDf95JeNt,GC7/M-TNT/AL6-COMMENT/COMMENT/COMMODITIES,GC7/M-TNT/AL6-COMMENT/COMMENT/COMMODITIES,AL 6's Comments,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Products,Comment,,No
[GC7/M-TNT/AL6-PROC/RESULT/COMMODITIES] AL 6's Under Procurement,wjph4XfkEox,GC7/M-TNT/AL6-PROC/RESULT/COMMODITIES,GC7/M-TNT/AL6-PROC/RESULT/COMMODITIES,AL 6's Under Procurement,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/M-TNT/AL6-SOR-D/RESULT/COMMODITIES] AL 6's SOR - Denominator,b3NzPvOt607,GC7/M-TNT/AL6-SOR-D/RESULT/COMMODITIES,GC7/M-TNT/AL6-SOR-D/RESULT/COMMODITIES,AL 6's SOR - Denominator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/M-TNT/AL6-SOR-N/RESULT/COMMODITIES] AL 6's SOR - Numerator,gEp5M2KKkEW,GC7/M-TNT/AL6-SOR-N/RESULT/COMMODITIES,GC7/M-TNT/AL6-SOR-N/RESULT/COMMODITIES,AL 6's SOR - Numerator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/M-TNT/ARTESUNATE-AMC/RESULT/COMMODITIES] ARTESUNATE Injectable AMC,mJyDaJjJ2ON,GC7/M-TNT/ARTESUNATE-AMC/RESULT/COMMODITIES,GC7/M-TNT/ARTESUNATE-AMC/RESULT/COMMODITIES,ARTESUNATE Injectable AMC,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/M-TNT/ARTESUNATE-BAL/RESULT/COMMODITIES] ARTESUNATE Injectable Ending Balance,gpwhRlFADur,GC7/M-TNT/ARTESUNATE-BAL/RESULT/COMMODITIES,GC7/M-TNT/ARTESUNATE-BAL/RESULT/COMMODITIES,ARTESUNATE Injectable Ending Balance,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/M-TNT/ARTESUNATE-COMMENT/COMMENT/COMMODITIES] ARTESUNATE Injectable Comments,LLhlE4uYiit,GC7/M-TNT/ARTESUNATE-COMMENT/COMMENT/COMMODITIES,GC7/M-TNT/ARTESUNATE-COMMENT/COMMENT/COMMODITIES,ARTESUNATE Injectable Comments,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Products,Comment,,No
[GC7/M-TNT/ARTESUNATE-PROC/RESULT/COMMODITIES] ARTESUNATE Injectable Under Procurement,eJGPfYyVxpA,GC7/M-TNT/ARTESUNATE-PROC/RESULT/COMMODITIES,GC7/M-TNT/ARTESUNATE-PROC/RESULT/COMMODITIES,ARTESUNATE Injectable Under Procurement,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/M-TNT/ARTESUNATE-SOR-D/RESULT/COMMODITIES] ARTESUNATE Injectable SOR - Denominator,d19dg5JNKmD,GC7/M-TNT/ARTESUNATE-SOR-D/RESULT/COMMODITIES,GC7/M-TNT/ARTESUNATE-SOR-D/RESULT/COMMODITIES,ARTESUNATE Injectable SOR - Denominator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/M-TNT/ARTESUNATE-SOR-N/RESULT/COMMODITIES] ARTESUNATE Injectable SOR - Numerator,sS4CmF7L0nn,GC7/M-TNT/ARTESUNATE-SOR-N/RESULT/COMMODITIES,GC7/M-TNT/ARTESUNATE-SOR-N/RESULT/COMMODITIES,ARTESUNATE Injectable SOR - Numerator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/M-TNT/CM-1a/COMMENT/COVERAGE] Proportion of suspected malaria cases that receive a parasitological test at public sector health facilities,wOYR9rWiKjs,GC7/M-TNT/COMMENT/CM-1a/COMMENT/COVERAGE,GC7/M-TNT/COMMENT/CM-1a/COMMENT/COVERAGE,Proportion of suspected malaria cases that receive a parasitological test at public sector health facilities,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/M-TNT/CM-1a/RESULT/COVERAGE] Proportion of suspected malaria cases that receive a parasitological test at public sector health facilities,NWBfxz1Iwmk,GC7/M-TNT/RESULT/CM-1a/RESULT/COVERAGE,GC7/M-TNT/RESULT/CM-1a/RESULT/COVERAGE,Proportion of suspected malaria cases that receive a parasitological test at public sector health facilities,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/M-TNT/CM-1a/TARGET/COVERAGE] Proportion of suspected malaria cases that receive a parasitological test at public sector health facilities,nTSvbcmKM6n,GC7/M-TNT/TARGET/CM-1a/TARGET/COVERAGE,GC7/M-TNT/TARGET/CM-1a/TARGET/COVERAGE,Proportion of suspected malaria cases that receive a parasitological test at public sector health facilities,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/M-TNT/CM-1b/COMMENT/COVERAGE] Proportion of suspected malaria cases that receive a parasitological test in the community,B1SQtjXlBSD,GC7/M-TNT/COMMENT/CM-1b/COMMENT/COVERAGE,GC7/M-TNT/COMMENT/CM-1b/COMMENT/COVERAGE,Proportion of suspected malaria cases that receive a parasitological test in the community,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/M-TNT/CM-1b/RESULT/COVERAGE] Proportion of suspected malaria cases that receive a parasitological test in the community,vr5NdiRw4Ek,GC7/M-TNT/RESULT/CM-1b/RESULT/COVERAGE,GC7/M-TNT/RESULT/CM-1b/RESULT/COVERAGE,Proportion of suspected malaria cases that receive a parasitological test in the community,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/M-TNT/CM-1b/TARGET/COVERAGE] Proportion of suspected malaria cases that receive a parasitological test in the community,gCrJ531OSWr,GC7/M-TNT/TARGET/CM-1b/TARGET/COVERAGE,GC7/M-TNT/TARGET/CM-1b/TARGET/COVERAGE,Proportion of suspected malaria cases that receive a parasitological test in the community,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/M-TNT/CM-2a/COMMENT/COVERAGE] Proportion of confirmed malaria cases that received first-line antimalarial treatment at public sector health facilities,bnFEwVwhMRx,GC7/M-TNT/COMMENT/CM-2a/COMMENT/COVERAGE,GC7/M-TNT/COMMENT/CM-2a/COMMENT/COVERAGE,Proportion of confirmed malaria cases that received first-line antimalarial treatment at public sector health facilities,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/M-TNT/CM-2a/RESULT/COVERAGE] Proportion of confirmed malaria cases that received first-line antimalarial treatment at public sector health facilities,LW3E4uW1tyW,GC7/M-TNT/RESULT/CM-2a/RESULT/COVERAGE,GC7/M-TNT/RESULT/CM-2a/RESULT/COVERAGE,Proportion of confirmed malaria cases that received first-line antimalarial treatment at public sector health facilities,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/M-TNT/CM-2a/TARGET/COVERAGE] Proportion of confirmed malaria cases that received first-line antimalarial treatment at public sector health facilities,H38Fkoei3wA,GC7/M-TNT/TARGET/CM-2a/TARGET/COVERAGE,GC7/M-TNT/TARGET/CM-2a/TARGET/COVERAGE,Proportion of confirmed malaria cases that received first-line antimalarial treatment at public sector health facilities,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/M-TNT/CM-2b/COMMENT/COVERAGE] Proportion of confirmed malaria cases that received first-line antimalarial treatment in the community,PfzpIwwUaxW,GC7/M-TNT/COMMENT/CM-2b/COMMENT/COVERAGE,GC7/M-TNT/COMMENT/CM-2b/COMMENT/COVERAGE,Proportion of confirmed malaria cases that received first-line antimalarial treatment in the community,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/M-TNT/CM-2b/RESULT/COVERAGE] Proportion of confirmed malaria cases that received first-line antimalarial treatment in the community,w0imlV0rfJR,GC7/M-TNT/RESULT/CM-2b/RESULT/COVERAGE,GC7/M-TNT/RESULT/CM-2b/RESULT/COVERAGE,Proportion of confirmed malaria cases that received first-line antimalarial treatment in the community,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/M-TNT/CM-2b/TARGET/COVERAGE] Proportion of confirmed malaria cases that received first-line antimalarial treatment in the community,gzkkOVtQPib,GC7/M-TNT/TARGET/CM-2b/TARGET/COVERAGE,GC7/M-TNT/TARGET/CM-2b/TARGET/COVERAGE,Proportion of confirmed malaria cases that received first-line antimalarial treatment in the community,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/M-TNT/COMMIT/FINANCE] PR Commitments,YxC5t8lxmA6,GC7/M-TNT/COMMIT/FINANCE,GC7/M-TNT/COMMIT/FINANCE,Commitments,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/M-TNT/CO_FINANCE_BUDGET/CO-FINANCE] Cumulative budget,qN1nxwLnqKr,GC7/M-TNT/CO_FINANCE_BUDGET/CO-FINANCE,GC7/M-TNT/CO_FINANCE_BUDGET/CO-FINANCE,Cumulative budget,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Co-financing,,,No
[GC7/M-TNT/CO_FINANCE_COMMENT/CO-FINANCE] Comments,lOUz8a9RSSU,GC7/M-TNT/CO_FINANCE_COMMENT/CO-FINANCE,GC7/M-TNT/CO_FINANCE_COMMENT/CO-FINANCE,Comments,NUMBER,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Co-financing,,,No
[GC7/M-TNT/CO_FINANCE_COMMIT/CO-FINANCE] Commitments,CyVPdK8AU1m,GC7/M-TNT/CO_FINANCE_COMMIT/CO-FINANCE,GC7/M-TNT/CO_FINANCE_COMMIT/CO-FINANCE,Commitments,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Co-financing,,,No
[GC7/M-TNT/CO_FINANCE_EXPENSES/CO-FINANCE] Cumulative expenditure,sWecX8iHtgD,GC7/M-TNT/CO_FINANCE_EXPENSES/CO-FINANCE,GC7/M-TNT/CO_FINANCE_EXPENSES/CO-FINANCE,Cumulative expenditure,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Co-financing,,,No
[GC7/M-TNT/CO_FINANCE_OBLIG/CO-FINANCE] Obligations,yztoy0edxO1,GC7/M-TNT/CO_FINANCE_OBLIG/CO-FINANCE,GC7/M-TNT/CO_FINANCE_OBLIG/CO-FINANCE,Obligations,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Co-financing,,,No
[GC7/M-TNT/CUM_BUDGET/FINANCE] PR Cumulative Budget,WQOEjabb4UI,GC7/M-TNT/CUM_BUDGET/FINANCE,GC7/M-TNT/CUM_BUDGET/FINANCE,Cumulative Budget,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/M-TNT/CUM_EXP_PR/FINANCE] PR Cumulative Funds Expensed by PR,clkwKpyLS3i,GC7/M-TNT/CUM_EXP_PR/FINANCE,GC7/M-TNT/CUM_EXP_PR/FINANCE,Cumulative Funds Expensed by PR,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/M-TNT/CUM_EXP_SR/FINANCE] PR Cumulative Funds Expensed by Sub Recipients,hHWmLEw0cAQ,GC7/M-TNT/CUM_EXP_SR/FINANCE,GC7/M-TNT/CUM_EXP_SR/FINANCE,Cumulative Funds Expensed by Sub Recipients,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/M-TNT/CUM_FUNDS_DISB_PR/FINANCE] PR Cumulative Funds Disbursed to PR,MCWVu2UzU2P,GC7/M-TNT/CUM_FUNDS_DISB_PR/FINANCE,GC7/M-TNT/CUM_FUNDS_DISB_PR/FINANCE,Cumulative Funds Disbursed to PR,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/M-TNT/CUM_FUNDS_DISB_SR/FINANCE] PR Cumulative Funds Disbursed to Sub Recipients,CCh0gagjmTD,GC7/M-TNT/CUM_FUNDS_DISB_SR/FINANCE,GC7/M-TNT/CUM_FUNDS_DISB_SR/FINANCE,Cumulative Funds Disbursed to Sub Recipients,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/M-TNT/CUM_SR_BUDGET/FINANCE] PR Cumulative Sub Recipients Budget Amount,E6JvGFTGMHE,GC7/M-TNT/CUM_SR_BUDGET/FINANCE,GC7/M-TNT/CUM_SR_BUDGET/FINANCE,Cumulative Sub Recipients Budget Amount,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/M-TNT/FIN_NARR/FINANCE] PR Comments,ox0F5jQxWeF,GC7/M-TNT/FIN_NARR/FINANCE,GC7/M-TNT/FIN_NARR/FINANCE,Comments,NUMBER,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Finance,,,No
[GC7/M-TNT/FIN_RATING/RATING] PR Financial Rating,RmfcXdH87HG,GC7/M-TNT/FIN_RATING/RATING,GC7/M-TNT/FIN_RATING/RATING,Financial Rating,NUMBER,AGGREGATE,TEXT,,,bjDvmb4bfuf,Rating,,,No
[GC7/M-TNT/FIN_RATING_COMMENT/RATING] PR Financial Rating Comments,PQQZ9sbtV41,GC7/M-TNT/FIN_RATING_COMMENT/RATING,GC7/M-TNT/FIN_RATING_COMMENT/RATING,Financial Rating Comments,NUMBER,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Rating,,,No
[GC7/M-TNT/FIN_RATING_END/RATING] PR Financial Rating End Date,jhzIJgRiSDi,GC7/M-TNT/FIN_RATING_END/RATING,GC7/M-TNT/FIN_RATING_END/RATING,Financial Rating End Date,NUMBER,AGGREGATE,DATE,,,bjDvmb4bfuf,Rating,,,No
[GC7/M-TNT/FIN_RATING_START/RATING] PR Financial Rating Start Date,B04QsNyb9uI,GC7/M-TNT/FIN_RATING_START/RATING,GC7/M-TNT/FIN_RATING_START/RATING,Financial Rating Start Date,NUMBER,AGGREGATE,DATE,,,bjDvmb4bfuf,Rating,,,No
[GC7/M-TNT/ITNS-AMC/RESULT/COMMODITIES] ITNs AMC,TOfVqFGvRPh,GC7/M-TNT/ITNS-AMC/RESULT/COMMODITIES,GC7/M-TNT/ITNS-AMC/RESULT/COMMODITIES,ITNs AMC,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/M-TNT/ITNS-BAL/RESULT/COMMODITIES] ITNs Ending Balance,UU1n52nF5xc,GC7/M-TNT/ITNS-BAL/RESULT/COMMODITIES,GC7/M-TNT/ITNS-BAL/RESULT/COMMODITIES,ITNs Ending Balance,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/M-TNT/ITNS-COMMENT/COMMENT/COMMODITIES] ITNs Comments,BIBdM8rPGCu,GC7/M-TNT/ITNS-COMMENT/COMMENT/COMMODITIES,GC7/M-TNT/ITNS-COMMENT/COMMENT/COMMODITIES,ITNs Comments,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Products,Comment,,No
[GC7/M-TNT/ITNS-PROC/RESULT/COMMODITIES] ITNs Under Procurement,SrAIPIOTeqC,GC7/M-TNT/ITNS-PROC/RESULT/COMMODITIES,GC7/M-TNT/ITNS-PROC/RESULT/COMMODITIES,ITNs Under Procurement,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/M-TNT/ITNS-SOR-D/RESULT/COMMODITIES] ITNs SOR - Denominator,dvBG2OvzGQ7,GC7/M-TNT/ITNS-SOR-D/RESULT/COMMODITIES,GC7/M-TNT/ITNS-SOR-D/RESULT/COMMODITIES,ITNs SOR - Denominator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/M-TNT/ITNS-SOR-N/RESULT/COMMODITIES] ITNs SOR - Numerator,O07OWnqfspr,GC7/M-TNT/ITNS-SOR-N/RESULT/COMMODITIES,GC7/M-TNT/ITNS-SOR-N/RESULT/COMMODITIES,ITNs SOR - Numerator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/M-TNT/LAB-Other /COMMENT/COVERAGE] Proportion of Laboratories performing light microscopy for malaria participating in external quality assurance,DAk4XPjTmB1,GC7/M-TNT/COMMENT/LAB-Other /COMMENT/COVERAGE,GC7/M-TNT/COMMENT/LAB-Other /COMMENT/COVERAGE,Proportion of Laboratories performing light microscopy for malaria participating in external quality assurance,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/M-TNT/LAB-Other /RESULT/COVERAGE] Proportion of Laboratories performing light microscopy for malaria participating in external quality assurance,JnvSmCZfu0Y,GC7/M-TNT/RESULT/LAB-Other /RESULT/COVERAGE,GC7/M-TNT/RESULT/LAB-Other /RESULT/COVERAGE,Proportion of Laboratories performing light microscopy for malaria participating in external quality assurance,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/M-TNT/LAB-Other /TARGET/COVERAGE] Proportion of Laboratories performing light microscopy for malaria participating in external quality assurance,Q3vMuDbNxSp,GC7/M-TNT/TARGET/LAB-Other /TARGET/COVERAGE,GC7/M-TNT/TARGET/LAB-Other /TARGET/COVERAGE,Proportion of Laboratories performing light microscopy for malaria participating in external quality assurance,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/M-TNT/M&E-2a/COMMENT/COVERAGE] Completeness of facility reporting: Percentage of expected facility monthly reports (for the reporting period) that are actually received,eSmaPb39e6L,GC7/M-TNT/COMMENT/M&E-2a/COMMENT/COVERAGE,GC7/M-TNT/COMMENT/M&E-2a/COMMENT/COVERAGE,Completeness of facility reporting: Percentage of expected facility monthly reports (for the reporting period) that are actually received,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/M-TNT/M&E-2a/RESULT/COVERAGE] Completeness of facility reporting: Percentage of expected facility monthly reports (for the reporting period) that are actually received,IiNsh48PGPA,GC7/M-TNT/RESULT/M&E-2a/RESULT/COVERAGE,GC7/M-TNT/RESULT/M&E-2a/RESULT/COVERAGE,Completeness of facility reporting: Percentage of expected facility monthly reports (for the reporting period) that are actually received,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/M-TNT/M&E-2a/TARGET/COVERAGE] Completeness of facility reporting: Percentage of expected facility monthly reports (for the reporting period) that are actually received,qhkatjC968g,GC7/M-TNT/TARGET/M&E-2a/TARGET/COVERAGE,GC7/M-TNT/TARGET/M&E-2a/TARGET/COVERAGE,Completeness of facility reporting: Percentage of expected facility monthly reports (for the reporting period) that are actually received,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/M-TNT/M&E-2b/COMMENT/COVERAGE] Timeliness of facility reporting: Percentage of submitted facility monthly reports (for the reporting period) that are received on time per the national guidelines,haxUpXAyXKe,GC7/M-TNT/COMMENT/M&E-2b/COMMENT/COVERAGE,GC7/M-TNT/COMMENT/M&E-2b/COMMENT/COVERAGE,Timeliness of facility reporting: Percentage of submitted facility monthly reports (for the reporting period) that are received on time per the national guidelines,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/M-TNT/M&E-2b/RESULT/COVERAGE] Timeliness of facility reporting: Percentage of submitted facility monthly reports (for the reporting period) that are received on time per the national guidelines,BvzujwiigNa,GC7/M-TNT/RESULT/M&E-2b/RESULT/COVERAGE,GC7/M-TNT/RESULT/M&E-2b/RESULT/COVERAGE,Timeliness of facility reporting: Percentage of submitted facility monthly reports (for the reporting period) that are received on time per the national guidelines,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/M-TNT/M&E-2b/TARGET/COVERAGE] Timeliness of facility reporting: Percentage of submitted facility monthly reports (for the reporting period) that are received on time per the national guidelines,Y6m5UN9k6gn,GC7/M-TNT/TARGET/M&E-2b/TARGET/COVERAGE,GC7/M-TNT/TARGET/M&E-2b/TARGET/COVERAGE,Timeliness of facility reporting: Percentage of submitted facility monthly reports (for the reporting period) that are received on time per the national guidelines,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/M-TNT/MRDTS-AMC/RESULT/COMMODITIES] mRDTs AMC,uPp0BTWlPb1,GC7/M-TNT/MRDTS-AMC/RESULT/COMMODITIES,GC7/M-TNT/MRDTS-AMC/RESULT/COMMODITIES,mRDTs AMC,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/M-TNT/MRDTS-BAL/RESULT/COMMODITIES] mRDTs Ending Balance,gFl5VRwVTk1,GC7/M-TNT/MRDTS-BAL/RESULT/COMMODITIES,GC7/M-TNT/MRDTS-BAL/RESULT/COMMODITIES,mRDTs Ending Balance,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/M-TNT/MRDTS-COMMENT/COMMENT/COMMODITIES] mRDTs Comments,Mzy7WclPvaJ,GC7/M-TNT/MRDTS-COMMENT/COMMENT/COMMODITIES,GC7/M-TNT/MRDTS-COMMENT/COMMENT/COMMODITIES,mRDTs Comments,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Products,Comment,,No
[GC7/M-TNT/MRDTS-PROC/RESULT/COMMODITIES] mRDTs Under Procurement,UwagPh6FGGA,GC7/M-TNT/MRDTS-PROC/RESULT/COMMODITIES,GC7/M-TNT/MRDTS-PROC/RESULT/COMMODITIES,mRDTs Under Procurement,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/M-TNT/MRDTS-SOR-D/RESULT/COMMODITIES] mRDTs SOR - Denominator,Meq7YwYYkTm,GC7/M-TNT/MRDTS-SOR-D/RESULT/COMMODITIES,GC7/M-TNT/MRDTS-SOR-D/RESULT/COMMODITIES,mRDTs SOR - Denominator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/M-TNT/MRDTS-SOR-N/RESULT/COMMODITIES] mRDTs SOR - Numerator,pUReOwbNaxa,GC7/M-TNT/MRDTS-SOR-N/RESULT/COMMODITIES,GC7/M-TNT/MRDTS-SOR-N/RESULT/COMMODITIES,mRDTs SOR - Numerator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/M-TNT/Malaria I-2.1/COMMENT/IMPACT] Confirmed malaria cases (microscopy or RDT): rate per 1000 persons per year,icIzhMrpJfG,GC7/M-TNT/COMMENT/Malaria I-2.1/COMMENT/IMPACT,GC7/M-TNT/COMMENT/Malaria I-2.1/COMMENT/IMPACT,Confirmed malaria cases (microscopy or RDT): rate per 1000 persons per year,LONG_TEXT,AGGREGATE,LONG_TEXT,,Inverse,bjDvmb4bfuf,Program,Comment,Impact,No
[GC7/M-TNT/Malaria I-2.1/RESULT/IMPACT] Confirmed malaria cases (microscopy or RDT): rate per 1000 persons per year,l2BhI5xZldM,GC7/M-TNT/RESULT/Malaria I-2.1/RESULT/IMPACT,GC7/M-TNT/RESULT/Malaria I-2.1/RESULT/IMPACT,Confirmed malaria cases (microscopy or RDT): rate per 1000 persons per year,NUMBER,AGGREGATE,NUMBER,,Inverse,bjDvmb4bfuf,Program,Result,Impact,No
[GC7/M-TNT/Malaria I-2.1/TARGET/IMPACT] Confirmed malaria cases (microscopy or RDT): rate per 1000 persons per year,QV62v5PrtfN,GC7/M-TNT/TARGET/Malaria I-2.1/TARGET/IMPACT,GC7/M-TNT/TARGET/Malaria I-2.1/TARGET/IMPACT,Confirmed malaria cases (microscopy or RDT): rate per 1000 persons per year,NUMBER,AGGREGATE,NUMBER,,Inverse,bjDvmb4bfuf,Program,Target,Impact,No
"[GC7/M-TNT/Malaria I-3.1/COMMENT/IMPACT] Inpatient malaria deaths per year: rate per 100,000 persons per year",EfrZID4TEeG,GC7/M-TNT/COMMENT/Malaria I-3.1/COMMENT/IMPACT,GC7/M-TNT/COMMENT/Malaria I-3.1/COMMENT/IMPACT,"Inpatient malaria deaths per year: rate per 100,000 persons per year",LONG_TEXT,AGGREGATE,LONG_TEXT,,Inverse,bjDvmb4bfuf,Program,Comment,Impact,No
"[GC7/M-TNT/Malaria I-3.1/RESULT/IMPACT] Inpatient malaria deaths per year: rate per 100,000 persons per year",OV0iTzbKbnj,GC7/M-TNT/RESULT/Malaria I-3.1/RESULT/IMPACT,GC7/M-TNT/RESULT/Malaria I-3.1/RESULT/IMPACT,"Inpatient malaria deaths per year: rate per 100,000 persons per year",NUMBER,AGGREGATE,NUMBER,,Malaria I-3.1,bjDvmb4bfuf,Program,Result,Impact,No
"[GC7/M-TNT/Malaria I-3.1/TARGET/IMPACT] Inpatient malaria deaths per year: rate per 100,000 persons per year",ArGUGH3fE9R,GC7/M-TNT/TARGET/Malaria I-3.1/TARGET/IMPACT,GC7/M-TNT/TARGET/Malaria I-3.1/TARGET/IMPACT,"Inpatient malaria deaths per year: rate per 100,000 persons per year",NUMBER,AGGREGATE,NUMBER,,Malaria I-3.1,bjDvmb4bfuf,Program,Target,Impact,No
[GC7/M-TNT/Malaria I-4/COMMENT/IMPACT] Malaria test positivity rate,IXYse0SjXXd,GC7/M-TNT/COMMENT/Malaria I-4/COMMENT/IMPACT,GC7/M-TNT/COMMENT/Malaria I-4/COMMENT/IMPACT,Malaria test positivity rate,LONG_TEXT,AGGREGATE,LONG_TEXT,,Inverse,bjDvmb4bfuf,Program,Comment,Impact,No
[GC7/M-TNT/Malaria I-4/RESULT/IMPACT] Malaria test positivity rate,e4HaSv7aD4T,GC7/M-TNT/RESULT/Malaria I-4/RESULT/IMPACT,GC7/M-TNT/RESULT/Malaria I-4/RESULT/IMPACT,Malaria test positivity rate,NUMBER,AGGREGATE,PERCENTAGE,,Inverse,bjDvmb4bfuf,Program,Result,Impact,No
[GC7/M-TNT/Malaria I-4/TARGET/IMPACT] Malaria test positivity rate,sLXsZaXOZgL,GC7/M-TNT/TARGET/Malaria I-4/TARGET/IMPACT,GC7/M-TNT/TARGET/Malaria I-4/TARGET/IMPACT,Malaria test positivity rate,NUMBER,AGGREGATE,PERCENTAGE,,Inverse,bjDvmb4bfuf,Program,Target,Impact,No
[GC7/M-TNT/Malaria I-5/COMMENT/IMPACT] Malaria parasite prevalence: Proportion of children aged 6-59 months with malaria infection,e2eB0De9IVq,GC7/M-TNT/COMMENT/Malaria I-5/COMMENT/IMPACT,GC7/M-TNT/COMMENT/Malaria I-5/COMMENT/IMPACT,Malaria parasite prevalence: Proportion of children aged 6-59 months with malaria infection,LONG_TEXT,AGGREGATE,LONG_TEXT,,Malaria I-4,bjDvmb4bfuf,Program,Comment,Impact,No
[GC7/M-TNT/Malaria I-5/RESULT/IMPACT] Malaria parasite prevalence: Proportion of children aged 6-59 months with malaria infection,GO8OXf4XQfd,GC7/M-TNT/RESULT/Malaria I-5/RESULT/IMPACT,GC7/M-TNT/RESULT/Malaria I-5/RESULT/IMPACT,Malaria parasite prevalence: Proportion of children aged 6-59 months with malaria infection,NUMBER,AGGREGATE,PERCENTAGE,,Malaria I-4,bjDvmb4bfuf,Program,Result,Impact,No
[GC7/M-TNT/Malaria I-5/TARGET/IMPACT] Malaria parasite prevalence: Proportion of children aged 6-59 months with malaria infection,yJ5wpFHbxBr,GC7/M-TNT/TARGET/Malaria I-5/TARGET/IMPACT,GC7/M-TNT/TARGET/Malaria I-5/TARGET/IMPACT,Malaria parasite prevalence: Proportion of children aged 6-59 months with malaria infection,NUMBER,AGGREGATE,PERCENTAGE,,Malaria I-4,bjDvmb4bfuf,Program,Target,Impact,No
[GC7/M-TNT/Malaria O-1a/COMMENT/OUTCOME] Proportion of population that slept under an insecticide-treated net the previous night,j8dEiVXNzsk,GC7/M-TNT/COMMENT/Malaria O-1a/COMMENT/OUTCOME,GC7/M-TNT/COMMENT/Malaria O-1a/COMMENT/OUTCOME,Proportion of population that slept under an insecticide-treated net the previous night,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Outcome,No
[GC7/M-TNT/Malaria O-1a/RESULT/OUTCOME] Proportion of population that slept under an insecticide-treated net the previous night,FnFgYep4LVU,GC7/M-TNT/RESULT/Malaria O-1a/RESULT/OUTCOME,GC7/M-TNT/RESULT/Malaria O-1a/RESULT/OUTCOME,Proportion of population that slept under an insecticide-treated net the previous night,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Outcome,No
[GC7/M-TNT/Malaria O-1a/TARGET/OUTCOME] Proportion of population that slept under an insecticide-treated net the previous night,L0XK90tw3Sh,GC7/M-TNT/TARGET/Malaria O-1a/TARGET/OUTCOME,GC7/M-TNT/TARGET/Malaria O-1a/TARGET/OUTCOME,Proportion of population that slept under an insecticide-treated net the previous night,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Outcome,No
[GC7/M-TNT/Malaria O-1b/COMMENT/OUTCOME] Proportion of children under five years old who slept under an insecticide-treated net the previous night,WpF9Jmg49mz,GC7/M-TNT/COMMENT/Malaria O-1b/COMMENT/OUTCOME,GC7/M-TNT/COMMENT/Malaria O-1b/COMMENT/OUTCOME,Proportion of children under five years old who slept under an insecticide-treated net the previous night,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Outcome,No
[GC7/M-TNT/Malaria O-1b/RESULT/OUTCOME] Proportion of children under five years old who slept under an insecticide-treated net the previous night,O7cmDgyHx0o,GC7/M-TNT/RESULT/Malaria O-1b/RESULT/OUTCOME,GC7/M-TNT/RESULT/Malaria O-1b/RESULT/OUTCOME,Proportion of children under five years old who slept under an insecticide-treated net the previous night,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Outcome,No
[GC7/M-TNT/Malaria O-1b/TARGET/OUTCOME] Proportion of children under five years old who slept under an insecticide-treated net the previous night,q7iFB52Y6ii,GC7/M-TNT/TARGET/Malaria O-1b/TARGET/OUTCOME,GC7/M-TNT/TARGET/Malaria O-1b/TARGET/OUTCOME,Proportion of children under five years old who slept under an insecticide-treated net the previous night,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Outcome,No
[GC7/M-TNT/Malaria O-1c/COMMENT/OUTCOME] Proportion of pregnant women who slept under an insecticide-treated net the previous night,tiPLy9fWUls,GC7/M-TNT/COMMENT/Malaria O-1c/COMMENT/OUTCOME,GC7/M-TNT/COMMENT/Malaria O-1c/COMMENT/OUTCOME,Proportion of pregnant women who slept under an insecticide-treated net the previous night,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Outcome,No
[GC7/M-TNT/Malaria O-1c/RESULT/OUTCOME] Proportion of pregnant women who slept under an insecticide-treated net the previous night,c5VlKSZQNyH,GC7/M-TNT/RESULT/Malaria O-1c/RESULT/OUTCOME,GC7/M-TNT/RESULT/Malaria O-1c/RESULT/OUTCOME,Proportion of pregnant women who slept under an insecticide-treated net the previous night,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Outcome,No
[GC7/M-TNT/Malaria O-1c/TARGET/OUTCOME] Proportion of pregnant women who slept under an insecticide-treated net the previous night,HsWEIfImlWD,GC7/M-TNT/TARGET/Malaria O-1c/TARGET/OUTCOME,GC7/M-TNT/TARGET/Malaria O-1c/TARGET/OUTCOME,Proportion of pregnant women who slept under an insecticide-treated net the previous night,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Outcome,No
[GC7/M-TNT/Malaria O-3/COMMENT/OUTCOME] Proportion of population using an insecticide-treated net among those with access to an insecticide-treated net,ribKndFYhLL,GC7/M-TNT/COMMENT/Malaria O-3/COMMENT/OUTCOME,GC7/M-TNT/COMMENT/Malaria O-3/COMMENT/OUTCOME,Proportion of population using an insecticide-treated net among those with access to an insecticide-treated net,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Outcome,No
[GC7/M-TNT/Malaria O-3/RESULT/OUTCOME] Proportion of population using an insecticide-treated net among those with access to an insecticide-treated net,RSxPtzmLakM,GC7/M-TNT/RESULT/Malaria O-3/RESULT/OUTCOME,GC7/M-TNT/RESULT/Malaria O-3/RESULT/OUTCOME,Proportion of population using an insecticide-treated net among those with access to an insecticide-treated net,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Outcome,No
[GC7/M-TNT/Malaria O-3/TARGET/OUTCOME] Proportion of population using an insecticide-treated net among those with access to an insecticide-treated net,LTnsT8iPnHI,GC7/M-TNT/TARGET/Malaria O-3/TARGET/OUTCOME,GC7/M-TNT/TARGET/Malaria O-3/TARGET/OUTCOME,Proportion of population using an insecticide-treated net among those with access to an insecticide-treated net,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Outcome,No
[GC7/M-TNT/Malaria O-4/COMMENT/OUTCOME] Proportion of households with at least one insecticide-treated net for every two people and/or sprayed by IRS within the last 12 months,C6RRKlak59Z,GC7/M-TNT/COMMENT/Malaria O-4/COMMENT/OUTCOME,GC7/M-TNT/COMMENT/Malaria O-4/COMMENT/OUTCOME,Proportion of households with at least one insecticide-treated net for every two people and/or sprayed by IRS within the last 12 months,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Outcome,No
[GC7/M-TNT/Malaria O-4/RESULT/OUTCOME] Proportion of households with at least one insecticide-treated net for every two people and/or sprayed by IRS within the last 12 months,SQdD901nXtn,GC7/M-TNT/RESULT/Malaria O-4/RESULT/OUTCOME,GC7/M-TNT/RESULT/Malaria O-4/RESULT/OUTCOME,Proportion of households with at least one insecticide-treated net for every two people and/or sprayed by IRS within the last 12 months,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Outcome,No
[GC7/M-TNT/Malaria O-4/TARGET/OUTCOME] Proportion of households with at least one insecticide-treated net for every two people and/or sprayed by IRS within the last 12 months,urH9dYh1Lky,GC7/M-TNT/TARGET/Malaria O-4/TARGET/OUTCOME,GC7/M-TNT/TARGET/Malaria O-4/TARGET/OUTCOME,Proportion of households with at least one insecticide-treated net for every two people and/or sprayed by IRS within the last 12 months,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Outcome,No
[GC7/M-TNT/OBLIG/FINANCE] PR Obligations,mNQrOONpwCU,GC7/M-TNT/OBLIG/FINANCE,GC7/M-TNT/OBLIG/FINANCE,Obligations,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/M-TNT/POST_OUTFLOWS/FINANCE] PR Postponed Outflows,PkaKR8uK49W,GC7/M-TNT/POST_OUTFLOWS/FINANCE,GC7/M-TNT/POST_OUTFLOWS/FINANCE,Postponed Outflows,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/M-TNT/PROG_RATING/RATING] PR Programmatic Rating,LZx5Sp1HGjY,GC7/M-TNT/PROG_RATING/RATING,GC7/M-TNT/PROG_RATING/RATING,Programmatic Rating,NUMBER,AGGREGATE,TEXT,,,bjDvmb4bfuf,Rating,,,No
[GC7/M-TNT/PROG_RATING_COMMENT/RATING] PR Programmatic Rating Comments,kUCLOCzzHcM,GC7/M-TNT/PROG_RATING_COMMENT/RATING,GC7/M-TNT/PROG_RATING_COMMENT/RATING,Programmatic Rating Comments,NUMBER,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Rating,,,No
[GC7/M-TNT/PROG_RATING_END/RATING] PR Programmatic Rating End Date,Z9qTnNIEehs,GC7/M-TNT/PROG_RATING_END/RATING,GC7/M-TNT/PROG_RATING_END/RATING,Programmatic Rating End Date,NUMBER,AGGREGATE,DATE,,,bjDvmb4bfuf,Rating,,,No
[GC7/M-TNT/PROG_RATING_START/RATING] PR Programmatic Rating Start Date,rmpP58VdlkB,GC7/M-TNT/PROG_RATING_START/RATING,GC7/M-TNT/PROG_RATING_START/RATING,Programmatic Rating Start Date,NUMBER,AGGREGATE,DATE,,,bjDvmb4bfuf,Rating,,,No
"[GC7/M-TNT/PSEAH-CA/COMM_PSEAH] % of community level actors/agents (TB Champions, peer educators, mentor mothers etc) sensitized on PSEAH/SEAH including SEAH reporting channels and have Signed Compliance Document ",jMwtTzdXvQ3,GC7/M-TNT/PSEAH-CA/COMM_PSEAH/COVERAGE,GC7/M-TNT/PSEAH-CA/COMM_PSEAH/COVERAGE,"% of community level actors/agents (TB Champions, peer educators, mentor mothers etc) sensitized on PSEAH/SEAH including SEAH reporting channels and have Signed Compliance Document ",LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,PSEAH,Comment,PSEAH,No
"[GC7/M-TNT/PSEAH-CA/RES_PSEAH] % of community level actors/agents (TB Champions, peer educators, mentor mothers etc) sensitized on PSEAH/SEAH including SEAH reporting channels and have Signed Compliance Document ",Br8JEkZIEon,GC7/M-TNT/PSEAH-CA/RES_PSEAH/COVERAGE,GC7/M-TNT/PSEAH-CA/RES_PSEAH/COVERAGE,"% of community level actors/agents (TB Champions, peer educators, mentor mothers etc) sensitized on PSEAH/SEAH including SEAH reporting channels and have Signed Compliance Document ",PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Result,PSEAH,No
"[GC7/M-TNT/PSEAH-CA/TAR_PSEAH] % of community level actors/agents (TB Champions, peer educators, mentor mothers etc) sensitized on PSEAH/SEAH including SEAH reporting channels and have Signed Compliance Document ",YL4rNSJqmWk,GC7/M-TNT/PSEAH-CA/TAR_PSEAH/COVERAGE,GC7/M-TNT/PSEAH-CA/TAR_PSEAH/COVERAGE,"% of community level actors/agents (TB Champions, peer educators, mentor mothers etc) sensitized on PSEAH/SEAH including SEAH reporting channels and have Signed Compliance Document ",PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Target,PSEAH,No
[GC7/M-TNT/PSEAH-PB/COMM_PSEAH] % of programme beneficiaries at community level assessed as being at high/medium risk of SEAH sensitized on PSEAH/SEAH including SEAH reporting channels,lPOAe1msXel,GC7/M-TNT/PSEAH-PB/COMM_PSEAH/COVERAGE,GC7/M-TNT/PSEAH-PB/COMM_PSEAH/COVERAGE,% of programme beneficiaries at community level assessed as being at high/medium risk of SEAH sensitized on PSEAH/SEAH including SEAH reporting channels,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,PSEAH,Comment,PSEAH,No
[GC7/M-TNT/PSEAH-PB/RES_PSEAH] % of programme beneficiaries at community level assessed as being at high/medium risk of SEAH sensitized on PSEAH/SEAH including SEAH reporting channels,SlxzVT111B2,GC7/M-TNT/PSEAH-PB/RES_PSEAH/COVERAGE,GC7/M-TNT/PSEAH-PB/RES_PSEAH/COVERAGE,% of programme beneficiaries at community level assessed as being at high/medium risk of SEAH sensitized on PSEAH/SEAH including SEAH reporting channels,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Result,PSEAH,No
[GC7/M-TNT/PSEAH-PB/TAR_PSEAH] % of programme beneficiaries at community level assessed as being at high/medium risk of SEAH sensitized on PSEAH/SEAH including SEAH reporting channels,WZ8fR0uVB5I,GC7/M-TNT/PSEAH-PB/TAR_PSEAH/COVERAGE,GC7/M-TNT/PSEAH-PB/TAR_PSEAH/COVERAGE,% of programme beneficiaries at community level assessed as being at high/medium risk of SEAH sensitized on PSEAH/SEAH including SEAH reporting channels,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Target,PSEAH,No
[GC7/M-TNT/PSEAH-PR/COMM_PSEAH] % of Principal Recipient (PR) Staff (including Interns and Volunteers) and Board Members Trained on PR PSEAH Policy and Signed Compliance Document Annually,lFeJGOOjwPP,GC7/M-TNT/PSEAH-PR/COMM_PSEAH/COVERAGE,GC7/M-TNT/PSEAH-PR/COMM_PSEAH/COVERAGE,% of Principal Recipient (PR) Staff (including Interns and Volunteers) and Board Members Trained on PR PSEAH Policy and Signed Compliance Document Annually,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,PSEAH,Comment,PSEAH,No
[GC7/M-TNT/PSEAH-PR/RES_PSEAH] % of Principal Recipient (PR) Staff (including Interns and Volunteers) and Board Members Trained on PR PSEAH Policy and Signed Compliance Document Annually,IkrKaLKkMtl,GC7/M-TNT/PSEAH-PR/RES_PSEAH/COVERAGE,GC7/M-TNT/PSEAH-PR/RES_PSEAH/COVERAGE,% of Principal Recipient (PR) Staff (including Interns and Volunteers) and Board Members Trained on PR PSEAH Policy and Signed Compliance Document Annually,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Result,PSEAH,No
[GC7/M-TNT/PSEAH-PR/TAR_PSEAH] % of Principal Recipient (PR) Staff (including Interns and Volunteers) and Board Members Trained on PR PSEAH Policy and Signed Compliance Document Annually,yriYPlM7Qp9,GC7/M-TNT/PSEAH-PR/TAR_PSEAH/COVERAGE,GC7/M-TNT/PSEAH-PR/TAR_PSEAH/COVERAGE,% of Principal Recipient (PR) Staff (including Interns and Volunteers) and Board Members Trained on PR PSEAH Policy and Signed Compliance Document Annually,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Target,PSEAH,No
[GC7/M-TNT/PSEAH-SR/COMM_PSEAH] % of Sub-Recipient (SRs) whose Staff (including Interns and Volunteers) and Board Members Trained on PSEAH Policy and have Signed Compliance Document Annually,I5YBrKcnf2s,GC7/M-TNT/PSEAH-SR/COMM_PSEAH/COVERAGE,GC7/M-TNT/PSEAH-SR/COMM_PSEAH/COVERAGE,% of Sub-Recipient (SRs) whose Staff (including Interns and Volunteers) and Board Members Trained on PSEAH Policy and have Signed Compliance Document Annually,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,PSEAH,Comment,PSEAH,No
[GC7/M-TNT/PSEAH-SR/RES_PSEAH] % of Sub-Recipient (SRs) whose Staff (including Interns and Volunteers) and Board Members Trained on PSEAH Policy and have Signed Compliance Document Annually,Xpn3DRMSvfe,GC7/M-TNT/PSEAH-SR/RES_PSEAH/COVERAGE,GC7/M-TNT/PSEAH-SR/RES_PSEAH/COVERAGE,% of Sub-Recipient (SRs) whose Staff (including Interns and Volunteers) and Board Members Trained on PSEAH Policy and have Signed Compliance Document Annually,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Result,PSEAH,No
[GC7/M-TNT/PSEAH-SR/TAR_PSEAH] % of Sub-Recipient (SRs) whose Staff (including Interns and Volunteers) and Board Members Trained on PSEAH Policy and have Signed Compliance Document Annually,NXpylChv2YK,GC7/M-TNT/PSEAH-SR/TAR_PSEAH/COVERAGE,GC7/M-TNT/PSEAH-SR/TAR_PSEAH/COVERAGE,% of Sub-Recipient (SRs) whose Staff (including Interns and Volunteers) and Board Members Trained on PSEAH Policy and have Signed Compliance Document Annually,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Target,PSEAH,No
[GC7/M-TNT/PSEAH-ZT/COMM_PSEAH] % of Sub-Recipients (SRs) with PSEAH Policy highlighting Zero Tolerance of SEAH,GycsrAsl4Mi,GC7/M-TNT/PSEAH-ZT/COMM_PSEAH/COVERAGE,GC7/M-TNT/PSEAH-ZT/COMM_PSEAH/COVERAGE,% of Sub-Recipients (SRs) with PSEAH Policy highlighting Zero Tolerance of SEAH,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,PSEAH,Comment,PSEAH,No
[GC7/M-TNT/PSEAH-ZT/RES_PSEAH] % of Sub-Recipients (SRs) with PSEAH Policy highlighting Zero Tolerance of SEAH,yv6LoSw8z2z,GC7/M-TNT/PSEAH-ZT/RES_PSEAH/COVERAGE,GC7/M-TNT/PSEAH-ZT/RES_PSEAH/COVERAGE,% of Sub-Recipients (SRs) with PSEAH Policy highlighting Zero Tolerance of SEAH,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Result,PSEAH,No
[GC7/M-TNT/PSEAH-ZT/TAR_PSEAH] % of Sub-Recipients (SRs) with PSEAH Policy highlighting Zero Tolerance of SEAH,QRZzHsohebU,GC7/M-TNT/PSEAH-ZT/TAR_PSEAH/COVERAGE,GC7/M-TNT/PSEAH-ZT/TAR_PSEAH/COVERAGE,% of Sub-Recipients (SRs) with PSEAH Policy highlighting Zero Tolerance of SEAH,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Target,PSEAH,No
[GC7/M-TNT/SAVINGS/FINANCE] PR Savings,ziF7gPtWvQ8,GC7/M-TNT/SAVINGS/FINANCE,GC7/M-TNT/SAVINGS/FINANCE,Savings,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/M-TNT/SP-AMC/RESULT/COMMODITIES] Sulfadoxine/Pyrimethamine AMC,rwvdXee1GPD,GC7/M-TNT/SP-AMC/RESULT/COMMODITIES,GC7/M-TNT/SP-AMC/RESULT/COMMODITIES,Sulfadoxine/Pyrimethamine AMC,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/M-TNT/SP-BAL/RESULT/COMMODITIES] Sulfadoxine/Pyrimethamine Ending Balance,ngzW4YvJ6IT,GC7/M-TNT/SP-BAL/RESULT/COMMODITIES,GC7/M-TNT/SP-BAL/RESULT/COMMODITIES,Sulfadoxine/Pyrimethamine Ending Balance,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/M-TNT/SP-COMMENT/COMMENT/COMMODITIES] Sulfadoxine/Pyrimethamine Comments,OwdG3a0LadZ,GC7/M-TNT/SP-COMMENT/COMMENT/COMMODITIES,GC7/M-TNT/SP-COMMENT/COMMENT/COMMODITIES,Sulfadoxine/Pyrimethamine Comments,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Products,Comment,,No
[GC7/M-TNT/SP-PROC/RESULT/COMMODITIES] Sulfadoxine/Pyrimethamine Under Procurement,M4UTuWJcOz4,GC7/M-TNT/SP-PROC/RESULT/COMMODITIES,GC7/M-TNT/SP-PROC/RESULT/COMMODITIES,Sulfadoxine/Pyrimethamine Under Procurement,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/M-TNT/SP-SOR-D/RESULT/COMMODITIES] Sulfadoxine/Pyrimethamine SOR - Denominator,ssikwbJOV5j,GC7/M-TNT/SP-SOR-D/RESULT/COMMODITIES,GC7/M-TNT/SP-SOR-D/RESULT/COMMODITIES,Sulfadoxine/Pyrimethamine SOR - Denominator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/M-TNT/SP-SOR-N/RESULT/COMMODITIES] Sulfadoxine/Pyrimethamine SOR - Numerator,UqqV82mI0ft,GC7/M-TNT/SP-SOR-N/RESULT/COMMODITIES,GC7/M-TNT/SP-SOR-N/RESULT/COMMODITIES,Sulfadoxine/Pyrimethamine SOR - Numerator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/M-TNT/SPI-1/COMMENT/COVERAGE] Proportion of pregnant women attending antenatal clinics who received three or more doses of intermittent preventive treatment for malaria,hYjdfewSXz0,GC7/M-TNT/COMMENT/SPI-1/COMMENT/COVERAGE,GC7/M-TNT/COMMENT/SPI-1/COMMENT/COVERAGE,Proportion of pregnant women attending antenatal clinics who received three or more doses of intermittent preventive treatment for malaria,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/M-TNT/SPI-1/RESULT/COVERAGE] Proportion of pregnant women attending antenatal clinics who received three or more doses of intermittent preventive treatment for malaria,ssVcyroNibY,GC7/M-TNT/RESULT/SPI-1/RESULT/COVERAGE,GC7/M-TNT/RESULT/SPI-1/RESULT/COVERAGE,Proportion of pregnant women attending antenatal clinics who received three or more doses of intermittent preventive treatment for malaria,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/M-TNT/SPI-1/TARGET/COVERAGE] Proportion of pregnant women attending antenatal clinics who received three or more doses of intermittent preventive treatment for malaria,wNkGD342KsQ,GC7/M-TNT/TARGET/SPI-1/TARGET/COVERAGE,GC7/M-TNT/TARGET/SPI-1/TARGET/COVERAGE,Proportion of pregnant women attending antenatal clinics who received three or more doses of intermittent preventive treatment for malaria,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/M-TNT/TOTAL_BUDGET/FINANCE] PR Total Budget,j3mpHckb5Kc,GC7/M-TNT/TOTAL_BUDGET/FINANCE,GC7/M-TNT/TOTAL_BUDGET/FINANCE,Total Budget,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/M-TNT/TOTAL_SR_BUDGET/FINANCE] PR Total Sub Recipients Budget Amount,GBN40oaMsdz,GC7/M-TNT/TOTAL_SR_BUDGET/FINANCE,GC7/M-TNT/TOTAL_SR_BUDGET/FINANCE,Total Sub Recipients Budget Amount,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/M-TNT/VC-1/COMMENT/COVERAGE] Number of long-lasting insecticidal nets distributed to at-risk populations through mass campaigns,ArvCAYUYj3X,GC7/M-TNT/COMMENT/VC-1/COMMENT/COVERAGE,GC7/M-TNT/COMMENT/VC-1/COMMENT/COVERAGE,Number of long-lasting insecticidal nets distributed to at-risk populations through mass campaigns,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/M-TNT/VC-1/RESULT/COVERAGE] Number of long-lasting insecticidal nets distributed to at-risk populations through mass campaigns,KIBw8mI1Tlw,GC7/M-TNT/RESULT/VC-1/RESULT/COVERAGE,GC7/M-TNT/RESULT/VC-1/RESULT/COVERAGE,Number of long-lasting insecticidal nets distributed to at-risk populations through mass campaigns,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/M-TNT/VC-1/TARGET/COVERAGE] Number of long-lasting insecticidal nets distributed to at-risk populations through mass campaigns,KQjfKZP8exy,GC7/M-TNT/TARGET/VC-1/TARGET/COVERAGE,GC7/M-TNT/TARGET/VC-1/TARGET/COVERAGE,Number of long-lasting insecticidal nets distributed to at-risk populations through mass campaigns,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/TNT-M/CO_FINANCE_ALLOCATION/CO-FINANCE] Total Budget Allocation,eUc30YtVMnM,GC7/TNT-M/CO_FINANCE_ALLOCATION/CO-FINANCE,GC7/TNT-M/CO_FINANCE_ALLOCATION/CO-FINANCE,Total Budget Allocation,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Co-financing,,,No
[GC7/AMREF-T/COMMIT/RSSH/FINANCE] PR Commitments,nCcBYpfFkPD,GC7/AMREF-T/COMMIT/RSSH/FINANCE,GC7/AMREF-T/COMMIT/RSSH/FINANCE,Commitments,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,RSSH,No
[GC7/AMREF-T/CUM_BUDGET/RSSH/FINANCE] PR Cumulative Budget,ymPBzL2xn2l,GC7/AMREF-T/CUM_BUDGET/RSSH/FINANCE,GC7/AMREF-T/CUM_BUDGET/RSSH/FINANCE,Cumulative Budget,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,RSSH,No
[GC7/AMREF-T/CUM_EXP_PR/RSSH/FINANCE] PR Cumulative Funds Expensed by PR,ai0EWOm69Za,GC7/AMREF-T/CUM_EXP_PR/RSSH/FINANCE,GC7/AMREF-T/CUM_EXP_PR/RSSH/FINANCE,Cumulative Funds Expensed by PR,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,RSSH,No
[GC7/AMREF-T/CUM_EXP_SR/RSSH/FINANCE] PR Cumulative Funds Expensed by Sub Recipients,uF3QU5sozER,GC7/AMREF-T/CUM_EXP_SR/RSSH/FINANCE,GC7/AMREF-T/CUM_EXP_SR/RSSH/FINANCE,Cumulative Funds Expensed by Sub Recipients,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,RSSH,No
[GC7/AMREF-T/CUM_FUNDS_DISB_PR/RSSH/FINANCE] PR Cumulative Funds Disbursed to PR,VxK9LOZ7f4n,GC7/AMREF-T/CUM_FUNDS_DISB_PR/RSSH/FINANCE,GC7/AMREF-T/CUM_FUNDS_DISB_PR/RSSH/FINANCE,Cumulative Funds Disbursed to PR,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,RSSH,No
[GC7/AMREF-T/CUM_FUNDS_DISB_SR/RSSH/FINANCE] PR Cumulative Funds Disbursed to Sub Recipients,S7xnUBvnjqa,GC7/AMREF-T/CUM_FUNDS_DISB_SR/RSSH/FINANCE,GC7/AMREF-T/CUM_FUNDS_DISB_SR/RSSH/FINANCE,Cumulative Funds Disbursed to Sub Recipients,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,RSSH,No
[GC7/AMREF-T/CUM_SR_BUDGET/RSSH/FINANCE] PR Cumulative Sub Recipients Budget Amount,N2tLxrtV5UI,GC7/AMREF-T/CUM_SR_BUDGET/RSSH/FINANCE,GC7/AMREF-T/CUM_SR_BUDGET/RSSH/FINANCE,Cumulative Sub Recipients Budget Amount,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,RSSH,No
[GC7/AMREF-T/FIN_NARR/RSSH/FINANCE] PR Comments,qNdcoSHqT5a,GC7/AMREF-T/FIN_NARR/RSSH/FINANCE,GC7/AMREF-T/FIN_NARR/RSSH/FINANCE,Comments,NUMBER,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Finance,,RSSH,No
[GC7/AMREF-T/OBLIG/RSSH/FINANCE] PR Obligations,SaOsY0it45n,GC7/AMREF-T/OBLIG/RSSH/FINANCE,GC7/AMREF-T/OBLIG/RSSH/FINANCE,Obligations,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,RSSH,No
[GC7/AMREF-T/POST_OUTFLOWS/RSSH/FINANCE] PR Postponed Outflows,u4T7GKebxvC,GC7/AMREF-T/POST_OUTFLOWS/RSSH/FINANCE,GC7/AMREF-T/POST_OUTFLOWS/RSSH/FINANCE,Postponed Outflows,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,RSSH,No
[GC7/AMREF-T/SAVINGS/RSSH/FINANCE] PR Savings,djCQl9PsxHp,GC7/AMREF-T/SAVINGS/RSSH/FINANCE,GC7/AMREF-T/SAVINGS/RSSH/FINANCE,Savings,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,RSSH,No
[GC7/AMREF-T/TOTAL_BUDGET/RSSH/FINANCE] PR Total Budget,lnl4p6uYVty,GC7/AMREF-T/TOTAL_BUDGET/RSSH/FINANCE,GC7/AMREF-T/TOTAL_BUDGET/RSSH/FINANCE,Total Budget,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,RSSH,No
[GC7/AMREF-T/TOTAL_SR_BUDGET/RSSH/FINANCE] PR Total Sub Recipients Budget Amount,mqOMd8e0b4z,GC7/AMREF-T/TOTAL_SR_BUDGET/RSSH/FINANCE,GC7/AMREF-T/TOTAL_SR_BUDGET/RSSH/FINANCE,Total Sub Recipients Budget Amount,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,RSSH,No
[GC7/T-AMREF/COMMIT/FINANCE] PR Commitments,fFa65uI4xW0,GC7/T-AMREF/COMMIT/FINANCE,GC7/T-AMREF/COMMIT/FINANCE,Commitments,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/T-AMREF/CUM_BUDGET/FINANCE] PR Cumulative Budget,D7UGcCJLgG0,GC7/T-AMREF/CUM_BUDGET/FINANCE,GC7/T-AMREF/CUM_BUDGET/FINANCE,Cumulative Budget,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/T-AMREF/CUM_EXP_PR/FINANCE] PR Cumulative Funds Expensed by PR,YDynJaO2fLx,GC7/T-AMREF/CUM_EXP_PR/FINANCE,GC7/T-AMREF/CUM_EXP_PR/FINANCE,Cumulative Funds Expensed by PR,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/T-AMREF/CUM_EXP_SR/FINANCE] PR Cumulative Funds Expensed by Sub Recipients,MgFBhy09kpP,GC7/T-AMREF/CUM_EXP_SR/FINANCE,GC7/T-AMREF/CUM_EXP_SR/FINANCE,Cumulative Funds Expensed by Sub Recipients,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/T-AMREF/CUM_FUNDS_DISB_PR/FINANCE] PR Cumulative Funds Disbursed to PR,DqR9bmOW4KK,GC7/T-AMREF/CUM_FUNDS_DISB_PR/FINANCE,GC7/T-AMREF/CUM_FUNDS_DISB_PR/FINANCE,Cumulative Funds Disbursed to PR,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/T-AMREF/CUM_FUNDS_DISB_SR/FINANCE] PR Cumulative Funds Disbursed to Sub Recipients,yQbuOZxxx9f,GC7/T-AMREF/CUM_FUNDS_DISB_SR/FINANCE,GC7/T-AMREF/CUM_FUNDS_DISB_SR/FINANCE,Cumulative Funds Disbursed to Sub Recipients,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/T-AMREF/CUM_SR_BUDGET/FINANCE] PR Cumulative Sub Recipients Budget Amount,IAQ30JVwtkT,GC7/T-AMREF/CUM_SR_BUDGET/FINANCE,GC7/T-AMREF/CUM_SR_BUDGET/FINANCE,Cumulative Sub Recipients Budget Amount,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/T-AMREF/FIN_NARR/FINANCE] PR Comments,w1foXhEapKI,GC7/T-AMREF/FIN_NARR/FINANCE,GC7/T-AMREF/FIN_NARR/FINANCE,Comments,NUMBER,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Finance,,,No
[GC7/T-AMREF/FIN_RATING/RATING] PR Financial Rating,S7Jza3EHg9x,GC7/T-AMREF/FIN_RATING/RATING,GC7/T-AMREF/FIN_RATING/RATING,Financial Rating,NUMBER,AGGREGATE,TEXT,,,bjDvmb4bfuf,Rating,,,No
[GC7/T-AMREF/FIN_RATING_COMMENT/RATING] PR Financial Rating Comments,fTSbZ0CyOjM,GC7/T-AMREF/FIN_RATING_COMMENT/RATING,GC7/T-AMREF/FIN_RATING_COMMENT/RATING,Financial Rating Comments,NUMBER,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Rating,,,No
[GC7/T-AMREF/FIN_RATING_END/RATING] PR Financial Rating End Date,jlXYhr6rGvP,GC7/T-AMREF/FIN_RATING_END/RATING,GC7/T-AMREF/FIN_RATING_END/RATING,Financial Rating End Date,NUMBER,AGGREGATE,DATE,,,bjDvmb4bfuf,Rating,,,No
[GC7/T-AMREF/FIN_RATING_START/RATING] PR Financial Rating Start Date,aTe0iU1bEsP,GC7/T-AMREF/FIN_RATING_START/RATING,GC7/T-AMREF/FIN_RATING_START/RATING,Financial Rating Start Date,NUMBER,AGGREGATE,DATE,,,bjDvmb4bfuf,Rating,,,No
[GC7/T-AMREF/OBLIG/FINANCE] PR Obligations,VZPI4jLZPXm,GC7/T-AMREF/OBLIG/FINANCE,GC7/T-AMREF/OBLIG/FINANCE,Obligations,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/T-AMREF/POST_OUTFLOWS/FINANCE] PR Postponed Outflows,R7xj9IGahe0,GC7/T-AMREF/POST_OUTFLOWS/FINANCE,GC7/T-AMREF/POST_OUTFLOWS/FINANCE,Postponed Outflows,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/T-AMREF/PROG_RATING/RATING] PR Programmatic Rating,H7EZMkArnH0,GC7/T-AMREF/PROG_RATING/RATING,GC7/T-AMREF/PROG_RATING/RATING,Programmatic Rating,NUMBER,AGGREGATE,TEXT,,,bjDvmb4bfuf,Rating,,,No
[GC7/T-AMREF/PROG_RATING_COMMENT/RATING] PR Programmatic Rating Comments,NjD3gliVVUn,GC7/T-AMREF/PROG_RATING_COMMENT/RATING,GC7/T-AMREF/PROG_RATING_COMMENT/RATING,Programmatic Rating Comments,NUMBER,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Rating,,,No
[GC7/T-AMREF/PROG_RATING_END/RATING] PR Programmatic Rating End Date,kgeUjELojjb,GC7/T-AMREF/PROG_RATING_END/RATING,GC7/T-AMREF/PROG_RATING_END/RATING,Programmatic Rating End Date,NUMBER,AGGREGATE,DATE,,,bjDvmb4bfuf,Rating,,,No
[GC7/T-AMREF/PROG_RATING_START/RATING] PR Programmatic Rating Start Date,dL16QZ5Dvwv,GC7/T-AMREF/PROG_RATING_START/RATING,GC7/T-AMREF/PROG_RATING_START/RATING,Programmatic Rating Start Date,NUMBER,AGGREGATE,DATE,,,bjDvmb4bfuf,Rating,,,No
"[GC7/T-AMREF/PSEAH-CA/COMM_PSEAH] % of community level actors/agents (TB Champions, peer educators, mentor mothers etc) sensitized on PSEAH/SEAH including SEAH reporting channels and have Signed Compliance Document ",FG7lSs0P0v6,GC7/T-AMREF/PSEAH-CA/COMM_PSEAH/COVERAGE,GC7/T-AMREF/PSEAH-CA/COMM_PSEAH/COVERAGE,"% of community level actors/agents (TB Champions, peer educators, mentor mothers etc) sensitized on PSEAH/SEAH including SEAH reporting channels and have Signed Compliance Document ",LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,PSEAH,Comment,PSEAH,No
"[GC7/T-AMREF/PSEAH-CA/RES_PSEAH] % of community level actors/agents (TB Champions, peer educators, mentor mothers etc) sensitized on PSEAH/SEAH including SEAH reporting channels and have Signed Compliance Document ",XvMzjJQHXdh,GC7/T-AMREF/PSEAH-CA/RES_PSEAH/COVERAGE,GC7/T-AMREF/PSEAH-CA/RES_PSEAH/COVERAGE,"% of community level actors/agents (TB Champions, peer educators, mentor mothers etc) sensitized on PSEAH/SEAH including SEAH reporting channels and have Signed Compliance Document ",PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Result,PSEAH,No
"[GC7/T-AMREF/PSEAH-CA/TAR_PSEAH] % of community level actors/agents (TB Champions, peer educators, mentor mothers etc) sensitized on PSEAH/SEAH including SEAH reporting channels and have Signed Compliance Document ",MYHAcvrs641,GC7/T-AMREF/PSEAH-CA/TAR_PSEAH/COVERAGE,GC7/T-AMREF/PSEAH-CA/TAR_PSEAH/COVERAGE,"% of community level actors/agents (TB Champions, peer educators, mentor mothers etc) sensitized on PSEAH/SEAH including SEAH reporting channels and have Signed Compliance Document ",PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Target,PSEAH,No
[GC7/T-AMREF/PSEAH-PB/COMM_PSEAH] % of programme beneficiaries at community level assessed as being at high/medium risk of SEAH sensitized on PSEAH/SEAH including SEAH reporting channels,rIdYJMph68y,GC7/T-AMREF/PSEAH-PB/COMM_PSEAH/COVERAGE,GC7/T-AMREF/PSEAH-PB/COMM_PSEAH/COVERAGE,% of programme beneficiaries at community level assessed as being at high/medium risk of SEAH sensitized on PSEAH/SEAH including SEAH reporting channels,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,PSEAH,Comment,PSEAH,No
[GC7/T-AMREF/PSEAH-PB/RES_PSEAH] % of programme beneficiaries at community level assessed as being at high/medium risk of SEAH sensitized on PSEAH/SEAH including SEAH reporting channels,Rc0cFUMjM5c,GC7/T-AMREF/PSEAH-PB/RES_PSEAH/COVERAGE,GC7/T-AMREF/PSEAH-PB/RES_PSEAH/COVERAGE,% of programme beneficiaries at community level assessed as being at high/medium risk of SEAH sensitized on PSEAH/SEAH including SEAH reporting channels,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Result,PSEAH,No
[GC7/T-AMREF/PSEAH-PB/TAR_PSEAH] % of programme beneficiaries at community level assessed as being at high/medium risk of SEAH sensitized on PSEAH/SEAH including SEAH reporting channels,PdBjFSEUBc4,GC7/T-AMREF/PSEAH-PB/TAR_PSEAH/COVERAGE,GC7/T-AMREF/PSEAH-PB/TAR_PSEAH/COVERAGE,% of programme beneficiaries at community level assessed as being at high/medium risk of SEAH sensitized on PSEAH/SEAH including SEAH reporting channels,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Target,PSEAH,No
[GC7/T-AMREF/PSEAH-PR/COMM_PSEAH] % of Principal Recipient (PR) Staff (including Interns and Volunteers) and Board Members Trained on PR PSEAH Policy and Signed Compliance Document Annually,ZgbqGTDVl3u,GC7/T-AMREF/PSEAH-PR/COMM_PSEAH/COVERAGE,GC7/T-AMREF/PSEAH-PR/COMM_PSEAH/COVERAGE,% of Principal Recipient (PR) Staff (including Interns and Volunteers) and Board Members Trained on PR PSEAH Policy and Signed Compliance Document Annually,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,PSEAH,Comment,PSEAH,No
[GC7/T-AMREF/PSEAH-PR/RES_PSEAH] % of Principal Recipient (PR) Staff (including Interns and Volunteers) and Board Members Trained on PR PSEAH Policy and Signed Compliance Document Annually,nCZ3zIc4VLB,GC7/T-AMREF/PSEAH-PR/RES_PSEAH/COVERAGE,GC7/T-AMREF/PSEAH-PR/RES_PSEAH/COVERAGE,% of Principal Recipient (PR) Staff (including Interns and Volunteers) and Board Members Trained on PR PSEAH Policy and Signed Compliance Document Annually,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Result,PSEAH,No
[GC7/T-AMREF/PSEAH-PR/TAR_PSEAH] % of Principal Recipient (PR) Staff (including Interns and Volunteers) and Board Members Trained on PR PSEAH Policy and Signed Compliance Document Annually,d7eBodjxXFB,GC7/T-AMREF/PSEAH-PR/TAR_PSEAH/COVERAGE,GC7/T-AMREF/PSEAH-PR/TAR_PSEAH/COVERAGE,% of Principal Recipient (PR) Staff (including Interns and Volunteers) and Board Members Trained on PR PSEAH Policy and Signed Compliance Document Annually,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Target,PSEAH,No
[GC7/T-AMREF/PSEAH-SR/COMM_PSEAH] % of Sub-Recipient (SRs) whose Staff (including Interns and Volunteers) and Board Members Trained on PSEAH Policy and have Signed Compliance Document Annually,y2evDHBNoKk,GC7/T-AMREF/PSEAH-SR/COMM_PSEAH/COVERAGE,GC7/T-AMREF/PSEAH-SR/COMM_PSEAH/COVERAGE,% of Sub-Recipient (SRs) whose Staff (including Interns and Volunteers) and Board Members Trained on PSEAH Policy and have Signed Compliance Document Annually,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,PSEAH,Comment,PSEAH,No
[GC7/T-AMREF/PSEAH-SR/RES_PSEAH] % of Sub-Recipient (SRs) whose Staff (including Interns and Volunteers) and Board Members Trained on PSEAH Policy and have Signed Compliance Document Annually,CxvzT4FmHjv,GC7/T-AMREF/PSEAH-SR/RES_PSEAH/COVERAGE,GC7/T-AMREF/PSEAH-SR/RES_PSEAH/COVERAGE,% of Sub-Recipient (SRs) whose Staff (including Interns and Volunteers) and Board Members Trained on PSEAH Policy and have Signed Compliance Document Annually,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Result,PSEAH,No
[GC7/T-AMREF/PSEAH-SR/TAR_PSEAH] % of Sub-Recipient (SRs) whose Staff (including Interns and Volunteers) and Board Members Trained on PSEAH Policy and have Signed Compliance Document Annually,PBInaUoK3mX,GC7/T-AMREF/PSEAH-SR/TAR_PSEAH/COVERAGE,GC7/T-AMREF/PSEAH-SR/TAR_PSEAH/COVERAGE,% of Sub-Recipient (SRs) whose Staff (including Interns and Volunteers) and Board Members Trained on PSEAH Policy and have Signed Compliance Document Annually,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Target,PSEAH,No
[GC7/T-AMREF/PSEAH-ZT/COMM_PSEAH] % of Sub-Recipients (SRs) with PSEAH Policy highlighting Zero Tolerance of SEAH,U0l5xWM5C9N,GC7/T-AMREF/PSEAH-ZT/COMM_PSEAH/COVERAGE,GC7/T-AMREF/PSEAH-ZT/COMM_PSEAH/COVERAGE,% of Sub-Recipients (SRs) with PSEAH Policy highlighting Zero Tolerance of SEAH,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,PSEAH,Comment,PSEAH,No
[GC7/T-AMREF/PSEAH-ZT/RES_PSEAH] % of Sub-Recipients (SRs) with PSEAH Policy highlighting Zero Tolerance of SEAH,ngLPbMq7tXD,GC7/T-AMREF/PSEAH-ZT/RES_PSEAH/COVERAGE,GC7/T-AMREF/PSEAH-ZT/RES_PSEAH/COVERAGE,% of Sub-Recipients (SRs) with PSEAH Policy highlighting Zero Tolerance of SEAH,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Result,PSEAH,No
[GC7/T-AMREF/PSEAH-ZT/TAR_PSEAH] % of Sub-Recipients (SRs) with PSEAH Policy highlighting Zero Tolerance of SEAH,hP0LQeAmseW,GC7/T-AMREF/PSEAH-ZT/TAR_PSEAH/COVERAGE,GC7/T-AMREF/PSEAH-ZT/TAR_PSEAH/COVERAGE,% of Sub-Recipients (SRs) with PSEAH Policy highlighting Zero Tolerance of SEAH,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Target,PSEAH,No
[GC7/T-AMREF/RSSH/TB-CSS-3/COMMENT/COVERAGE] Percentage of health service delivery sites with a community-led monitoring mechanism in place,tfb52hekLy0,GC7/T-AMREF/COMMENT/RSSH/TB-CSS-3/COMMENT/COVERAGE,GC7/T-AMREF/COMMENT/RSSH/TB-CSS-3/COMMENT/COVERAGE,Percentage of health service delivery sites with a community-led monitoring mechanism in place,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,RSSH,No
[GC7/T-AMREF/RSSH/TB-CSS-3/RESULT/COVERAGE] Percentage of health service delivery sites with a community-led monitoring mechanism in place,iFicxwNqTG4,GC7/T-AMREF/RESULT/RSSH/TB-CSS-3/RESULT/COVERAGE,GC7/T-AMREF/RESULT/RSSH/TB-CSS-3/RESULT/COVERAGE,Percentage of health service delivery sites with a community-led monitoring mechanism in place,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,RSSH,No
[GC7/T-AMREF/RSSH/TB-CSS-3/TARGET/COVERAGE] Percentage of health service delivery sites with a community-led monitoring mechanism in place,edtjeFJ9Ilp,GC7/T-AMREF/TARGET/RSSH/TB-CSS-3/TARGET/COVERAGE,GC7/T-AMREF/TARGET/RSSH/TB-CSS-3/TARGET/COVERAGE,Percentage of health service delivery sites with a community-led monitoring mechanism in place,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,RSSH,No
[GC7/T-AMREF/SAVINGS/FINANCE] PR Savings,MomKxqHebW2,GC7/T-AMREF/SAVINGS/FINANCE,GC7/T-AMREF/SAVINGS/FINANCE,Savings,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/T-AMREF/TB-DRTB-MSS/COMMENT/COVERAGE] Number of DRTB Patients provided with Monthly social support during treatment over the grant implementation period,dq03fVxIkmO,GC7/T-AMREF/COMMENT/TB-DRTB-MSS/COMMENT/COVERAGE,GC7/T-AMREF/COMMENT/TB-DRTB-MSS/COMMENT/COVERAGE,Number of DRTB Patients provided with Monthly social support during treatment over the grant implementation period,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/T-AMREF/TB-DRTB-MSS/RESULT/COVERAGE] Number of DRTB Patients provided with Monthly social support during treatment over the grant implementation period,P9sp5BRRqsO,GC7/T-AMREF/RESULT/TB-DRTB-MSS/RESULT/COVERAGE,GC7/T-AMREF/RESULT/TB-DRTB-MSS/RESULT/COVERAGE,Number of DRTB Patients provided with Monthly social support during treatment over the grant implementation period,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/T-AMREF/TB-DRTB-MSS/TARGET/COVERAGE] Number of DRTB Patients provided with Monthly social support during treatment over the grant implementation period,QyZXLoIdmPG,GC7/T-AMREF/TARGET/TB-DRTB-MSS/TARGET/COVERAGE,GC7/T-AMREF/TARGET/TB-DRTB-MSS/TARGET/COVERAGE,Number of DRTB Patients provided with Monthly social support during treatment over the grant implementation period,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/T-AMREF/TB-HUB-TEST/COMMENT/COVERAGE] Number of Integrated samples Transported to the hubs for testing,SvbOfjLPNxJ,GC7/T-AMREF/COMMENT/TB-HUB-TEST/COMMENT/COVERAGE,GC7/T-AMREF/COMMENT/TB-HUB-TEST/COMMENT/COVERAGE,Number of Integrated samples Transported to the hubs for testing,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/T-AMREF/TB-HUB-TEST/RESULT/COVERAGE] Number of Integrated samples Transported to the hubs for testing,qJldiQJRWzP,GC7/T-AMREF/RESULT/TB-HUB-TEST/RESULT/COVERAGE,GC7/T-AMREF/RESULT/TB-HUB-TEST/RESULT/COVERAGE,Number of Integrated samples Transported to the hubs for testing,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/T-AMREF/TB-HUB-TEST/TARGET/COVERAGE] Number of Integrated samples Transported to the hubs for testing,IFd1B7xiGz6,GC7/T-AMREF/TARGET/TB-HUB-TEST/TARGET/COVERAGE,GC7/T-AMREF/TARGET/TB-HUB-TEST/TARGET/COVERAGE,Number of Integrated samples Transported to the hubs for testing,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/T-AMREF/TB-INDEX-HHS/COMMENT/COVERAGE] Households visited for contact screening by CHVs,TjJaYbkVD3T,GC7/T-AMREF/COMMENT/TB-INDEX-HHS/COMMENT/COVERAGE,GC7/T-AMREF/COMMENT/TB-INDEX-HHS/COMMENT/COVERAGE,Households visited for contact screening by CHVs,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/T-AMREF/TB-INDEX-HHS/RESULT/COVERAGE] Households visited for contact screening by CHVs,FH65CczcqR6,GC7/T-AMREF/RESULT/TB-INDEX-HHS/RESULT/COVERAGE,GC7/T-AMREF/RESULT/TB-INDEX-HHS/RESULT/COVERAGE,Households visited for contact screening by CHVs,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/T-AMREF/TB-INDEX-HHS/TARGET/COVERAGE] Households visited for contact screening by CHVs,YwuQihtUJMh,GC7/T-AMREF/TARGET/TB-INDEX-HHS/TARGET/COVERAGE,GC7/T-AMREF/TARGET/TB-INDEX-HHS/TARGET/COVERAGE,Households visited for contact screening by CHVs,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/T-AMREF/TB-KVP/COMMENT/COVERAGE] Number of TB cases notified from the targeted outreaches conducted in the reporting period,djwg6NPupTV,GC7/T-AMREF/COMMENT/TB-KVP/COMMENT/COVERAGE,GC7/T-AMREF/COMMENT/TB-KVP/COMMENT/COVERAGE,Number of TB cases notified from the targeted outreaches conducted in the reporting period,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/T-AMREF/TB-KVP/RESULT/COVERAGE] Number of TB cases notified from the targeted outreaches conducted in the reporting period,uyQsIQfw03X,GC7/T-AMREF/RESULT/TB-KVP/RESULT/COVERAGE,GC7/T-AMREF/RESULT/TB-KVP/RESULT/COVERAGE,Number of TB cases notified from the targeted outreaches conducted in the reporting period,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/T-AMREF/TB-KVP/TARGET/COVERAGE] Number of TB cases notified from the targeted outreaches conducted in the reporting period,qBuUp6LWQ8a,GC7/T-AMREF/TARGET/TB-KVP/TARGET/COVERAGE,GC7/T-AMREF/TARGET/TB-KVP/TARGET/COVERAGE,Number of TB cases notified from the targeted outreaches conducted in the reporting period,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/T-AMREF/TB-REFER/COMMENT/COVERAGE] Number of contacts referred to health facilities for TB services,BEkiDrpuzE1,GC7/T-AMREF/COMMENT/TB-REFER/COMMENT/COVERAGE,GC7/T-AMREF/COMMENT/TB-REFER/COMMENT/COVERAGE,Number of contacts referred to health facilities for TB services,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/T-AMREF/TB-REFER/RESULT/COVERAGE] Number of contacts referred to health facilities for TB services,HDkA4uYQYqf,GC7/T-AMREF/RESULT/TB-REFER/RESULT/COVERAGE,GC7/T-AMREF/RESULT/TB-REFER/RESULT/COVERAGE,Number of contacts referred to health facilities for TB services,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/T-AMREF/TB-REFER/TARGET/COVERAGE] Number of contacts referred to health facilities for TB services,csSBLOhgjeP,GC7/T-AMREF/TARGET/TB-REFER/TARGET/COVERAGE,GC7/T-AMREF/TARGET/TB-REFER/TARGET/COVERAGE,Number of contacts referred to health facilities for TB services,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/T-AMREF/TB-SCREEN/COMMENT/COVERAGE] Number of contacts of identified index TB patients screened  for TB,lD9Tp71v7Ms,GC7/T-AMREF/COMMENT/TB-SCREEN/COMMENT/COVERAGE,GC7/T-AMREF/COMMENT/TB-SCREEN/COMMENT/COVERAGE,Number of contacts of identified index TB patients screened  for TB,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/T-AMREF/TB-SCREEN/RESULT/COVERAGE] Number of contacts of identified index TB patients screened  for TB,o4et3ZRZKHj,GC7/T-AMREF/RESULT/TB-SCREEN/RESULT/COVERAGE,GC7/T-AMREF/RESULT/TB-SCREEN/RESULT/COVERAGE,Number of contacts of identified index TB patients screened  for TB,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/T-AMREF/TB-SCREEN/TARGET/COVERAGE] Number of contacts of identified index TB patients screened  for TB,UcWRLQj8XjZ,GC7/T-AMREF/TARGET/TB-SCREEN/TARGET/COVERAGE,GC7/T-AMREF/TARGET/TB-SCREEN/TARGET/COVERAGE,Number of contacts of identified index TB patients screened  for TB,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Target,Coverage,No
"[GC7/T-AMREF/TBDT-3c/COMMENT/COVERAGE] Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers",zccgcBbnJLB,GC7/T-AMREF/COMMENT/TBDT-3c/COMMENT/COVERAGE,GC7/T-AMREF/COMMENT/TBDT-3c/COMMENT/COVERAGE,"Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers",LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
"[GC7/T-AMREF/TBDT-3c/RESULT/COVERAGE] Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers",LuHV2ryS31C,GC7/T-AMREF/RESULT/TBDT-3c/RESULT/COVERAGE,GC7/T-AMREF/RESULT/TBDT-3c/RESULT/COVERAGE,"Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers",NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Coverage,No
"[GC7/T-AMREF/TBDT-3c/TARGET/COVERAGE] Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers",puuDK0kOYqr,GC7/T-AMREF/TARGET/TBDT-3c/TARGET/COVERAGE,GC7/T-AMREF/TARGET/TBDT-3c/TARGET/COVERAGE,"Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers",NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/T-AMREF/TBP-1/COMMENT/COVERAGE] Number of people in contact with TB patients who began preventive therapy,u9iAbHm22op,GC7/T-AMREF/COMMENT/TBP-1/COMMENT/COVERAGE,GC7/T-AMREF/COMMENT/TBP-1/COMMENT/COVERAGE,Number of people in contact with TB patients who began preventive therapy,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/T-AMREF/TBP-1/RESULT/COVERAGE] Number of people in contact with TB patients who began preventive therapy,YKIceLTFtUN,GC7/T-AMREF/RESULT/TBP-1/RESULT/COVERAGE,GC7/T-AMREF/RESULT/TBP-1/RESULT/COVERAGE,Number of people in contact with TB patients who began preventive therapy,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/T-AMREF/TBP-1/TARGET/COVERAGE] Number of people in contact with TB patients who began preventive therapy,O0wKCqNNupN,GC7/T-AMREF/TARGET/TBP-1/TARGET/COVERAGE,GC7/T-AMREF/TARGET/TBP-1/TARGET/COVERAGE,Number of people in contact with TB patients who began preventive therapy,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/T-AMREF/TB_RTC/COMMENT/COVERAGE] Proportion of Treatment interrupters traced & referred back,kdRPs5Wp1hN,GC7/T-AMREF/COMMENT/TB_RTC/COMMENT/COVERAGE,GC7/T-AMREF/COMMENT/TB_RTC/COMMENT/COVERAGE,Proportion of Treatment interrupters traced & referred back,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/T-AMREF/TB_RTC/RESULT/COVERAGE] Proportion of Treatment interrupters traced & referred back,YjfR7vVBF8R,GC7/T-AMREF/RESULT/TB_RTC/RESULT/COVERAGE,GC7/T-AMREF/RESULT/TB_RTC/RESULT/COVERAGE,Proportion of Treatment interrupters traced & referred back,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/T-AMREF/TB_RTC/TARGET/COVERAGE] Proportion of Treatment interrupters traced & referred back,y2fMNTAoiFJ,GC7/T-AMREF/TARGET/TB_RTC/TARGET/COVERAGE,GC7/T-AMREF/TARGET/TB_RTC/TARGET/COVERAGE,Proportion of Treatment interrupters traced & referred back,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/T-AMREF/TOTAL_BUDGET/FINANCE] PR Total Budget,HAw1OWN3K7f,GC7/T-AMREF/TOTAL_BUDGET/FINANCE,GC7/T-AMREF/TOTAL_BUDGET/FINANCE,Total Budget,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/T-AMREF/TOTAL_SR_BUDGET/FINANCE] PR Total Sub Recipients Budget Amount,r0eObGTUTap,GC7/T-AMREF/TOTAL_SR_BUDGET/FINANCE,GC7/T-AMREF/TOTAL_SR_BUDGET/FINANCE,Total Sub Recipients Budget Amount,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/T-TNT/Bedaquiline 100mg-AMC/RESULT/COMMODITIES] Bedaquiline 100mg AMC,qV67MU579gM,GC7/T-TNT/Bedaquiline 100mg-AMC/RESULT/COMMODITIES,GC7/T-TNT/Bedaquiline 100mg-AMC/RESULT/COMMODITIES,Bedaquiline 100mg AMC,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/Bedaquiline 100mg-BAL/RESULT/COMMODITIES] Bedaquiline 100mg Ending Balance,KWjXS13t0VT,GC7/T-TNT/Bedaquiline 100mg-BAL/RESULT/COMMODITIES,GC7/T-TNT/Bedaquiline 100mg-BAL/RESULT/COMMODITIES,Bedaquiline 100mg Ending Balance,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/Bedaquiline 100mg-COMMENT/COMMENT/COMMODITIES] Bedaquiline 100mg Comments,NRt86egkq6h,GC7/T-TNT/Bedaquiline 100mg-COMMENT/COMMENT/COMMOD,GC7/T-TNT/Bedaquiline 100mg-COMMENT/COMMENT/COMMOD,Bedaquiline 100mg Comments,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Products,Comment,,No
[GC7/T-TNT/Bedaquiline 100mg-PROC/RESULT/COMMODITIES] Bedaquiline 100mg Under Procurement,X4kIayRBb5J,GC7/T-TNT/Bedaquiline 100mg-PROC/RESULT/COMMODITIE,GC7/T-TNT/Bedaquiline 100mg-PROC/RESULT/COMMODITIE,Bedaquiline 100mg Under Procurement,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/Bedaquiline 100mg-SOR-D/RESULT/COMMODITIES] Bedaquiline 100mg SOR - Denominator,d6BtdGyf6xz,GC7/T-TNT/Bedaquiline 100mg-SOR-D/RESULT/COMMODITI,GC7/T-TNT/Bedaquiline 100mg-SOR-D/RESULT/COMMODITI,Bedaquiline 100mg SOR - Denominator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/Bedaquiline 100mg-SOR-N/RESULT/COMMODITIES] Bedaquiline 100mg SOR - Numerator,dwTA1znSGiT,GC7/T-TNT/Bedaquiline 100mg-SOR-N/RESULT/COMMODITI,GC7/T-TNT/Bedaquiline 100mg-SOR-N/RESULT/COMMODITI,Bedaquiline 100mg SOR - Numerator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/DRTB-1/COMMENT/COVERAGE] Percentage of DST laboratories showing adequate performance on External Quality Assurance,upTgrwTjrMH,GC7/T-TNT/COMMENT/DRTB-1/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/DRTB-1/COMMENT/COVERAGE,Percentage of DST laboratories showing adequate performance on External Quality Assurance,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/T-TNT/DRTB-1/RESULT/COVERAGE] Percentage of DST laboratories showing adequate performance on External Quality Assurance,kgwHYFakZYF,GC7/T-TNT/RESULT/DRTB-1/RESULT/COVERAGE,GC7/T-TNT/RESULT/DRTB-1/RESULT/COVERAGE,Percentage of DST laboratories showing adequate performance on External Quality Assurance,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/T-TNT/DRTB-1/TARGET/COVERAGE] Percentage of DST laboratories showing adequate performance on External Quality Assurance,DYKhRkmoP7q,GC7/T-TNT/TARGET/DRTB-1/TARGET/COVERAGE,GC7/T-TNT/TARGET/DRTB-1/TARGET/COVERAGE,Percentage of DST laboratories showing adequate performance on External Quality Assurance,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/T-TNT/DRTB-2/COMMENT/COVERAGE] Number of people with confirmed RR-TB and/or MDR-TB notified,TfirSwJ9A2Z,GC7/T-TNT/COMMENT/DRTB-2/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/DRTB-2/COMMENT/COVERAGE,Number of people with confirmed RR-TB and/or MDR-TB notified,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/T-TNT/DRTB-2/RESULT/COVERAGE] Number of people with confirmed RR-TB and/or MDR-TB notified,lkBwCFWZqQr,GC7/T-TNT/RESULT/DRTB-2/RESULT/COVERAGE,GC7/T-TNT/RESULT/DRTB-2/RESULT/COVERAGE,Number of people with confirmed RR-TB and/or MDR-TB notified,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/T-TNT/DRTB-2/TARGET/COVERAGE] Number of people with confirmed RR-TB and/or MDR-TB notified,WYoE73Gc3YV,GC7/T-TNT/TARGET/DRTB-2/TARGET/COVERAGE,GC7/T-TNT/TARGET/DRTB-2/TARGET/COVERAGE,Number of people with confirmed RR-TB and/or MDR-TB notified,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/T-TNT/DRTB-3/COMMENT/COVERAGE] Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment,SB3pH7HbtlS,GC7/T-TNT/COMMENT/DRTB-3/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/DRTB-3/COMMENT/COVERAGE,Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/T-TNT/DRTB-3/RESULT/COVERAGE] Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment,EvQhadHYExe,GC7/T-TNT/RESULT/DRTB-3/RESULT/COVERAGE,GC7/T-TNT/RESULT/DRTB-3/RESULT/COVERAGE,Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/T-TNT/DRTB-3/TARGET/COVERAGE] Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment,HIltxQjQxvr,GC7/T-TNT/TARGET/DRTB-3/TARGET/COVERAGE,GC7/T-TNT/TARGET/DRTB-3/TARGET/COVERAGE,Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/T-TNT/DRTB-6/COMMENT/COVERAGE] Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) patients during the reporting period,xshtklVYslW,GC7/T-TNT/COMMENT/DRTB-6/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/DRTB-6/COMMENT/COVERAGE,Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) patients during the reporting period,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/T-TNT/DRTB-6/RESULT/COVERAGE] Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) patients during the reporting period,yMc0FeGifb7,GC7/T-TNT/RESULT/DRTB-6/RESULT/COVERAGE,GC7/T-TNT/RESULT/DRTB-6/RESULT/COVERAGE,Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) patients during the reporting period,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/T-TNT/DRTB-6/TARGET/COVERAGE] Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) patients during the reporting period,PG1v99bBSSe,GC7/T-TNT/TARGET/DRTB-6/TARGET/COVERAGE,GC7/T-TNT/TARGET/DRTB-6/TARGET/COVERAGE,Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) patients during the reporting period,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/T-TNT/DRTB-9/COMMENT/COVERAGE] Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated,oX8mbua08Ec,GC7/T-TNT/COMMENT/DRTB-9/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/DRTB-9/COMMENT/COVERAGE,Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/T-TNT/DRTB-9/RESULT/COVERAGE] Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated,UL0BcvgtYt8,GC7/T-TNT/RESULT/DRTB-9/RESULT/COVERAGE,GC7/T-TNT/RESULT/DRTB-9/RESULT/COVERAGE,Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/T-TNT/DRTB-9/TARGET/COVERAGE] Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated,kGuAqby0jnP,GC7/T-TNT/TARGET/DRTB-9/TARGET/COVERAGE,GC7/T-TNT/TARGET/DRTB-9/TARGET/COVERAGE,Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/T-TNT/Ethambutol 100mgs-AMC/RESULT/COMMODITIES] Ethambutol 100mgs AMC,welLKgCeH7c,GC7/T-TNT/Ethambutol 100mgs-AMC/RESULT/COMMODITIES,GC7/T-TNT/Ethambutol 100mgs-AMC/RESULT/COMMODITIES,Ethambutol 100mgs AMC,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/Ethambutol 100mgs-BAL/RESULT/COMMODITIES] Ethambutol 100mgs Ending Balance,E93Z5BnFJgN,GC7/T-TNT/Ethambutol 100mgs-BAL/RESULT/COMMODITIES,GC7/T-TNT/Ethambutol 100mgs-BAL/RESULT/COMMODITIES,Ethambutol 100mgs Ending Balance,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/Ethambutol 100mgs-PROC/RESULT/COMMODITIES] Ethambutol 100mgs Under Procurement,VZpzVdSrDyT,GC7/T-TNT/Ethambutol 100mgs-PROC/RESULT/COMMODITIE,GC7/T-TNT/Ethambutol 100mgs-PROC/RESULT/COMMODITIE,Ethambutol 100mgs Under Procurement,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/Ethambutol 100mgs-SOR-D/RESULT/COMMODITIES] Ethambutol 100mgs SOR - Denominator,dJCygLU1oaR,GC7/T-TNT/Ethambutol 100mgs-SOR-D/RESULT/COMMODITI,GC7/T-TNT/Ethambutol 100mgs-SOR-D/RESULT/COMMODITI,Ethambutol 100mgs SOR - Denominator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/Ethambutol 100mgs-SOR-N/RESULT/COMMODITIES] Ethambutol 100mgs SOR - Numerator,t6ShzlCTvtN,GC7/T-TNT/Ethambutol 100mgs-SOR-N/RESULT/COMMODITI,GC7/T-TNT/Ethambutol 100mgs-SOR-N/RESULT/COMMODITI,Ethambutol 100mgs SOR - Numerator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/Ethambutol 100mgs/COMMENT/COMMODITIES] Ethambutol 100mgs Comments,cesRVJAlx2s,GC7/T-TNT/Ethambutol 100mgs/COMMENT/COMMODITIES,GC7/T-TNT/Ethambutol 100mgs/COMMENT/COMMODITIES,Ethambutol 100mgs Comments,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Products,Comment,,No
[GC7/T-TNT/KVP-1/COMMENT/COVERAGE] Number of people with TB (all forms) notified among prisoners; *includes only those with new and relapse TB,RszO0lQuBjL,GC7/T-TNT/COMMENT/KVP-1/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/KVP-1/COMMENT/COVERAGE,Number of people with TB (all forms) notified among prisoners; *includes only those with new and relapse TB,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/T-TNT/KVP-1/RESULT/COVERAGE] Number of people with TB (all forms) notified among prisoners; *includes only those with new and relapse TB,QR4Oh4xnXtD,GC7/T-TNT/RESULT/KVP-1/RESULT/COVERAGE,GC7/T-TNT/RESULT/KVP-1/RESULT/COVERAGE,Number of people with TB (all forms) notified among prisoners; *includes only those with new and relapse TB,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/T-TNT/KVP-1/TARGET/COVERAGE] Number of people with TB (all forms) notified among prisoners; *includes only those with new and relapse TB,E4PP3m6GIHi,GC7/T-TNT/TARGET/KVP-1/TARGET/COVERAGE,GC7/T-TNT/TARGET/KVP-1/TARGET/COVERAGE,Number of people with TB (all forms) notified among prisoners; *includes only those with new and relapse TB,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/T-TNT/Linezolid 600mg-AMC/RESULT/COMMODITIES] Linezolid 600mg AMC,dppMoeT1sZh,GC7/T-TNT/Linezolid 600mg-AMC/RESULT/COMMODITIES,GC7/T-TNT/Linezolid 600mg-AMC/RESULT/COMMODITIES,Linezolid 600mg AMC,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/Linezolid 600mg-BAL/RESULT/COMMODITIES] Linezolid 600mg Ending Balance,lcV8trTHlej,GC7/T-TNT/Linezolid 600mg-BAL/RESULT/COMMODITIES,GC7/T-TNT/Linezolid 600mg-BAL/RESULT/COMMODITIES,Linezolid 600mg Ending Balance,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/Linezolid 600mg-COMMENT/COMMENT/COMMODITIES] Linezolid 600mg Comments,DYQ7InQtA2a,GC7/T-TNT/Linezolid 600mg-COMMENT/COMMENT/COMMODIT,GC7/T-TNT/Linezolid 600mg-COMMENT/COMMENT/COMMODIT,Linezolid 600mg Comments,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Products,Comment,,No
[GC7/T-TNT/Linezolid 600mg-PROC/RESULT/COMMODITIES] Linezolid 600mg Under Procurement,D581V6Jyw0p,GC7/T-TNT/Linezolid 600mg-PROC/RESULT/COMMODITIES,GC7/T-TNT/Linezolid 600mg-PROC/RESULT/COMMODITIES,Linezolid 600mg Under Procurement,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/Linezolid 600mg-SOR-D/RESULT/COMMODITIES] Linezolid 600mg SOR - Denominator,IJ7YCXRqyAD,GC7/T-TNT/Linezolid 600mg-SOR-D/RESULT/COMMODITIES,GC7/T-TNT/Linezolid 600mg-SOR-D/RESULT/COMMODITIES,Linezolid 600mg SOR - Denominator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/Linezolid 600mg-SOR-N/RESULT/COMMODITIES] Linezolid 600mg SOR - Numerator,PEltvoj6hHD,GC7/T-TNT/Linezolid 600mg-SOR-N/RESULT/COMMODITIES,GC7/T-TNT/Linezolid 600mg-SOR-N/RESULT/COMMODITIES,Linezolid 600mg SOR - Numerator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/Moxifloxacin 400mg-AMC/RESULT/COMMODITIES] Moxifloxacin 400mg AMC,JykNIRfXa7K,GC7/T-TNT/Moxifloxacin 400mg-AMC/RESULT/COMMODITIE,GC7/T-TNT/Moxifloxacin 400mg-AMC/RESULT/COMMODITIE,Moxifloxacin 400mg AMC,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/Moxifloxacin 400mg-BAL/RESULT/COMMODITIES] Moxifloxacin 400mg Ending Balance,rHCvZwpFzob,GC7/T-TNT/Moxifloxacin 400mg-BAL/RESULT/COMMODITIE,GC7/T-TNT/Moxifloxacin 400mg-BAL/RESULT/COMMODITIE,Moxifloxacin 400mg Ending Balance,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/Moxifloxacin 400mg-COMMENT/COMMENT/COMMODITIES] Moxifloxacin 400mg Comments,vKoujeXsQcP,GC7/T-TNT/Moxifloxacin 400mg-COMMENT/COMMENT/COMMO,GC7/T-TNT/Moxifloxacin 400mg-COMMENT/COMMENT/COMMO,Moxifloxacin 400mg Comments,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Products,Comment,,No
[GC7/T-TNT/Moxifloxacin 400mg-PROC/RESULT/COMMODITIES] Moxifloxacin 400mg Under Procurement,NK0JJAPVaAS,GC7/T-TNT/Moxifloxacin 400mg-PROC/RESULT/COMMODITI,GC7/T-TNT/Moxifloxacin 400mg-PROC/RESULT/COMMODITI,Moxifloxacin 400mg Under Procurement,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/Moxifloxacin 400mg-SOR-D/RESULT/COMMODITIES] Moxifloxacin 400mg SOR - Denominator,QqP2seiv9kO,GC7/T-TNT/Moxifloxacin 400mg-SOR-D/RESULT/COMMODIT,GC7/T-TNT/Moxifloxacin 400mg-SOR-D/RESULT/COMMODIT,Moxifloxacin 400mg SOR - Denominator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/Moxifloxacin 400mg-SOR-N/RESULT/COMMODITIES] Moxifloxacin 400mg SOR - Numerator,p2MCPHoFHJJ,GC7/T-TNT/Moxifloxacin 400mg-SOR-N/RESULT/COMMODIT,GC7/T-TNT/Moxifloxacin 400mg-SOR-N/RESULT/COMMODIT,Moxifloxacin 400mg SOR - Numerator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
"[GC7/T-TNT/PSEAH-CA/COMM_PSEAH] % of community level actors/agents (TB Champions, peer educators, mentor mothers etc) sensitized on PSEAH/SEAH including SEAH reporting channels and have Signed Compliance Document ",vD75RvP3za8,GC7/T-TNT/PSEAH-CA/COMM_PSEAH/COVERAGE,GC7/T-TNT/PSEAH-CA/COMM_PSEAH/COVERAGE,"% of community level actors/agents (TB Champions, peer educators, mentor mothers etc) sensitized on PSEAH/SEAH including SEAH reporting channels and have Signed Compliance Document ",LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,PSEAH,Comment,PSEAH,No
"[GC7/T-TNT/PSEAH-CA/RES_PSEAH] % of community level actors/agents (TB Champions, peer educators, mentor mothers etc) sensitized on PSEAH/SEAH including SEAH reporting channels and have Signed Compliance Document ",bVkBMgm8Yc7,GC7/T-TNT/PSEAH-CA/RES_PSEAH/COVERAGE,GC7/T-TNT/PSEAH-CA/RES_PSEAH/COVERAGE,"% of community level actors/agents (TB Champions, peer educators, mentor mothers etc) sensitized on PSEAH/SEAH including SEAH reporting channels and have Signed Compliance Document ",PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Result,PSEAH,No
"[GC7/T-TNT/PSEAH-CA/TAR_PSEAH] % of community level actors/agents (TB Champions, peer educators, mentor mothers etc) sensitized on PSEAH/SEAH including SEAH reporting channels and have Signed Compliance Document ",VtipBWQ86ip,GC7/T-TNT/PSEAH-CA/TAR_PSEAH/COVERAGE,GC7/T-TNT/PSEAH-CA/TAR_PSEAH/COVERAGE,"% of community level actors/agents (TB Champions, peer educators, mentor mothers etc) sensitized on PSEAH/SEAH including SEAH reporting channels and have Signed Compliance Document ",PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Target,PSEAH,No
[GC7/T-TNT/PSEAH-PB/COMM_PSEAH] % of programme beneficiaries at community level assessed as being at high/medium risk of SEAH sensitized on PSEAH/SEAH including SEAH reporting channels,Gb9HjF4Tv5j,GC7/T-TNT/PSEAH-PB/COMM_PSEAH/COVERAGE,GC7/T-TNT/PSEAH-PB/COMM_PSEAH/COVERAGE,% of programme beneficiaries at community level assessed as being at high/medium risk of SEAH sensitized on PSEAH/SEAH including SEAH reporting channels,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,PSEAH,Comment,PSEAH,No
[GC7/T-TNT/PSEAH-PB/RES_PSEAH] % of programme beneficiaries at community level assessed as being at high/medium risk of SEAH sensitized on PSEAH/SEAH including SEAH reporting channels,rjKzeeWGEmc,GC7/T-TNT/PSEAH-PB/RES_PSEAH/COVERAGE,GC7/T-TNT/PSEAH-PB/RES_PSEAH/COVERAGE,% of programme beneficiaries at community level assessed as being at high/medium risk of SEAH sensitized on PSEAH/SEAH including SEAH reporting channels,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Result,PSEAH,No
[GC7/T-TNT/PSEAH-PB/TAR_PSEAH] % of programme beneficiaries at community level assessed as being at high/medium risk of SEAH sensitized on PSEAH/SEAH including SEAH reporting channels,lmUJRBWiHhU,GC7/T-TNT/PSEAH-PB/TAR_PSEAH/COVERAGE,GC7/T-TNT/PSEAH-PB/TAR_PSEAH/COVERAGE,% of programme beneficiaries at community level assessed as being at high/medium risk of SEAH sensitized on PSEAH/SEAH including SEAH reporting channels,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Target,PSEAH,No
[GC7/T-TNT/PSEAH-PR/COMM_PSEAH] % of Principal Recipient (PR) Staff (including Interns and Volunteers) and Board Members Trained on PR PSEAH Policy and Signed Compliance Document Annually,yb7mIfC0US4,GC7/T-TNT/PSEAH-PR/COMM_PSEAH/COVERAGE,GC7/T-TNT/PSEAH-PR/COMM_PSEAH/COVERAGE,% of Principal Recipient (PR) Staff (including Interns and Volunteers) and Board Members Trained on PR PSEAH Policy and Signed Compliance Document Annually,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,PSEAH,Comment,PSEAH,No
[GC7/T-TNT/PSEAH-PR/RES_PSEAH] % of Principal Recipient (PR) Staff (including Interns and Volunteers) and Board Members Trained on PR PSEAH Policy and Signed Compliance Document Annually,ZqmaYJExtwB,GC7/T-TNT/PSEAH-PR/RES_PSEAH/COVERAGE,GC7/T-TNT/PSEAH-PR/RES_PSEAH/COVERAGE,% of Principal Recipient (PR) Staff (including Interns and Volunteers) and Board Members Trained on PR PSEAH Policy and Signed Compliance Document Annually,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Result,PSEAH,No
[GC7/T-TNT/PSEAH-PR/TAR_PSEAH] % of Principal Recipient (PR) Staff (including Interns and Volunteers) and Board Members Trained on PR PSEAH Policy and Signed Compliance Document Annually,nFgUTnDOFJg,GC7/T-TNT/PSEAH-PR/TAR_PSEAH/COVERAGE,GC7/T-TNT/PSEAH-PR/TAR_PSEAH/COVERAGE,% of Principal Recipient (PR) Staff (including Interns and Volunteers) and Board Members Trained on PR PSEAH Policy and Signed Compliance Document Annually,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Target,PSEAH,No
[GC7/T-TNT/PSEAH-SR/COMM_PSEAH] % of Sub-Recipient (SRs) whose Staff (including Interns and Volunteers) and Board Members Trained on PSEAH Policy and have Signed Compliance Document Annually,RXKLtBYI8Pu,GC7/T-TNT/PSEAH-SR/COMM_PSEAH/COVERAGE,GC7/T-TNT/PSEAH-SR/COMM_PSEAH/COVERAGE,% of Sub-Recipient (SRs) whose Staff (including Interns and Volunteers) and Board Members Trained on PSEAH Policy and have Signed Compliance Document Annually,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,PSEAH,Comment,PSEAH,No
[GC7/T-TNT/PSEAH-SR/RES_PSEAH] % of Sub-Recipient (SRs) whose Staff (including Interns and Volunteers) and Board Members Trained on PSEAH Policy and have Signed Compliance Document Annually,aUTnb9yYYMO,GC7/T-TNT/PSEAH-SR/RES_PSEAH/COVERAGE,GC7/T-TNT/PSEAH-SR/RES_PSEAH/COVERAGE,% of Sub-Recipient (SRs) whose Staff (including Interns and Volunteers) and Board Members Trained on PSEAH Policy and have Signed Compliance Document Annually,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Result,PSEAH,No
[GC7/T-TNT/PSEAH-SR/TAR_PSEAH] % of Sub-Recipient (SRs) whose Staff (including Interns and Volunteers) and Board Members Trained on PSEAH Policy and have Signed Compliance Document Annually,zpdsF4gvDae,GC7/T-TNT/PSEAH-SR/TAR_PSEAH/COVERAGE,GC7/T-TNT/PSEAH-SR/TAR_PSEAH/COVERAGE,% of Sub-Recipient (SRs) whose Staff (including Interns and Volunteers) and Board Members Trained on PSEAH Policy and have Signed Compliance Document Annually,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Target,PSEAH,No
[GC7/T-TNT/PSEAH-ZT/COMM_PSEAH] % of Sub-Recipients (SRs) with PSEAH Policy highlighting Zero Tolerance of SEAH,fMISyPVvvGJ,GC7/T-TNT/PSEAH-ZT/COMM_PSEAH/COVERAGE,GC7/T-TNT/PSEAH-ZT/COMM_PSEAH/COVERAGE,% of Sub-Recipients (SRs) with PSEAH Policy highlighting Zero Tolerance of SEAH,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,PSEAH,Comment,PSEAH,No
[GC7/T-TNT/PSEAH-ZT/RES_PSEAH] % of Sub-Recipients (SRs) with PSEAH Policy highlighting Zero Tolerance of SEAH,CHIB2kJJ1c8,GC7/T-TNT/PSEAH-ZT/RES_PSEAH/COVERAGE,GC7/T-TNT/PSEAH-ZT/RES_PSEAH/COVERAGE,% of Sub-Recipients (SRs) with PSEAH Policy highlighting Zero Tolerance of SEAH,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Result,PSEAH,No
[GC7/T-TNT/PSEAH-ZT/TAR_PSEAH] % of Sub-Recipients (SRs) with PSEAH Policy highlighting Zero Tolerance of SEAH,M6js9bfDeS0,GC7/T-TNT/PSEAH-ZT/TAR_PSEAH/COVERAGE,GC7/T-TNT/PSEAH-ZT/TAR_PSEAH/COVERAGE,% of Sub-Recipients (SRs) with PSEAH Policy highlighting Zero Tolerance of SEAH,PERCENTAGE,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,PSEAH,Target,PSEAH,No
[GC7/T-TNT/Pretomanid 200mgs-AMC/RESULT/COMMODITIES] Pretomanid 200mgs AMC,wRCuqn9fRlz,GC7/T-TNT/Pretomanid 200mgs-AMC/RESULT/COMMODITIES,GC7/T-TNT/Pretomanid 200mgs-AMC/RESULT/COMMODITIES,Pretomanid 200mgs AMC,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/Pretomanid 200mgs-BAL/RESULT/COMMODITIES] Pretomanid 200mgs Ending Balance,c8z2RFVPG2u,GC7/T-TNT/Pretomanid 200mgs-BAL/RESULT/COMMODITIES,GC7/T-TNT/Pretomanid 200mgs-BAL/RESULT/COMMODITIES,Pretomanid 200mgs Ending Balance,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/Pretomanid 200mgs-COMMENT/COMMENT/COMMODITIES] Pretomanid 200mgs Comments,RObgPf2JtTz,GC7/T-TNT/Pretomanid 200mgs-COMMENT/COMMENT/COMMOD,GC7/T-TNT/Pretomanid 200mgs-COMMENT/COMMENT/COMMOD,Pretomanid 200mgs Comments,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Products,Comment,,No
[GC7/T-TNT/Pretomanid 200mgs-PROC/RESULT/COMMODITIES] Pretomanid 200mgs Under Procurement,CxnEdzQaLFi,GC7/T-TNT/Pretomanid 200mgs-PROC/RESULT/COMMODITIE,GC7/T-TNT/Pretomanid 200mgs-PROC/RESULT/COMMODITIE,Pretomanid 200mgs Under Procurement,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/Pretomanid 200mgs-SOR-D/RESULT/COMMODITIES] Pretomanid 200mgs SOR - Denominator,jQGbHpPMgk6,GC7/T-TNT/Pretomanid 200mgs-SOR-D/RESULT/COMMODITI,GC7/T-TNT/Pretomanid 200mgs-SOR-D/RESULT/COMMODITI,Pretomanid 200mgs SOR - Denominator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/Pretomanid 200mgs-SOR-N/RESULT/COMMODITIES] Pretomanid 200mgs SOR - Numerator,kLzi199Z8WT,GC7/T-TNT/Pretomanid 200mgs-SOR-N/RESULT/COMMODITI,GC7/T-TNT/Pretomanid 200mgs-SOR-N/RESULT/COMMODITI,Pretomanid 200mgs SOR - Numerator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/R/H -50/75mg -AMC/RESULT/COMMODITIES] R/H -50/75mg  AMC,kNbJEb1R5g2,GC7/T-TNT/R/H -50/75mg -AMC/RESULT/COMMODITIES,GC7/T-TNT/R/H -50/75mg -AMC/RESULT/COMMODITIES,R/H -50/75mg  AMC,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/R/H -50/75mg -BAL/RESULT/COMMODITIES] R/H -50/75mg  Ending Balance,A9FV5AsGy1M,GC7/T-TNT/R/H -50/75mg -BAL/RESULT/COMMODITIES,GC7/T-TNT/R/H -50/75mg -BAL/RESULT/COMMODITIES,R/H -50/75mg  Ending Balance,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/R/H -50/75mg -COMMENT/COMMENT/COMMODITIES] R/H -50/75mg  Comments,CPKpgNXdfpu,GC7/T-TNT/R/H -50/75mg -COMMENT/COMMENT/COMMODITIE,GC7/T-TNT/R/H -50/75mg -COMMENT/COMMENT/COMMODITIE,R/H -50/75mg  Comments,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Products,Comment,,No
[GC7/T-TNT/R/H -50/75mg -PROC/RESULT/COMMODITIES] R/H -50/75mg  Under Procurement,EcBTw8FdYS2,GC7/T-TNT/R/H -50/75mg -PROC/RESULT/COMMODITIES,GC7/T-TNT/R/H -50/75mg -PROC/RESULT/COMMODITIES,R/H -50/75mg  Under Procurement,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/R/H -50/75mg -SOR-D/RESULT/COMMODITIES] R/H -50/75mg  SOR - Denominator,DZU8utrJSrn,GC7/T-TNT/R/H -50/75mg -SOR-D/RESULT/COMMODITIES,GC7/T-TNT/R/H -50/75mg -SOR-D/RESULT/COMMODITIES,R/H -50/75mg  SOR - Denominator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/R/H -50/75mg -SOR-N/RESULT/COMMODITIES] R/H -50/75mg  SOR - Numerator,RM6hlRjNuFJ,GC7/T-TNT/R/H -50/75mg -SOR-N/RESULT/COMMODITIES,GC7/T-TNT/R/H -50/75mg -SOR-N/RESULT/COMMODITIES,R/H -50/75mg  SOR - Numerator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/R/H/Z- 50/75/150mgs -AMC/RESULT/COMMODITIES] R/H/Z- 50/75/150mgs  AMC,aJK5LfThEx3,GC7/T-TNT/R/H/Z- 50/75/150mgs -AMC/RESULT/COMMODIT,GC7/T-TNT/R/H/Z- 50/75/150mgs -AMC/RESULT/COMMODIT,R/H/Z- 50/75/150mgs  AMC,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/R/H/Z- 50/75/150mgs -BAL/RESULT/COMMODITIES] R/H/Z- 50/75/150mgs  Ending Balance,zD1A1b2ribr,GC7/T-TNT/R/H/Z- 50/75/150mgs -BAL/RESULT/COMMODIT,GC7/T-TNT/R/H/Z- 50/75/150mgs -BAL/RESULT/COMMODIT,R/H/Z- 50/75/150mgs  Ending Balance,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/R/H/Z- 50/75/150mgs -COMMENT/COMMENT/COMMODITIES] R/H/Z- 50/75/150mgs  Comments,GZp2ELiW2b1,GC7/T-TNT/R/H/Z- 50/75/150mgs -COMMENT/COMMENT/COM,GC7/T-TNT/R/H/Z- 50/75/150mgs -COMMENT/COMMENT/COM,R/H/Z- 50/75/150mgs  Comments,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Products,Comment,,No
[GC7/T-TNT/R/H/Z- 50/75/150mgs -PROC/RESULT/COMMODITIES] R/H/Z- 50/75/150mgs  Under Procurement,VL1TvZyNeCt,GC7/T-TNT/R/H/Z- 50/75/150mgs -PROC/RESULT/COMMODI,GC7/T-TNT/R/H/Z- 50/75/150mgs -PROC/RESULT/COMMODI,R/H/Z- 50/75/150mgs  Under Procurement,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/R/H/Z- 50/75/150mgs -SOR-D/RESULT/COMMODITIES] R/H/Z- 50/75/150mgs  SOR - Denominator,UFBnsP8z1cd,GC7/T-TNT/R/H/Z- 50/75/150mgs -SOR-D/RESULT/COMMOD,GC7/T-TNT/R/H/Z- 50/75/150mgs -SOR-D/RESULT/COMMOD,R/H/Z- 50/75/150mgs  SOR - Denominator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/R/H/Z- 50/75/150mgs -SOR-N/RESULT/COMMODITIES] R/H/Z- 50/75/150mgs  SOR - Numerator,EJUxHvUuDxj,GC7/T-TNT/R/H/Z- 50/75/150mgs -SOR-N/RESULT/COMMOD,GC7/T-TNT/R/H/Z- 50/75/150mgs -SOR-N/RESULT/COMMOD,R/H/Z- 50/75/150mgs  SOR - Numerator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
"[GC7/T-TNT/RSSH O-1/COMMENT/OUTCOME] Percentage of facilities providing HIV, TB and malaria integrated services to pregnant women",BJflWq54fD7,GC7/T-TNT/COMMENT/RSSH O-1/COMMENT/OUTCOME,GC7/T-TNT/COMMENT/RSSH O-1/COMMENT/OUTCOME,"Percentage of facilities providing HIV, TB and malaria integrated services to pregnant women",LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,RSSH,No
"[GC7/T-TNT/RSSH O-1/RESULT/OUTCOME] Percentage of facilities providing HIV, TB and malaria integrated services to pregnant women",R4Hk8WLwzzb,GC7/T-TNT/RESULT/RSSH O-1/RESULT/OUTCOME,GC7/T-TNT/RESULT/RSSH O-1/RESULT/OUTCOME,"Percentage of facilities providing HIV, TB and malaria integrated services to pregnant women",NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,RSSH,No
"[GC7/T-TNT/RSSH O-1/TARGET/OUTCOME] Percentage of facilities providing HIV, TB and malaria integrated services to pregnant women",cMp3FR4IwR1,GC7/T-TNT/TARGET/RSSH O-1/TARGET/OUTCOME,GC7/T-TNT/TARGET/RSSH O-1/TARGET/OUTCOME,"Percentage of facilities providing HIV, TB and malaria integrated services to pregnant women",NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,RSSH,No
"[GC7/T-TNT/RSSH O-3/COMMENT/OUTCOME] On-shelf availability: Percentage of facilities with tracer health products for the three diseases - HIV, TB, malaria (as applicable) available on the day of the visit or day of reporting",T6QxvRACSaE,GC7/T-TNT/COMMENT/RSSH O-3/COMMENT/OUTCOME,GC7/T-TNT/COMMENT/RSSH O-3/COMMENT/OUTCOME,"On-shelf availability: Percentage of facilities with tracer health products for the three diseases - HIV, TB, malaria (as applicable) available on the day of the visit or day of reporting",LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,RSSH,No
"[GC7/T-TNT/RSSH O-3/RESULT/OUTCOME] On-shelf availability: Percentage of facilities with tracer health products for the three diseases - HIV, TB, malaria (as applicable) available on the day of the visit or day of reporting",kzvkUqdfSp4,GC7/T-TNT/RESULT/RSSH O-3/RESULT/OUTCOME,GC7/T-TNT/RESULT/RSSH O-3/RESULT/OUTCOME,"On-shelf availability: Percentage of facilities with tracer health products for the three diseases - HIV, TB, malaria (as applicable) available on the day of the visit or day of reporting",NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,RSSH,No
"[GC7/T-TNT/RSSH O-3/TARGET/OUTCOME] On-shelf availability: Percentage of facilities with tracer health products for the three diseases - HIV, TB, malaria (as applicable) available on the day of the visit or day of reporting",w6p339fNLza,GC7/T-TNT/TARGET/RSSH O-3/TARGET/OUTCOME,GC7/T-TNT/TARGET/RSSH O-3/TARGET/OUTCOME,"On-shelf availability: Percentage of facilities with tracer health products for the three diseases - HIV, TB, malaria (as applicable) available on the day of the visit or day of reporting",NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,RSSH,No
[GC7/T-TNT/RSSH/HFS-1/COMMENT/COVERAGE] Percentage of public financial management system components used for grant financial management,EdBmYgiu3WX,GC7/T-TNT/COMMENT/HFS-1/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/HFS-1/COMMENT/COVERAGE,Percentage of public financial management system components used for grant financial management,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,RSSH,No
[GC7/T-TNT/RSSH/HFS-1/RESULT/COVERAGE] Percentage of public financial management system components used for grant financial management,JsADwFdhYPU,GC7/T-TNT/RESULT/HFS-1/RESULT/COVERAGE,GC7/T-TNT/RESULT/HFS-1/RESULT/COVERAGE,Percentage of public financial management system components used for grant financial management,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,RSSH,No
[GC7/T-TNT/RSSH/HFS-1/TARGET/COVERAGE] Percentage of public financial management system components used for grant financial management,DdKkxXkbdbB,GC7/T-TNT/TARGET/HFS-1/TARGET/COVERAGE,GC7/T-TNT/TARGET/HFS-1/TARGET/COVERAGE,Percentage of public financial management system components used for grant financial management,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,RSSH,No
[GC7/T-TNT/RSSH/HFS-2/COMMENT/COVERAGE] Percentage of the government budget allocated to health,BIw9cBlHAJl,GC7/T-TNT/COMMENT/HFS-2/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/HFS-2/COMMENT/COVERAGE,Percentage of the government budget allocated to health,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,RSSH,No
[GC7/T-TNT/RSSH/HFS-2/RESULT/COVERAGE] Percentage of the government budget allocated to health,uVbODo3BFZk,GC7/T-TNT/RESULT/HFS-2/RESULT/COVERAGE,GC7/T-TNT/RESULT/HFS-2/RESULT/COVERAGE,Percentage of the government budget allocated to health,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,RSSH,No
[GC7/T-TNT/RSSH/HFS-2/TARGET/COVERAGE] Percentage of the government budget allocated to health,PvCofx6irmX,GC7/T-TNT/TARGET/HFS-2/TARGET/COVERAGE,GC7/T-TNT/TARGET/HFS-2/TARGET/COVERAGE,Percentage of the government budget allocated to health,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,RSSH,No
[GC7/T-TNT/RSSH/HPM-1/COMMENT/COVERAGE] LMIS Reporting Rate - Percentage of all health facilities that are required to report that submit an LMIS report to central authority,seLYYdNij0i,GC7/T-TNT/COMMENT/HPM-1/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/HPM-1/COMMENT/COVERAGE,LMIS Reporting Rate - Percentage of all health facilities that are required to report that submit an LMIS report to central authority,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,RSSH,No
[GC7/T-TNT/RSSH/HPM-1/RESULT/COVERAGE] LMIS Reporting Rate - Percentage of all health facilities that are required to report that submit an LMIS report to central authority,PyFsHQPGUfk,GC7/T-TNT/RESULT/HPM-1/RESULT/COVERAGE,GC7/T-TNT/RESULT/HPM-1/RESULT/COVERAGE,LMIS Reporting Rate - Percentage of all health facilities that are required to report that submit an LMIS report to central authority,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,RSSH,No
[GC7/T-TNT/RSSH/HPM-1/TARGET/COVERAGE] LMIS Reporting Rate - Percentage of all health facilities that are required to report that submit an LMIS report to central authority,vFoxgWupK3S,GC7/T-TNT/TARGET/HPM-1/TARGET/COVERAGE,GC7/T-TNT/TARGET/HPM-1/TARGET/COVERAGE,LMIS Reporting Rate - Percentage of all health facilities that are required to report that submit an LMIS report to central authority,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,RSSH,No
[GC7/T-TNT/RSSH/PP HRH-5/COMMENT/COVERAGE] Percentage of facilities that implement supportive supervision (meeting all key attributes),v0sSlIWUOMs,GC7/T-TNT/COMMENT/RSSH/PP HRH-5/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/RSSH/PP HRH-5/COMMENT/COVERAGE,Percentage of facilities that implement supportive supervision (meeting all key attributes),LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,RSSH,No
[GC7/T-TNT/RSSH/PP HRH-5/RESULT/COVERAGE] Percentage of facilities that implement supportive supervision (meeting all key attributes),QkcAe8pq8Cq,GC7/T-TNT/RESULT/RSSH/PP HRH-5/RESULT/COVERAGE,GC7/T-TNT/RESULT/RSSH/PP HRH-5/RESULT/COVERAGE,Percentage of facilities that implement supportive supervision (meeting all key attributes),NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,RSSH,No
[GC7/T-TNT/RSSH/PP HRH-5/TARGET/COVERAGE] Percentage of facilities that implement supportive supervision (meeting all key attributes),XfcQN4JR8lc,GC7/T-TNT/TARGET/RSSH/PP HRH-5/TARGET/COVERAGE,GC7/T-TNT/TARGET/RSSH/PP HRH-5/TARGET/COVERAGE,Percentage of facilities that implement supportive supervision (meeting all key attributes),NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,RSSH,No
[GC7/T-TNT/RSSH/PP HRH-7/COMMENT/COVERAGE] Percentage of facilities providing patient-centered quality of care,SrrmZLkiU4x,GC7/T-TNT/COMMENT/RSSH/PP HRH-7/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/RSSH/PP HRH-7/COMMENT/COVERAGE,Percentage of facilities providing patient-centered quality of care,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,RSSH,No
[GC7/T-TNT/RSSH/PP HRH-7/RESULT/COVERAGE] Percentage of facilities providing patient-centered quality of care,YNq2V4fE0FA,GC7/T-TNT/RESULT/RSSH/PP HRH-7/RESULT/COVERAGE,GC7/T-TNT/RESULT/RSSH/PP HRH-7/RESULT/COVERAGE,Percentage of facilities providing patient-centered quality of care,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,RSSH,No
[GC7/T-TNT/RSSH/PP HRH-7/TARGET/COVERAGE] Percentage of facilities providing patient-centered quality of care,mBqjD4UDihH,GC7/T-TNT/TARGET/RSSH/PP HRH-7/TARGET/COVERAGE,GC7/T-TNT/TARGET/RSSH/PP HRH-7/TARGET/COVERAGE,Percentage of facilities providing patient-centered quality of care,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,RSSH,No
[GC7/T-TNT/RSSH/PP LAB-1/COMMENT/COVERAGE] Percentage of laboratories accredited according to ISO15189 standard or achieving at least four stars towards accreditation or two-star incremental improvement,uIrut8LKHdD,GC7/T-TNT/COMMENT/RSSH/PP LAB-1/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/RSSH/PP LAB-1/COMMENT/COVERAGE,Percentage of laboratories accredited according to ISO15189 standard or achieving at least four stars towards accreditation or two-star incremental improvement,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,RSSH,No
[GC7/T-TNT/RSSH/PP LAB-1/RESULT/COVERAGE] Percentage of laboratories accredited according to ISO15189 standard or achieving at least four stars towards accreditation or two-star incremental improvement,H09TraA6Rz9,GC7/T-TNT/RESULT/RSSH/PP LAB-1/RESULT/COVERAGE,GC7/T-TNT/RESULT/RSSH/PP LAB-1/RESULT/COVERAGE,Percentage of laboratories accredited according to ISO15189 standard or achieving at least four stars towards accreditation or two-star incremental improvement,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,RSSH,No
[GC7/T-TNT/RSSH/PP LAB-1/TARGET/COVERAGE] Percentage of laboratories accredited according to ISO15189 standard or achieving at least four stars towards accreditation or two-star incremental improvement,i6lpmf0eMkj,GC7/T-TNT/TARGET/RSSH/PP LAB-1/TARGET/COVERAGE,GC7/T-TNT/TARGET/RSSH/PP LAB-1/TARGET/COVERAGE,Percentage of laboratories accredited according to ISO15189 standard or achieving at least four stars towards accreditation or two-star incremental improvement,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,RSSH,No
[GC7/T-TNT/RSSH/PP LAB-2/COMMENT/COVERAGE] Percentage of molecular diagnostic analyzers achieving at least 85% functionality (ability to test samples) during the reporting period,kg1Bsep2HUK,GC7/T-TNT/COMMENT/RSSH/PP LAB-2/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/RSSH/PP LAB-2/COMMENT/COVERAGE,Percentage of molecular diagnostic analyzers achieving at least 85% functionality (ability to test samples) during the reporting period,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,RSSH,No
[GC7/T-TNT/RSSH/PP LAB-2/RESULT/COVERAGE] Percentage of molecular diagnostic analyzers achieving at least 85% functionality (ability to test samples) during the reporting period,VD87i1xYEHw,GC7/T-TNT/RESULT/RSSH/PP LAB-2/RESULT/COVERAGE,GC7/T-TNT/RESULT/RSSH/PP LAB-2/RESULT/COVERAGE,Percentage of molecular diagnostic analyzers achieving at least 85% functionality (ability to test samples) during the reporting period,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,RSSH,No
[GC7/T-TNT/RSSH/PP LAB-2/TARGET/COVERAGE] Percentage of molecular diagnostic analyzers achieving at least 85% functionality (ability to test samples) during the reporting period,JA2U31uoIHl,GC7/T-TNT/TARGET/RSSH/PP LAB-2/TARGET/COVERAGE,GC7/T-TNT/TARGET/RSSH/PP LAB-2/TARGET/COVERAGE,Percentage of molecular diagnostic analyzers achieving at least 85% functionality (ability to test samples) during the reporting period,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,RSSH,No
[GC7/T-TNT/RSSH/PP M&E-1/COMMENT/COVERAGE] Completeness of reporting: Percentage of expected monthly reports (for the reporting period) that are actually received,mJPUSjzlBQc,GC7/T-TNT/COMMENT/RSSH/PP M&E-1/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/RSSH/PP M&E-1/COMMENT/COVERAGE,Completeness of reporting: Percentage of expected monthly reports (for the reporting period) that are actually received,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,RSSH,No
[GC7/T-TNT/RSSH/PP M&E-1/RESULT/COVERAGE] Completeness of reporting: Percentage of expected monthly reports (for the reporting period) that are actually received,uvUffww1cxe,GC7/T-TNT/RESULT/RSSH/PP M&E-1/RESULT/COVERAGE,GC7/T-TNT/RESULT/RSSH/PP M&E-1/RESULT/COVERAGE,Completeness of reporting: Percentage of expected monthly reports (for the reporting period) that are actually received,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,RSSH,No
[GC7/T-TNT/RSSH/PP M&E-1/TARGET/COVERAGE] Completeness of reporting: Percentage of expected monthly reports (for the reporting period) that are actually received,tEuFv4s4KIw,GC7/T-TNT/TARGET/RSSH/PP M&E-1/TARGET/COVERAGE,GC7/T-TNT/TARGET/RSSH/PP M&E-1/TARGET/COVERAGE,Completeness of reporting: Percentage of expected monthly reports (for the reporting period) that are actually received,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,RSSH,No
[GC7/T-TNT/RSSH/PP M&E-2/COMMENT/COVERAGE] Timeliness of reporting: Percentage of submitted monthly reports (for the reporting period) that are received on time per the national guidelines,Av5iFYT9zUy,GC7/T-TNT/COMMENT/RSSH/PP M&E-2/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/RSSH/PP M&E-2/COMMENT/COVERAGE,Timeliness of reporting: Percentage of submitted monthly reports (for the reporting period) that are received on time per the national guidelines,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,RSSH,No
[GC7/T-TNT/RSSH/PP M&E-2/RESULT/COVERAGE] Timeliness of reporting: Percentage of submitted monthly reports (for the reporting period) that are received on time per the national guidelines,JVoDMiDspat,GC7/T-TNT/RESULT/RSSH/PP M&E-2/RESULT/COVERAGE,GC7/T-TNT/RESULT/RSSH/PP M&E-2/RESULT/COVERAGE,Timeliness of reporting: Percentage of submitted monthly reports (for the reporting period) that are received on time per the national guidelines,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,RSSH,No
[GC7/T-TNT/RSSH/PP M&E-2/TARGET/COVERAGE] Timeliness of reporting: Percentage of submitted monthly reports (for the reporting period) that are received on time per the national guidelines,lCaUb0zf9x5,GC7/T-TNT/TARGET/RSSH/PP M&E-2/TARGET/COVERAGE,GC7/T-TNT/TARGET/RSSH/PP M&E-2/TARGET/COVERAGE,Timeliness of reporting: Percentage of submitted monthly reports (for the reporting period) that are received on time per the national guidelines,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,RSSH,No
[GC7/T-TNT/RSSH/PP O-1/COMMENT/OUTCOME] Systems readiness index for CHWs,jiW0qayQxSK,GC7/T-TNT/COMMENT/RSSH/PP O-1/COMMENT/OUTCOME,GC7/T-TNT/COMMENT/RSSH/PP O-1/COMMENT/OUTCOME,Systems readiness index for CHWs,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,RSSH,No
[GC7/T-TNT/RSSH/PP O-1/RESULT/OUTCOME] Systems readiness index for CHWs,WPNuVB4UmPb,GC7/T-TNT/RESULT/RSSH/PP O-1/RESULT/OUTCOME,GC7/T-TNT/RESULT/RSSH/PP O-1/RESULT/OUTCOME,Systems readiness index for CHWs,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Result,RSSH,No
[GC7/T-TNT/RSSH/PP O-1/TARGET/OUTCOME] Systems readiness index for CHWs,EaAMBIrlymG,GC7/T-TNT/TARGET/RSSH/PP O-1/TARGET/OUTCOME,GC7/T-TNT/TARGET/RSSH/PP O-1/TARGET/OUTCOME,Systems readiness index for CHWs,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Target,RSSH,No
[GC7/T-TNT/Rifapentine/isoniazid 300/300mgs-AMC/RESULT/COMMODITIES] Rifapentine/isoniazid 300/300mgs AMC,VHjmDZfO4zp,GC7/T-TNT/Rifapentine/isoniazid 300/300mgs-AMC/RES,GC7/T-TNT/Rifapentine/isoniazid 300/300mgs-AMC/RES,Rifapentine/isoniazid 300/300mgs AMC,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/Rifapentine/isoniazid 300/300mgs-BAL/RESULT/COMMODITIES] Rifapentine/isoniazid 300/300mgs Ending Balance,p9qxV4kdw0U,GC7/T-TNT/Rifapentine/isoniazid 300/300mgs-BAL/RES,GC7/T-TNT/Rifapentine/isoniazid 300/300mgs-BAL/RES,Rifapentine/isoniazid 300/300mgs Ending Balance,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/Rifapentine/isoniazid 300/300mgs-PROC/RESULT/COMMODITIES] Rifapentine/isoniazid 300/300mgs Under Procurement,GZlpYWUUQOA,GC7/T-TNT/Rifapentine/isoniazid 300/300mgs-PROC/RE,GC7/T-TNT/Rifapentine/isoniazid 300/300mgs-PROC/RE,Rifapentine/isoniazid 300/300mgs Under Procurement,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/Rifapentine/isoniazid 300/300mgs-SOR-D/RESULT/COMMODITIES] Rifapentine/isoniazid 300/300mgs SOR - Denominator,Nrev8UFxKSS,GC7/T-TNT/Rifapentine/isoniazid 300/300mgs-SOR-D/R,GC7/T-TNT/Rifapentine/isoniazid 300/300mgs-SOR-D/R,Rifapentine/isoniazid 300/300mgs SOR - Denominator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/Rifapentine/isoniazid 300/300mgs-SOR-N/RESULT/COMMODITIES] Rifapentine/isoniazid 300/300mgs SOR - Numerator,bnuG4zctJEb,GC7/T-TNT/Rifapentine/isoniazid 300/300mgs-SOR-N/R,GC7/T-TNT/Rifapentine/isoniazid 300/300mgs-SOR-N/R,Rifapentine/isoniazid 300/300mgs SOR - Numerator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/Rifapentine/isoniazid 300/300mgs/COMMENT/COMMODITIES] Rifapentine/isoniazid 300/300mgs Comments,pYYCnl2T3Pd,GC7/T-TNT/Rifapentine/isoniazid 300/300mgs/COMMENT,GC7/T-TNT/Rifapentine/isoniazid 300/300mgs/COMMENT,Rifapentine/isoniazid 300/300mgs Comments,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Products,Comment,,No
"[GC7/T-TNT/TB I-2/COMMENT/IMPACT] TB incidence rate per 100,000 population",ftoxaP1yabr,GC7/T-TNT/COMMENT/TB I-2/COMMENT/IMPACT,GC7/T-TNT/COMMENT/TB I-2/COMMENT/IMPACT,"TB incidence rate per 100,000 population",LONG_TEXT,AGGREGATE,LONG_TEXT,,Inverse,bjDvmb4bfuf,Program,Comment,Impact,No
"[GC7/T-TNT/TB I-2/RESULT/IMPACT] TB incidence rate per 100,000 population",uH4gviGpQkW,GC7/T-TNT/RESULT/TB I-2/RESULT/IMPACT,GC7/T-TNT/RESULT/TB I-2/RESULT/IMPACT,"TB incidence rate per 100,000 population",NUMBER,AGGREGATE,NUMBER,,Inverse,bjDvmb4bfuf,Program,Result,Impact,No
"[GC7/T-TNT/TB I-2/TARGET/IMPACT] TB incidence rate per 100,000 population",uUhaLkSVCyJ,GC7/T-TNT/TARGET/TB I-2/TARGET/IMPACT,GC7/T-TNT/TARGET/TB I-2/TARGET/IMPACT,"TB incidence rate per 100,000 population",NUMBER,AGGREGATE,NUMBER,,Inverse,bjDvmb4bfuf,Program,Target,Impact,No
"[GC7/T-TNT/TB I-3/COMMENT/IMPACT] TB mortality rate per 100,000 population",XFar3phwWAG,GC7/T-TNT/COMMENT/TB I-3/COMMENT/IMPACT,GC7/T-TNT/COMMENT/TB I-3/COMMENT/IMPACT,"TB mortality rate per 100,000 population",LONG_TEXT,AGGREGATE,LONG_TEXT,,Inverse,bjDvmb4bfuf,Program,Comment,Impact,No
"[GC7/T-TNT/TB I-3/RESULT/IMPACT] TB mortality rate per 100,000 population",XeXgPBTA1T4,GC7/T-TNT/RESULT/TB I-3/RESULT/IMPACT,GC7/T-TNT/RESULT/TB I-3/RESULT/IMPACT,"TB mortality rate per 100,000 population",NUMBER,AGGREGATE,NUMBER,,Inverse,bjDvmb4bfuf,Program,Result,Impact,No
"[GC7/T-TNT/TB I-3/TARGET/IMPACT] TB mortality rate per 100,000 population",BCcaax1X8li,GC7/T-TNT/TARGET/TB I-3/TARGET/IMPACT,GC7/T-TNT/TARGET/TB I-3/TARGET/IMPACT,"TB mortality rate per 100,000 population",NUMBER,AGGREGATE,NUMBER,,Inverse,bjDvmb4bfuf,Program,Target,Impact,No
[GC7/T-TNT/TB LAM-AMC/RESULT/COMMODITIES] TB LAM AMC,bx7v0JFvJag,GC7/T-TNT/TB LAM-AMC/RESULT/COMMODITIES,GC7/T-TNT/TB LAM-AMC/RESULT/COMMODITIES,TB LAM AMC,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/TB LAM-BAL/RESULT/COMMODITIES] TB LAM Ending Balance,XlL3mqz3mP1,GC7/T-TNT/TB LAM-BAL/RESULT/COMMODITIES,GC7/T-TNT/TB LAM-BAL/RESULT/COMMODITIES,TB LAM Ending Balance,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/TB LAM-COMMENT/COMMENT/COMMODITIES] TB LAM Comments,I5nyM7PyTS5,GC7/T-TNT/TB LAM-COMMENT/COMMENT/COMMODITIES,GC7/T-TNT/TB LAM-COMMENT/COMMENT/COMMODITIES,TB LAM Comments,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Products,Comment,,No
[GC7/T-TNT/TB LAM-PROC/RESULT/COMMODITIES] TB LAM Under Procurement,q5o2WFVHmls,GC7/T-TNT/TB LAM-PROC/RESULT/COMMODITIES,GC7/T-TNT/TB LAM-PROC/RESULT/COMMODITIES,TB LAM Under Procurement,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/TB LAM-SOR-D/RESULT/COMMODITIES] TB LAM SOR - Denominator,Jy8Mokzg20M,GC7/T-TNT/TB LAM-SOR-D/RESULT/COMMODITIES,GC7/T-TNT/TB LAM-SOR-D/RESULT/COMMODITIES,TB LAM SOR - Denominator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/TB LAM-SOR-N/RESULT/COMMODITIES] TB LAM SOR - Numerator,XzPNrGAKLXx,GC7/T-TNT/TB LAM-SOR-N/RESULT/COMMODITIES,GC7/T-TNT/TB LAM-SOR-N/RESULT/COMMODITIES,TB LAM SOR - Numerator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
"[GC7/T-TNT/TB O - 1 Other 1/COMMENT/OUTCOME] Number of patients under 15yrs with all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB",lkMlJILVhFB,GC7/T-TNT/COMMENT/TB O - 1 Other 1/COMMENT/OUTCOME,GC7/T-TNT/COMMENT/TB O - 1 Other 1/COMMENT/OUTCOME,"Number of patients under 15yrs with all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB",LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Outcome,No
"[GC7/T-TNT/TB O - 1 Other 1/RESULT/OUTCOME] Number of patients under 15yrs with all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB",vKHAH1ZZhoJ,GC7/T-TNT/RESULT/TB O - 1 Other 1/RESULT/OUTCOME,GC7/T-TNT/RESULT/TB O - 1 Other 1/RESULT/OUTCOME,"Number of patients under 15yrs with all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB",NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Result,Outcome,No
"[GC7/T-TNT/TB O - 1 Other 1/TARGET/OUTCOME] Number of patients under 15yrs with all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB",xa9X9NdNqP8,GC7/T-TNT/TARGET/TB O - 1 Other 1/TARGET/OUTCOME,GC7/T-TNT/TARGET/TB O - 1 Other 1/TARGET/OUTCOME,"Number of patients under 15yrs with all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB",NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Target,Outcome,No
"[GC7/T-TNT/TB O - 1 Other 2/COMMENT/OUTCOME] Number of female patients with all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB",GV7RnsKEGWk,GC7/T-TNT/COMMENT/TB O - 1 Other 2/COMMENT/OUTCOME,GC7/T-TNT/COMMENT/TB O - 1 Other 2/COMMENT/OUTCOME,"Number of female patients with all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB",LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Outcome,No
"[GC7/T-TNT/TB O - 1 Other 2/RESULT/OUTCOME] Number of female patients with all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB",g3SGPHlIpHC,GC7/T-TNT/RESULT/TB O - 1 Other 2/RESULT/OUTCOME,GC7/T-TNT/RESULT/TB O - 1 Other 2/RESULT/OUTCOME,"Number of female patients with all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB",NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Result,Outcome,No
"[GC7/T-TNT/TB O - 1 Other 2/TARGET/OUTCOME] Number of female patients with all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB",TZE2N8U80zu,GC7/T-TNT/TARGET/TB O - 1 Other 2/TARGET/OUTCOME,GC7/T-TNT/TARGET/TB O - 1 Other 2/TARGET/OUTCOME,"Number of female patients with all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB",NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Target,Outcome,No
[GC7/T-TNT/TB O-5/COMMENT/OUTCOME] TB treatment coverage: Percentage of patients with new and relapse TB that were notified and treated among the estimated number of incident TB in the same year (all forms of TB - bacteriologicall,eKsbzz1K4vP,GC7/T-TNT/COMMENT/TB O-5/COMMENT/OUTCOME,GC7/T-TNT/COMMENT/TB O-5/COMMENT/OUTCOME,TB treatment coverage: Percentage of patients with new and relapse TB that were notified and treated among the estimated number of incident TB in the same year (all forms of TB - bacteriologically confirmed plus clinically diagnosed,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Outcome,No
[GC7/T-TNT/TB O-5/RESULT/OUTCOME] TB treatment coverage: Percentage of patients with new and relapse TB that were notified and treated among the estimated number of incident TB in the same year (all forms of TB - bacteriologically,rPDcCZCHPmV,GC7/T-TNT/RESULT/TB O-5/RESULT/OUTCOME,GC7/T-TNT/RESULT/TB O-5/RESULT/OUTCOME,TB treatment coverage: Percentage of patients with new and relapse TB that were notified and treated among the estimated number of incident TB in the same year (all forms of TB - bacteriologically confirmed plus clinically diagnosed,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Result,Outcome,No
[GC7/T-TNT/TB O-5/TARGET/OUTCOME] TB treatment coverage: Percentage of patients with new and relapse TB that were notified and treated among the estimated number of incident TB in the same year (all forms of TB - bacteriologically,Ov2jMnDmDAW,GC7/T-TNT/TARGET/TB O-5/TARGET/OUTCOME,GC7/T-TNT/TARGET/TB O-5/TARGET/OUTCOME,TB treatment coverage: Percentage of patients with new and relapse TB that were notified and treated among the estimated number of incident TB in the same year (all forms of TB - bacteriologically confirmed plus clinically diagnosed,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Target,Outcome,No
[GC7/T-TNT/TB O-7/COMMENT/OUTCOME] Percentage of people diagnosed with TB who experienced self-stigma that inhibited them from seeking and accessing TB services,LiLFZPf8ukW,GC7/T-TNT/COMMENT/TB O-7/COMMENT/OUTCOME,GC7/T-TNT/COMMENT/TB O-7/COMMENT/OUTCOME,Percentage of people diagnosed with TB who experienced self-stigma that inhibited them from seeking and accessing TB services,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Outcome,No
[GC7/T-TNT/TB O-7/RESULT/OUTCOME] Percentage of people diagnosed with TB who experienced self-stigma that inhibited them from seeking and accessing TB services,wkgcffMK0zr,GC7/T-TNT/RESULT/TB O-7/RESULT/OUTCOME,GC7/T-TNT/RESULT/TB O-7/RESULT/OUTCOME,Percentage of people diagnosed with TB who experienced self-stigma that inhibited them from seeking and accessing TB services,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Outcome,No
[GC7/T-TNT/TB O-7/TARGET/OUTCOME] Percentage of people diagnosed with TB who experienced self-stigma that inhibited them from seeking and accessing TB services,K8DZHi0f6KI,GC7/T-TNT/TARGET/TB O-7/TARGET/OUTCOME,GC7/T-TNT/TARGET/TB O-7/TARGET/OUTCOME,Percentage of people diagnosed with TB who experienced self-stigma that inhibited them from seeking and accessing TB services,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Outcome,No
[GC7/T-TNT/TB O-8/COMMENT/OUTCOME] Percentage of people diagnosed with TB who report stigma in health care settings that inhibited them from seeking and accessing TB services,u4sJJxiRq3P,GC7/T-TNT/COMMENT/TB O-8/COMMENT/OUTCOME,GC7/T-TNT/COMMENT/TB O-8/COMMENT/OUTCOME,Percentage of people diagnosed with TB who report stigma in health care settings that inhibited them from seeking and accessing TB services,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Outcome,No
[GC7/T-TNT/TB O-8/RESULT/OUTCOME] Percentage of people diagnosed with TB who report stigma in health care settings that inhibited them from seeking and accessing TB services,ADdDXcsFhPm,GC7/T-TNT/RESULT/TB O-8/RESULT/OUTCOME,GC7/T-TNT/RESULT/TB O-8/RESULT/OUTCOME,Percentage of people diagnosed with TB who report stigma in health care settings that inhibited them from seeking and accessing TB services,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Outcome,No
[GC7/T-TNT/TB O-8/TARGET/OUTCOME] Percentage of people diagnosed with TB who report stigma in health care settings that inhibited them from seeking and accessing TB services,wBFCk8yjpCC,GC7/T-TNT/TARGET/TB O-8/TARGET/OUTCOME,GC7/T-TNT/TARGET/TB O-8/TARGET/OUTCOME,Percentage of people diagnosed with TB who report stigma in health care settings that inhibited them from seeking and accessing TB services,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Outcome,No
[GC7/T-TNT/TB Patient Packs-AMC/RESULT/COMMODITIES] TB Patient Packs AMC,YlK7XUQd0Yr,GC7/T-TNT/TB Patient Packs-AMC/RESULT/COMMODITIES,GC7/T-TNT/TB Patient Packs-AMC/RESULT/COMMODITIES,TB Patient Packs AMC,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/TB Patient Packs-BAL/RESULT/COMMODITIES] TB Patient Packs Ending Balance,Ij5Xf8Eidhz,GC7/T-TNT/TB Patient Packs-BAL/RESULT/COMMODITIES,GC7/T-TNT/TB Patient Packs-BAL/RESULT/COMMODITIES,TB Patient Packs Ending Balance,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/TB Patient Packs-COMMENT/COMMENT/COMMODITIES] TB Patient Packs Comments,iu8Qg8YGSY7,GC7/T-TNT/TB Patient Packs-COMMENT/COMMENT/COMMODI,GC7/T-TNT/TB Patient Packs-COMMENT/COMMENT/COMMODI,TB Patient Packs Comments,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Products,Comment,,No
[GC7/T-TNT/TB Patient Packs-PROC/RESULT/COMMODITIES] TB Patient Packs Under Procurement,Qhid8BGw5CG,GC7/T-TNT/TB Patient Packs-PROC/RESULT/COMMODITIES,GC7/T-TNT/TB Patient Packs-PROC/RESULT/COMMODITIES,TB Patient Packs Under Procurement,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/TB Patient Packs-SOR-D/RESULT/COMMODITIES] TB Patient Packs SOR - Denominator,BOExZbi7euB,GC7/T-TNT/TB Patient Packs-SOR-D/RESULT/COMMODITIE,GC7/T-TNT/TB Patient Packs-SOR-D/RESULT/COMMODITIE,TB Patient Packs SOR - Denominator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/TB Patient Packs-SOR-N/RESULT/COMMODITIES] TB Patient Packs SOR - Numerator,QSVFGjkkt9J,GC7/T-TNT/TB Patient Packs-SOR-N/RESULT/COMMODITIE,GC7/T-TNT/TB Patient Packs-SOR-N/RESULT/COMMODITIE,TB Patient Packs SOR - Numerator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
"[GC7/T-TNT/TB/HIV I-1/COMMENT/IMPACT] TB/HIV mortality rate per 100,000 population",pbdVBbrGKYL,GC7/T-TNT/COMMENT/TB/HIV I-1/COMMENT/IMPACT,GC7/T-TNT/COMMENT/TB/HIV I-1/COMMENT/IMPACT,"TB/HIV mortality rate per 100,000 population",LONG_TEXT,AGGREGATE,LONG_TEXT,,Inverse,bjDvmb4bfuf,Program,Comment,Impact,No
"[GC7/T-TNT/TB/HIV I-1/RESULT/IMPACT] TB/HIV mortality rate per 100,000 population",Oy7y4ZCDk3F,GC7/T-TNT/RESULT/TB/HIV I-1/RESULT/IMPACT,GC7/T-TNT/RESULT/TB/HIV I-1/RESULT/IMPACT,"TB/HIV mortality rate per 100,000 population",NUMBER,AGGREGATE,NUMBER,,Inverse,bjDvmb4bfuf,Program,Result,Impact,No
"[GC7/T-TNT/TB/HIV I-1/TARGET/IMPACT] TB/HIV mortality rate per 100,000 population",fPF0YxlVgAL,GC7/T-TNT/TARGET/TB/HIV I-1/TARGET/IMPACT,GC7/T-TNT/TARGET/TB/HIV I-1/TARGET/IMPACT,"TB/HIV mortality rate per 100,000 population",NUMBER,AGGREGATE,NUMBER,,Inverse,bjDvmb4bfuf,Program,Target,Impact,No
[GC7/T-TNT/TB/HIV-5/COMMENT/COVERAGE] Percentage of registered new and relapse TB patients with documented HIV status,idQGKFxMJFI,GC7/T-TNT/COMMENT/TB/HIV-5/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/TB/HIV-5/COMMENT/COVERAGE,Percentage of registered new and relapse TB patients with documented HIV status,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/T-TNT/TB/HIV-5/RESULT/COVERAGE] Percentage of registered new and relapse TB patients with documented HIV status,POmdrt4JICp,GC7/T-TNT/RESULT/TB/HIV-5/RESULT/COVERAGE,GC7/T-TNT/RESULT/TB/HIV-5/RESULT/COVERAGE,Percentage of registered new and relapse TB patients with documented HIV status,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/T-TNT/TB/HIV-5/TARGET/COVERAGE] Percentage of registered new and relapse TB patients with documented HIV status,jug2v1nkCrd,GC7/T-TNT/TARGET/TB/HIV-5/TARGET/COVERAGE,GC7/T-TNT/TARGET/TB/HIV-5/TARGET/COVERAGE,Percentage of registered new and relapse TB patients with documented HIV status,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/T-TNT/TB/HIV-6/COMMENT/COVERAGE] Percentage of HIV-positive new and relapse TB patients on ART during TB treatment,LiolroIInFp,GC7/T-TNT/COMMENT/TB/HIV-6/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/TB/HIV-6/COMMENT/COVERAGE,Percentage of HIV-positive new and relapse TB patients on ART during TB treatment,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/T-TNT/TB/HIV-6/RESULT/COVERAGE] Percentage of HIV-positive new and relapse TB patients on ART during TB treatment,VBfTm6a5OTH,GC7/T-TNT/RESULT/TB/HIV-6/RESULT/COVERAGE,GC7/T-TNT/RESULT/TB/HIV-6/RESULT/COVERAGE,Percentage of HIV-positive new and relapse TB patients on ART during TB treatment,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/T-TNT/TB/HIV-6/TARGET/COVERAGE] Percentage of HIV-positive new and relapse TB patients on ART during TB treatment,KJ7DfbsjWw6,GC7/T-TNT/TARGET/TB/HIV-6/TARGET/COVERAGE,GC7/T-TNT/TARGET/TB/HIV-6/TARGET/COVERAGE,Percentage of HIV-positive new and relapse TB patients on ART during TB treatment,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Coverage,No
"[GC7/T-TNT/TBC-1/COMMENT/COVERAGE] Treatment Success Rate in private sector: Percentage of TB patients (all forms) bacteriologically confirmed plus clinically diagnosed, successfully treated in the private sector",pS6QyS2JHlG,GC7/T-TNT/COMMENT/TBC-1/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/TBC-1/COMMENT/COVERAGE,"Treatment Success Rate in private sector: Percentage of TB patients (all forms) bacteriologically confirmed plus clinically diagnosed, successfully treated in the private sector",LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
"[GC7/T-TNT/TBC-1/RESULT/COVERAGE] Treatment Success Rate in private sector: Percentage of TB patients (all forms) bacteriologically confirmed plus clinically diagnosed, successfully treated in the private sector",DUVeTZMSIiw,GC7/T-TNT/RESULT/TBC-1/RESULT/COVERAGE,GC7/T-TNT/RESULT/TBC-1/RESULT/COVERAGE,"Treatment Success Rate in private sector: Percentage of TB patients (all forms) bacteriologically confirmed plus clinically diagnosed, successfully treated in the private sector",NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Coverage,No
"[GC7/T-TNT/TBC-1/TARGET/COVERAGE] Treatment Success Rate in private sector: Percentage of TB patients (all forms) bacteriologically confirmed plus clinically diagnosed, successfully treated in the private sector",PwRYqsPb6bU,GC7/T-TNT/TARGET/TBC-1/TARGET/COVERAGE,GC7/T-TNT/TARGET/TBC-1/TARGET/COVERAGE,"Treatment Success Rate in private sector: Percentage of TB patients (all forms) bacteriologically confirmed plus clinically diagnosed, successfully treated in the private sector",NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Coverage,No
"[GC7/T-TNT/TBDT-1/COMMENT/COVERAGE] Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB",Rp5WHZseaS3,GC7/T-TNT/COMMENT/TBDT-1/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/TBDT-1/COMMENT/COVERAGE,"Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB",LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
"[GC7/T-TNT/TBDT-1/RESULT/COVERAGE] Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB",af2kyyGFjMe,GC7/T-TNT/RESULT/TBDT-1/RESULT/COVERAGE,GC7/T-TNT/RESULT/TBDT-1/RESULT/COVERAGE,"Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB",NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Result,Coverage,No
"[GC7/T-TNT/TBDT-1/TARGET/COVERAGE] Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB",JmVn9fzCBTi,GC7/T-TNT/TARGET/TBDT-1/TARGET/COVERAGE,GC7/T-TNT/TARGET/TBDT-1/TARGET/COVERAGE,"Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB",NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Target,Coverage,No
"[GC7/T-TNT/TBDT-2/COMMENT/COVERAGE] Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among",XAQm2PM5uoV,GC7/T-TNT/COMMENT/TBDT-2/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/TBDT-2/COMMENT/COVERAGE,"Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB",LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
"[GC7/T-TNT/TBDT-2/RESULT/COVERAGE] Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among ",mpf50epYV9t,GC7/T-TNT/RESULT/TBDT-2/RESULT/COVERAGE,GC7/T-TNT/RESULT/TBDT-2/RESULT/COVERAGE,"Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB",NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Coverage,No
"[GC7/T-TNT/TBDT-2/TARGET/COVERAGE] Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among ",AM37pSKfXSb,GC7/T-TNT/TARGET/TBDT-2/TARGET/COVERAGE,GC7/T-TNT/TARGET/TBDT-2/TARGET/COVERAGE,"Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB",NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Coverage,No
"[GC7/T-TNT/TBDT-3a/COMMENT/COVERAGE] Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- private/non-governmental facili",lbrHi9nSyT7,GC7/T-TNT/COMMENT/TBDT-3a/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/TBDT-3a/COMMENT/COVERAGE,"Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- private/non-governmental facilities; *includes only those with new and relapse TB",LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
"[GC7/T-TNT/TBDT-3a/RESULT/COVERAGE] Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- private/non-governmental facilit",OYwf35yMvgr,GC7/T-TNT/RESULT/TBDT-3a/RESULT/COVERAGE,GC7/T-TNT/RESULT/TBDT-3a/RESULT/COVERAGE,"Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- private/non-governmental facilities; *includes only those with new and relapse TB",NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Coverage,No
"[GC7/T-TNT/TBDT-3a/TARGET/COVERAGE] Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- private/non-governmental facilit",E9WPdMRZWcT,GC7/T-TNT/TARGET/TBDT-3a/TARGET/COVERAGE,GC7/T-TNT/TARGET/TBDT-3a/TARGET/COVERAGE,"Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- private/non-governmental facilities; *includes only those with new and relapse TB",NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Coverage,No
"[GC7/T-TNT/TBDT-3c/COMMENT/COVERAGE] Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes ",Uw6yQNryKT5,GC7/T-TNT/COMMENT/TBDT-3c/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/TBDT-3c/COMMENT/COVERAGE,"Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes only those with new and relapse TB",LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
"[GC7/T-TNT/TBDT-3c/RESULT/COVERAGE] Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes o",zGhKchRJmsq,GC7/T-TNT/RESULT/TBDT-3c/RESULT/COVERAGE,GC7/T-TNT/RESULT/TBDT-3c/RESULT/COVERAGE,"Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes only those with new and relapse TB",NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Coverage,No
"[GC7/T-TNT/TBDT-3c/TARGET/COVERAGE] Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes o",ENs2444TSDP,GC7/T-TNT/TARGET/TBDT-3c/TARGET/COVERAGE,GC7/T-TNT/TARGET/TBDT-3c/TARGET/COVERAGE,"Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes only those with new and relapse TB",NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/T-TNT/TBDT-4/COMMENT/COVERAGE] Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis,OU2L8fARHAM,GC7/T-TNT/COMMENT/TBDT-4/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/TBDT-4/COMMENT/COVERAGE,Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/T-TNT/TBDT-4/RESULT/COVERAGE] Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis,m4c77hUkSov,GC7/T-TNT/RESULT/TBDT-4/RESULT/COVERAGE,GC7/T-TNT/RESULT/TBDT-4/RESULT/COVERAGE,Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/T-TNT/TBDT-4/TARGET/COVERAGE] Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis,DoiVt5TOy4M,GC7/T-TNT/TARGET/TBDT-4/TARGET/COVERAGE,GC7/T-TNT/TARGET/TBDT-4/TARGET/COVERAGE,Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis,NUMBER,AGGREGATE,PERCENTAGE,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/T-TNT/TBP-1/COMMENT/COVERAGE] Number of people in contact with TB patients who began preventive therapy,titdAqHfbQY,GC7/T-TNT/COMMENT/TBP-1/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/TBP-1/COMMENT/COVERAGE,Number of people in contact with TB patients who began preventive therapy,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Program,Comment,Coverage,No
[GC7/T-TNT/TBP-1/RESULT/COVERAGE] Number of people in contact with TB patients who began preventive therapy,frtKoyP8was,GC7/T-TNT/RESULT/TBP-1/RESULT/COVERAGE,GC7/T-TNT/RESULT/TBP-1/RESULT/COVERAGE,Number of people in contact with TB patients who began preventive therapy,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Result,Coverage,No
[GC7/T-TNT/TBP-1/TARGET/COVERAGE] Number of people in contact with TB patients who began preventive therapy,LI5zw53sMc5,GC7/T-TNT/TARGET/TBP-1/TARGET/COVERAGE,GC7/T-TNT/TARGET/TBP-1/TARGET/COVERAGE,Number of people in contact with TB patients who began preventive therapy,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Program,Target,Coverage,No
[GC7/T-TNT/Truenat-AMC/RESULT/COMMODITIES] Truenat AMC,tX4fcafej5K,GC7/T-TNT/Truenat-AMC/RESULT/COMMODITIES,GC7/T-TNT/Truenat-AMC/RESULT/COMMODITIES,Truenat AMC,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/Truenat-BAL/RESULT/COMMODITIES] Truenat Ending Balance,WVIQHcIaSr8,GC7/T-TNT/Truenat-BAL/RESULT/COMMODITIES,GC7/T-TNT/Truenat-BAL/RESULT/COMMODITIES,Truenat Ending Balance,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/Truenat-COMMENT/COMMENT/COMMODITIES] Truenat Comments,FxVOj6OTnSr,GC7/T-TNT/Truenat-COMMENT/COMMENT/COMMODITIES,GC7/T-TNT/Truenat-COMMENT/COMMENT/COMMODITIES,Truenat Comments,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Products,Comment,,No
[GC7/T-TNT/Truenat-PROC/RESULT/COMMODITIES] Truenat Under Procurement,Vh3AJfnXJdt,GC7/T-TNT/Truenat-PROC/RESULT/COMMODITIES,GC7/T-TNT/Truenat-PROC/RESULT/COMMODITIES,Truenat Under Procurement,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/Truenat-SOR-D/RESULT/COMMODITIES] Truenat SOR - Denominator,cmqgcnH3j3D,GC7/T-TNT/Truenat-SOR-D/RESULT/COMMODITIES,GC7/T-TNT/Truenat-SOR-D/RESULT/COMMODITIES,Truenat SOR - Denominator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/Truenat-SOR-N/RESULT/COMMODITIES] Truenat SOR - Numerator,MIUZsWvqsHL,GC7/T-TNT/Truenat-SOR-N/RESULT/COMMODITIES,GC7/T-TNT/Truenat-SOR-N/RESULT/COMMODITIES,Truenat SOR - Numerator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/Xpert Cartridges-AMC/RESULT/COMMODITIES] Xpert Cartridges AMC,ZU7E1lgA2L7,GC7/T-TNT/Xpert Cartridges-AMC/RESULT/COMMODITIES,GC7/T-TNT/Xpert Cartridges-AMC/RESULT/COMMODITIES,Xpert Cartridges AMC,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/Xpert Cartridges-BAL/RESULT/COMMODITIES] Xpert Cartridges Ending Balance,Leya2epLT8n,GC7/T-TNT/Xpert Cartridges-BAL/RESULT/COMMODITIES,GC7/T-TNT/Xpert Cartridges-BAL/RESULT/COMMODITIES,Xpert Cartridges Ending Balance,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/Xpert Cartridges-COMMENT/COMMENT/COMMODITIES] Xpert Cartridges Comments,vtjLeoWgoBz,GC7/T-TNT/Xpert Cartridges-COMMENT/COMMENT/COMMODI,GC7/T-TNT/Xpert Cartridges-COMMENT/COMMENT/COMMODI,Xpert Cartridges Comments,LONG_TEXT,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Products,Comment,,No
[GC7/T-TNT/Xpert Cartridges-PROC/RESULT/COMMODITIES] Xpert Cartridges Under Procurement,jZieACXqNXt,GC7/T-TNT/Xpert Cartridges-PROC/RESULT/COMMODITIES,GC7/T-TNT/Xpert Cartridges-PROC/RESULT/COMMODITIES,Xpert Cartridges Under Procurement,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/Xpert Cartridges-SOR-D/RESULT/COMMODITIES] Xpert Cartridges SOR - Denominator,COURcWLgaNx,GC7/T-TNT/Xpert Cartridges-SOR-D/RESULT/COMMODITIE,GC7/T-TNT/Xpert Cartridges-SOR-D/RESULT/COMMODITIE,Xpert Cartridges SOR - Denominator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/T-TNT/Xpert Cartridges-SOR-N/RESULT/COMMODITIES] Xpert Cartridges SOR - Numerator,XtNp66712Ss,GC7/T-TNT/Xpert Cartridges-SOR-N/RESULT/COMMODITIE,GC7/T-TNT/Xpert Cartridges-SOR-N/RESULT/COMMODITIE,Xpert Cartridges SOR - Numerator,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Products,Result,,No
[GC7/TNT-T/COMMIT/FINANCE] PR Commitments,g7T8KF8LhtL,GC7/TNT-T/COMMIT/FINANCE,GC7/TNT-T/COMMIT/FINANCE,Commitments,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/TNT-T/COMMIT/RSSH/FINANCE] PR Commitments,D4a2RAY0n92,GC7/TNT-T/COMMIT/RSSH/FINANCE,GC7/TNT-T/COMMIT/RSSH/FINANCE,Commitments,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,RSSH,No
[GC7/TNT-T/CO_FINANCE_ALLOCATION/CO-FINANCE] Total Budget Allocation,r3M120FaD26,GC7/TNT-T/CO_FINANCE_ALLOCATION/CO-FINANCE,GC7/TNT-T/CO_FINANCE_ALLOCATION/CO-FINANCE,Total Budget Allocation,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Co-financing,,,No
[GC7/TNT-T/CO_FINANCE_BUDGET/CO-FINANCE] Cumulative budget,D3DTn5H4BtJ,GC7/TNT-T/CO_FINANCE_BUDGET/CO-FINANCE,GC7/TNT-T/CO_FINANCE_BUDGET/CO-FINANCE,Cumulative budget,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Co-financing,,,No
[GC7/TNT-T/CO_FINANCE_COMMENT/CO-FINANCE] Comments,CWlJSFpktdI,GC7/TNT-T/CO_FINANCE_COMMENT/CO-FINANCE,GC7/TNT-T/CO_FINANCE_COMMENT/CO-FINANCE,Comments,NUMBER,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Co-financing,,,No
[GC7/TNT-T/CO_FINANCE_COMMIT/CO-FINANCE] Commitments,QojYJpuhMoL,GC7/TNT-T/CO_FINANCE_COMMIT/CO-FINANCE,GC7/TNT-T/CO_FINANCE_COMMIT/CO-FINANCE,Commitments,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Co-financing,,,No
[GC7/TNT-T/CO_FINANCE_EXPENSES/CO-FINANCE] Cumulative expenditure,muMVzdik2FZ,GC7/TNT-T/CO_FINANCE_EXPENSES/CO-FINANCE,GC7/TNT-T/CO_FINANCE_EXPENSES/CO-FINANCE,Cumulative expenditure,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Co-financing,,,No
[GC7/TNT-T/CO_FINANCE_OBLIG/CO-FINANCE] Obligations,m39KuW48UgX,GC7/TNT-T/CO_FINANCE_OBLIG/CO-FINANCE,GC7/TNT-T/CO_FINANCE_OBLIG/CO-FINANCE,Obligations,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Co-financing,,,No
[GC7/TNT-T/CUM_BUDGET/FINANCE] PR Cumulative Budget,GBWcHzpowNW,GC7/TNT-T/CUM_BUDGET/FINANCE,GC7/TNT-T/CUM_BUDGET/FINANCE,Cumulative Budget,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/TNT-T/CUM_BUDGET/RSSH/FINANCE] PR Cumulative Budget,pDIkch9aMjK,GC7/TNT-T/CUM_BUDGET/RSSH/FINANCE,GC7/TNT-T/CUM_BUDGET/RSSH/FINANCE,Cumulative Budget,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,RSSH,No
[GC7/TNT-T/CUM_EXP_PR/FINANCE] PR Cumulative Funds Expensed by PR,lCRlefRhPO4,GC7/TNT-T/CUM_EXP_PR/FINANCE,GC7/TNT-T/CUM_EXP_PR/FINANCE,Cumulative Funds Expensed by PR,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/TNT-T/CUM_EXP_PR/RSSH/FINANCE] PR Cumulative Funds Expensed by PR,wyJtlM39BCY,GC7/TNT-T/CUM_EXP_PR/RSSH/FINANCE,GC7/TNT-T/CUM_EXP_PR/RSSH/FINANCE,Cumulative Funds Expensed by PR,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,RSSH,No
[GC7/TNT-T/CUM_EXP_SR/FINANCE] PR Cumulative Funds Expensed by Sub Recipients,YEoeG2bXU3D,GC7/TNT-T/CUM_EXP_SR/FINANCE,GC7/TNT-T/CUM_EXP_SR/FINANCE,Cumulative Funds Expensed by Sub Recipients,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/TNT-T/CUM_EXP_SR/RSSH/FINANCE] PR Cumulative Funds Expensed by Sub Recipients,kihuggylILI,GC7/TNT-T/CUM_EXP_SR/RSSH/FINANCE,GC7/TNT-T/CUM_EXP_SR/RSSH/FINANCE,Cumulative Funds Expensed by Sub Recipients,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,RSSH,No
[GC7/TNT-T/CUM_FUNDS_DISB_PR/FINANCE] PR Cumulative Funds Disbursed to PR,eyg33xTrZp4,GC7/TNT-T/CUM_FUNDS_DISB_PR/FINANCE,GC7/TNT-T/CUM_FUNDS_DISB_PR/FINANCE,Cumulative Funds Disbursed to PR,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/TNT-T/CUM_FUNDS_DISB_PR/RSSH/FINANCE] PR Cumulative Funds Disbursed to PR,SWSIWN1D70q,GC7/TNT-T/CUM_FUNDS_DISB_PR/RSSH/FINANCE,GC7/TNT-T/CUM_FUNDS_DISB_PR/RSSH/FINANCE,Cumulative Funds Disbursed to PR,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,RSSH,No
[GC7/TNT-T/CUM_FUNDS_DISB_SR/FINANCE] PR Cumulative Funds Disbursed to Sub Recipients,KcYPovSrHNT,GC7/TNT-T/CUM_FUNDS_DISB_SR/FINANCE,GC7/TNT-T/CUM_FUNDS_DISB_SR/FINANCE,Cumulative Funds Disbursed to Sub Recipients,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/TNT-T/CUM_FUNDS_DISB_SR/RSSH/FINANCE] PR Cumulative Funds Disbursed to Sub Recipients,mzqO2sFexPX,GC7/TNT-T/CUM_FUNDS_DISB_SR/RSSH/FINANCE,GC7/TNT-T/CUM_FUNDS_DISB_SR/RSSH/FINANCE,Cumulative Funds Disbursed to Sub Recipients,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,RSSH,No
[GC7/TNT-T/CUM_SR_BUDGET/FINANCE] PR Cumulative Sub Recipients Budget Amount,XOnW8hQZZtA,GC7/TNT-T/CUM_SR_BUDGET/FINANCE,GC7/TNT-T/CUM_SR_BUDGET/FINANCE,Cumulative Sub Recipients Budget Amount,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/TNT-T/CUM_SR_BUDGET/RSSH/FINANCE] PR Cumulative Sub Recipients Budget Amount,qRq5EUKSq6R,GC7/TNT-T/CUM_SR_BUDGET/RSSH/FINANCE,GC7/TNT-T/CUM_SR_BUDGET/RSSH/FINANCE,Cumulative Sub Recipients Budget Amount,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,RSSH,No
[GC7/TNT-T/FIN_NARR/FINANCE] PR Comments,aFh9ZHEz3Pc,GC7/TNT-T/FIN_NARR/FINANCE,GC7/TNT-T/FIN_NARR/FINANCE,Comments,NUMBER,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Finance,,,No
[GC7/TNT-T/FIN_NARR/RSSH/FINANCE] PR Comments,Az9EDzy4j7t,GC7/TNT-T/FIN_NARR/RSSH/FINANCE,GC7/TNT-T/FIN_NARR/RSSH/FINANCE,Comments,NUMBER,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Finance,,RSSH,No
[GC7/TNT-T/FIN_RATING/RATING] PR Financial Rating,EJT6IRPMQFg,GC7/TNT-T/FIN_RATING/RATING,GC7/TNT-T/FIN_RATING/RATING,Financial Rating,NUMBER,AGGREGATE,TEXT,,,bjDvmb4bfuf,Rating,,,No
[GC7/TNT-T/FIN_RATING_COMMENT/RATING] PR Financial Rating Comments,ebycp1ggdr1,GC7/TNT-T/FIN_RATING_COMMENT/RATING,GC7/TNT-T/FIN_RATING_COMMENT/RATING,Financial Rating Comments,NUMBER,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Rating,,,No
[GC7/TNT-T/FIN_RATING_END/RATING] PR Financial Rating End Date,jEdz15wZuDh,GC7/TNT-T/FIN_RATING_END/RATING,GC7/TNT-T/FIN_RATING_END/RATING,Financial Rating End Date,NUMBER,AGGREGATE,DATE,,,bjDvmb4bfuf,Rating,,,No
[GC7/TNT-T/FIN_RATING_START/RATING] PR Financial Rating Start Date,ry5K9WGo7pf,GC7/TNT-T/FIN_RATING_START/RATING,GC7/TNT-T/FIN_RATING_START/RATING,Financial Rating Start Date,NUMBER,AGGREGATE,DATE,,,bjDvmb4bfuf,Rating,,,No
[GC7/TNT-T/OBLIG/FINANCE] PR Obligations,lUCId0Dea8I,GC7/TNT-T/OBLIG/FINANCE,GC7/TNT-T/OBLIG/FINANCE,Obligations,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/TNT-T/OBLIG/RSSH/FINANCE] PR Obligations,Dlms3UR5dHU,GC7/TNT-T/OBLIG/RSSH/FINANCE,GC7/TNT-T/OBLIG/RSSH/FINANCE,Obligations,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,RSSH,No
[GC7/TNT-T/POST_OUTFLOWS/FINANCE] PR Postponed Outflows,aBJAhSIJnqF,GC7/TNT-T/POST_OUTFLOWS/FINANCE,GC7/TNT-T/POST_OUTFLOWS/FINANCE,Postponed Outflows,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/TNT-T/POST_OUTFLOWS/RSSH/FINANCE] PR Postponed Outflows,zhjjQDLIHOh,GC7/TNT-T/POST_OUTFLOWS/RSSH/FINANCE,GC7/TNT-T/POST_OUTFLOWS/RSSH/FINANCE,Postponed Outflows,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,RSSH,No
[GC7/TNT-T/PROG_RATING/RATING] PR Programmatic Rating,TQhhXYVsLxn,GC7/TNT-T/PROG_RATING/RATING,GC7/TNT-T/PROG_RATING/RATING,Programmatic Rating,NUMBER,AGGREGATE,TEXT,,,bjDvmb4bfuf,Rating,,,No
[GC7/TNT-T/PROG_RATING_COMMENT/RATING] PR Programmatic Rating Comments,u78Jb8KDtfE,GC7/TNT-T/PROG_RATING_COMMENT/RATING,GC7/TNT-T/PROG_RATING_COMMENT/RATING,Programmatic Rating Comments,NUMBER,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,Rating,,,No
[GC7/TNT-T/PROG_RATING_END/RATING] PR Programmatic Rating End Date,e8oLr2JKh9G,GC7/TNT-T/PROG_RATING_END/RATING,GC7/TNT-T/PROG_RATING_END/RATING,Programmatic Rating End Date,NUMBER,AGGREGATE,DATE,,,bjDvmb4bfuf,Rating,,,No
[GC7/TNT-T/PROG_RATING_START/RATING] PR Programmatic Rating Start Date,uN83aMWwG7Z,GC7/TNT-T/PROG_RATING_START/RATING,GC7/TNT-T/PROG_RATING_START/RATING,Programmatic Rating Start Date,NUMBER,AGGREGATE,DATE,,,bjDvmb4bfuf,Rating,,,No
[GC7/TNT-T/SAVINGS/FINANCE] PR Savings,q5opsPu4oXw,GC7/TNT-T/SAVINGS/FINANCE,GC7/TNT-T/SAVINGS/FINANCE,Savings,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/TNT-T/SAVINGS/RSSH/FINANCE] PR Savings,IeZR4x6WZCJ,GC7/TNT-T/SAVINGS/RSSH/FINANCE,GC7/TNT-T/SAVINGS/RSSH/FINANCE,Savings,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,RSSH,No
[GC7/TNT-T/TOTAL_BUDGET/FINANCE] PR Total Budget,G1ZiXZN0QgZ,GC7/TNT-T/TOTAL_BUDGET/FINANCE,GC7/TNT-T/TOTAL_BUDGET/FINANCE,Total Budget,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/TNT-T/TOTAL_BUDGET/RSSH/FINANCE] PR Total Budget,qdgZQg4WNHn,GC7/TNT-T/TOTAL_BUDGET/RSSH/FINANCE,GC7/TNT-T/TOTAL_BUDGET/RSSH/FINANCE,Total Budget,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,RSSH,No
[GC7/TNT-T/TOTAL_SR_BUDGET/FINANCE] PR Total Sub Recipients Budget Amount,HOcqPH4f8TO,GC7/TNT-T/TOTAL_SR_BUDGET/FINANCE,GC7/TNT-T/TOTAL_SR_BUDGET/FINANCE,Total Sub Recipients Budget Amount,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,,No
[GC7/TNT-T/TOTAL_SR_BUDGET/RSSH/FINANCE] PR Total Sub Recipients Budget Amount,FZedWY3haac,GC7/TNT-T/TOTAL_SR_BUDGET/RSSH/FINANCE,GC7/TNT-T/TOTAL_SR_BUDGET/RSSH/FINANCE,Total Sub Recipients Budget Amount,NUMBER,AGGREGATE,NUMBER,,,bjDvmb4bfuf,Finance,,RSSH,No
FIN: SR Commitments,fXaAQE6czud,SR_COMMIT,SR Commitments,SR Commitments,SR Commitments,AGGREGATE,NUMBER,,,bjDvmb4bfuf,,,,No
FIN: SR Cumulative budget,TTtHXtzK3cj,SR_GRANT_BUDGET,FIN: SR Cumulative budget,SR Cumulative budget,SR Cumulative budget,AGGREGATE,NUMBER,,,bjDvmb4bfuf,,,,No
FIN: SR Cumulative funds disbursed to SR by the PR,D0VwIokse5N,SR_DISRBURSE,SR Cumulative funds disbursed to SR,SR Cumulative funds disbursed to SR,SR Cumulative funds disbursed to SR,AGGREGATE,NUMBER,,,bjDvmb4bfuf,,,,No
FIN: SR Cumulative funds expensed by SR,YMW1iITg7sf,SR_EXPENSE,Cumulative funds expensed by SR,SR Cumulative funds expensed by SR,SR Cumulative funds expensed by SR,AGGREGATE,NUMBER,,,bjDvmb4bfuf,,,,No
FIN: SR Narrative - Quarterly,ichIpQ8gsLU,FIN_SR_NARRATIVE_QUARTERLY,FIN: SR Narrative - Quarterly,FIN: SR Narrative - Quarterly,FIN: SR Narrative - Quarterly,AGGREGATE,LONG_TEXT,,,bjDvmb4bfuf,,,,No
FIN: SR Obligations,ip1LvYW2H81,SR_OBLIG,SR Obligations,SR Obligations,SR Obligations,AGGREGATE,NUMBER,,,bjDvmb4bfuf,,,,No
FIN: SR Savings,Yu6Str2CTV9,SR_SAVING,SR Savings,SR Savings,SR Savings,AGGREGATE,NUMBER,,,bjDvmb4bfuf,,,,No
FIN: SR Total Budget,z57NxRYdObM,SR _TOTAL_BUDGET,SR Total Budget,SR Total grant budgeted amount,SR Total grant budgeted amount,AGGREGATE,NUMBER,,No,bjDvmb4bfuf,,,,No
FIN: SR postponed outflows,kCPQkJn0bT7,SR_POSTPONED_OUTFLOW,SR postponed outflows,SR postponed outflows,SR postponed outflows,AGGREGATE,NUMBER,,,bjDvmb4bfuf,,,,No
